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Abstract
Diarrheal diseases are a major global public health threat. The Gram-negative bacterial pathogen
Salmonella enterica serovar Typhimurium causes diarrheal disease in humans. Immune responses to
Salmonella have been extensively studied in mice, where it causes a systemic typhoid-like disease, but
our understanding of the human innate immune responses to Salmonella remain limited. Salmonella uses
molecular syringe-like machinery called type III secretion systems (T3SS) to inject effectors into the host
cell cytosol. These T3SSs enable Salmonella to invade and replicate within host cells such as intestinal
epithelial cells (IECs) and macrophages. It is therefore critical to understand how IECs and macrophages,
which serve both as targets of infection by Salmonella, as well as the first line of defense against invading
enteric pathogens, are sensing and responding to infection. Host cells can recognize T3SS components
via cytosolic receptors termed inflammasomes. One such inflammasome, called the NAIP/NLRC4
inflammasome, recognizes bacterial T3SS components and flagellin. Inflammasome activation leads to
proinflammatory cytokine release and cell death, alerting nearby cells of the infection and eliminating the
pathogen’s replicative niche. In mice, Salmonella infection triggers activation of the NAIP/NLRC4
inflammasome and this response is critical for protecting mice from Salmonella. In this dissertation, we
investigated inflammasome responses to Salmonella in human macrophages and IECs. We found that
like mice, the NAIP/NLRC4 inflammasome in human macrophages is activated upon Salmonella
infection. Two additional inflammasomes, the NLRP3 and CASP4/5 inflammasomes are also activated in
human macrophages during Salmonella infection. Importantly, NAIP and NLRP3 inflammasome
activation mediates restriction of Salmonella replication in human macrophages, highlighting the
importance of these pathways in host defense. In contrast to macrophages, human IECs do not engage
the NAIP or NLRP3 inflammasome pathways. Instead, human IECs partially require caspase-1 and
absolutely require caspase-4 for inflammasome responses to Salmonella infection. Our findings highlight
the cell type-specific inflammasome pathways that are activated during Salmonella infection in humans.
Importantly, we demonstrate how different the responses in human cells are compared to murine cells,
underscoring the importance of studying human-specific immune responses to infection.
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ABSTRACT
INVESTIGATING HUMAN CELL TYPE-SPECIFIC INFLAMMASOME RESPONSES TO
SALMONELLA INFECTION
Nawar Naseer
Sunny Shin
Diarrheal diseases are a major global public health threat. The Gram-negative bacterial
pathogen Salmonella enterica serovar Typhimurium causes diarrheal disease in humans.
Immune responses to Salmonella have been extensively studied in mice, where it causes a
systemic typhoid-like disease, but our understanding of the human innate immune responses to
Salmonella remain limited. Salmonella uses molecular syringe-like machinery called type III
secretion systems (T3SS) to inject effectors into the host cell cytosol. These T3SSs enable
Salmonella to invade and replicate within host cells such as intestinal epithelial cells (IECs) and
macrophages. It is therefore critical to understand how IECs and macrophages, which serve both
as targets of infection by Salmonella, as well as the first line of defense against invading enteric
pathogens, are sensing and responding to infection. Host cells can recognize T3SS components
via cytosolic receptors termed inflammasomes. One such inflammasome, called the NAIP/NLRC4
inflammasome, recognizes bacterial T3SS components and flagellin. Inflammasome activation
leads to proinflammatory cytokine release and cell death, alerting nearby cells of the infection and
eliminating the pathogen’s replicative niche. In mice, Salmonella infection triggers activation of
the NAIP/NLRC4 inflammasome and this response is critical for protecting mice from Salmonella.
In this dissertation, we investigated inflammasome responses to Salmonella in human
macrophages and IECs. We found that like mice, the NAIP/NLRC4 inflammasome in human
macrophages is activated upon Salmonella infection. Two additional inflammasomes, the NLRP3
and CASP4/5 inflammasomes are also activated in human macrophages during Salmonella
infection. Importantly, NAIP and NLRP3 inflammasome activation mediates restriction of
Salmonella replication in human macrophages, highlighting the importance of these pathways in
host defense. In contrast to macrophages, human IECs do not engage the NAIP or NLRP3
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inflammasome pathways. Instead, human IECs partially require caspase-1 and absolutely require
caspase-4 for inflammasome responses to Salmonella infection. Our findings highlight the cell
type-specific inflammasome pathways that are activated during Salmonella infection in humans.
Importantly, we demonstrate how different the responses in human cells are compared to murine
cells, underscoring the importance of studying human-specific immune responses to infection.
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CHAPTER 1: INTRODUCTION

Portions of this chapter appeared as a published peer-reviewed article titled “Effector-triggered
immunity and pathogen sensing in metazoans” by Natasha Lopes Fischer*, Nawar Naseer*,
Sunny Shin, and Igor E. Brodsky. Nature Microbiology, 2020. *indicates co-first authorship

1

Our bodies are surrounded by microorganisms; the number of microbes in our gut alone
is higher than the number of cells within our entire body (Littman & Pamer, 2011). Some of these
microbes are commensals and generally do not harm us, while others are pathogenic and can
cause disease. Our bodies must therefore distinguish between these commensal and pathogenic
microorganisms and mount appropriate immune responses.
Our first line of defense against invading pathogens are our skin and other mucosal
surfaces such as the intestinal epithelium. These surfaces provide a physical barrier to entry
against pathogens. A thick layer of mucus lining the intestine prevents commensals from
interacting with intestinal epithelial cells and underlying tissue (Littman & Pamer, 2011). Microbes
that can circumvent these barriers must contend with our innate immune system, which use a
variety of strategies to sense and respond to pathogens. While these strategies are designed to
eliminate invading pathogens, excessive inflammation can cause tissue damage and disrupt the
barrier lining, allowing commensal microbes to traverse into underlying tissue. Host immune
defenses must therefore balance controlling infection with maintaining barrier integrity.
Microbial pathogens possess an arsenal of strategies to invade their hosts, evade
immune defenses, and promote infection. For example, bacteria use virulence factors such as
secreted toxins and effector proteins to manipulate host cellular processes and establish a
replicative niche. Survival of eukaryotic organisms in the face of such microbial challenge
requires host mechanisms to detect and counteract these pathogen-specific virulence strategies.
In this dissertation, we explore one particular mechanism that mammalian host immune systems
use called inflammasomes, and the role inflammasomes play in sensing and responding to the
Gram-negative bacterial pathogen Salmonella enterica serovar Typhimurium (hereafter referred
to as Salmonella). In this Chapter, we highlight the interplay between a few different host immune
mechanisms and pathogen virulence strategies, provide an overview of Salmonella pathogenesis
and its interaction with the host immune system, and summarize the dissertation aims.
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1.1 Recognition of pathogen-associated molecular patterns (PAMPs) by
pattern recognition receptors (PRRs)
Metazoan organisms use multiple strategies to protect themselves against invading
pathogens. As originally proposed by Charles Janeway, germline-encoded pattern recognition
receptors (PRRs) sense unique microbial structures such as cell wall components, termed
pathogen-associated molecular patterns (PAMPs) (Ausubel, 2005; Janeway, 1989) (Fig. 1.1).
PRRs activate signaling pathways that lead to altered transcription of thousands of crucial
immune defense genes, including cytokines (Medzhitov & Janeway, 2002). Recognition of
PAMPs by PRRs allows the host to differentiate between self and non-self. This mechanism
serves as the first checkpoint for our immune system to determine the severity of threat posed by
a particular microbial attack (Fig. 1.2) (Blander & Sander, 2012).

Figure 1.1: PRRs represent an evolutionarily conserved mechanism to directly detect
microbial products (termed PAMPs).
PAMPs are general structural features of specific categories or classes of microorganisms. PAMP
sensing by host PRRs triggers release of inflammatory mediators from the host cell. These
mediators can, in turn, activate other cells to amplify the immune response.

1.1.1 TLR-mediated immune responses
One family of PRRs are Toll-like receptors (TLRs), which are type I transmembrane
proteins. They recognize PAMPs via ectodomains containing leucine-rich repeats and induce
downstream signaling through intracellular Toll-interleukin 1 (IL-1) receptor (TIR) domains (Kawai

3

& Akira, 2010). Humans are currently known to have 10 functional TLRs, while mice have 12.
TLR1 through TLR9 are conserved in both humans and mice. Mice do not have a functional
TLR10, and humans have lost the genes expressing TLR11, TLR12, and TLR13 (Kawai & Akira,
2010). There are two subgroups of TLRs: those expressed on the cell surface that detect
extracellular PAMPs (TLR1, TLR2, TLR4, TLR5, TLR6), and those expressed on the surface of
endolysosomal compartments that detect intracellular PAMPs (TLR3, TLR7, TLR8, TLR9, TLR11,
TLR12, TLR13). Expression of different TLRs can also vary across cell and tissue types (Broz &
Monack, 2013).
TLR2 forms heterodimers with TLR1 or TLR6 to sense lipoproteins. TLR1/TLR2 sense
triacylated lipopeptides from gram negative bacterial membranes and mycoplasma, while
TLR2/TLR6 recognize diacylated lipopeptides from gram positive bacterial membranes and
mycoplasma. TLR4, in conjunction with MD2, recognizes bacterial lipopolysaccharide (LPS), a
component of gram-negative bacterial outer membranes. LPS-binding protein (LBP) and CD14
assist in forming the TLR4-MD2-LPS complex. TLR5 senses flagellin (Kawai & Akira, 2010).
Both TLR2 heterodimers and TLR4-MD2-LPS homodimers induce NF-κB signaling by
recruiting the TIR domain containing adaptors TIRAP and MyD88. NF-κB signaling induces the
expression of inflammatory cytokines. In addition, the TLR4-MD2-LPS complex is internalized into
the endosome, where it recruits TRAM and TRIF, leading to the activation of IRF3. This leads to
late NF-κB signaling and induction of Type I IFN signaling through IRF3. TLR5 engages MyD88
and leads to downstream NF-κB signaling (Kawai & Akira, 2010).
Within the cell, endosomal TLR3 senses viral double-stranded RNA (dsRNA), TLR7
recognizes viral single-stranded RNA (ssRNA), and TLR9 detects viral and bacterial DNA (Kawai
& Akira, 2010). TLR8 can sense GU-rich ssRNA, short dsRNA, and human TLR8 can also sense
bacterial RNA (Broz & Monack, 2013). TLR11 has recently been shown to sense flagellin.
Additionally, TLR11 can form heterodimers with TLR12 to recognize profilin-like proteins from
parasites such as Toxoplasma gondii and Plasmodium falciparum. Both TLR11 and TLR12
require the protein unc-93 homolog B1 (UNC93B1) for their proper function. TLR12 homodimers
can also recognize profilin. TLR13 detects bacterial ribosomal RNA (Broz & Monack, 2013)
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TLR3 homodimers recruit TRIF, which leads to both NF-κB signaling and induction of
Type I IFN signaling through IRF3. TLR7 and TLR9 both induce downstream NF-κB signaling via
MyD88 and induction of Type I IFN signaling through IRF7. TLR12 and TLR13 recruit MyD88 and
induce downstream NF-κB signaling (Broz & Monack, 2013). Overall, TLR-mediated recognition
of PAMPs triggers signaling pathways such as NF-κB and MAPK, leading to upregulation of
cytokines and other innate immune genes.

1.1.2 NLR-mediated immune responses
Another family of PRRs are the NOD-like Receptor (NLR) family. NLRs in animals serve
as sentinels that detect pathogenic activity in the cytosol of host cells. NLRs all contain a Cterminal leucine-rich repeat (LRR) domain and nucleotide binding domains (NBD). There are
multiple subfamilies of NLRs, categorized based on their N-termini (Lamkanfi & Dixit, 2014). The
NLRC subfamily have caspase recruitment (CARD) domains at their N-termini, whereas the
NLRP subfamily have pyrin domains (PYD) (Platnich & Muruve, 2019). Humans have 22 NLRs,
while mice have at least 33 (G. Chen et al., 2009). However, the function of only a subset of
these NLRs have been extensively characterized.
Two well-characterized members of the NLR family include NOD1 and NOD2. They both
recognize distinct components of peptidoglycan, an essential constituent of both Gram-negative
and Gram-positive bacterial cell walls. NOD1/2 signaling leads to downstream activation of the
NF-κB pathway (Martinon & Tschopp, 2005). Some mammalian NLRs form inflammasome
complexes that mediate the release of IL-1 family cytokines and a type of cell death called
pyroptosis (Cookson & Brennan, 2001). Host NLRs can thus be considered guards of “cytosolic
sanctity,” as they detect pathogenic insults in the otherwise sterile environment of the host cell
cytosol (Lamkanfi & Dixit, 2009). NLRs oligomerize to form inflammasomes that recruit and
activate the cysteine protease caspase-1 (Lamkanfi & Dixit, 2014). The NLRC family, which
contains a CARD domain, can recruit caspases directly, while the NLRP family, which does not
contain a CARD domain, must interact with an adaptor protein such as apoptosis-associated
speck-like protein ASC. ASC contains both PYD and CARD domains and can thus serve as a
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bridge between NLRP family members and caspases. Caspase-1 cleaves specific substrates,
including the pro-IL-1 family cytokines IL-1β and IL-18, as well as the pore-forming protein
gasdermin D (GSDMD), thereby allowing for the subsequent release of IL-1 cytokines and
pyroptotic cell death (Lamkanfi & Dixit, 2014) (Fig. 1.2). Details about different types of
inflammasomes and their mechanism of action are discussed in later sections.

1.1.3 Recognition of vita-PAMPs
The host can distinguish between live and dead pathogens by detecting viabilityassociated PAMPs, or vita-PAMPs (Sander et al., 2011) (Fig. 1.2). Several examples of vitaPAMPs have been described for bacteria. Bacterial nucleic acids, such as mRNA and cyclic
dinucleotides, can be sensed in the host cytosol by the NLRP3 inflammasome and the sensor
stimulator of interferon genes (STING), respectively, and trigger a robust innate immune
response (Burdette et al., 2011; Sander et al., 2011). Furthermore, bacterial outer membrane
vesicles (OMVs) secreted by Gram-negative bacteria can deliver LPS into the cytosol, which can
be sensed by the inflammasome and induce pyroptotic cell death (Finethy et al., 2017; Vanaja et
al., 2016). These vita-PAMPs are produced in large quantities when bacteria replicate during an
infection, and thus can elicit a stronger response from the host than non-replicating dead
bacteria.
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Figure 1.2: Microbial threat checkpoints gauge the level of threat posed by a pathogen and
fine-tune the host immune response.
Host immune responses are tuned according to the microbial threat level. (1) Low-level threats,
such as PAMPs and dead microorganisms, lead to upregulation of cytokines and pro-survival
factors. Negative regulators—such as IL-10, suppressor of cytokine signaling (SOCS) proteins
and dual specificity phosphatases (DUSPs)—control and prevent excessive responses under
such conditions. (2) Intracellular, viable non-pathogens and vita-PAMPs (for example, bacterial
mRNA) pose a moderate level threat to the host and therefore lead to limited inflammasome
activation (i) and release of proinflammatory cytokines and IL-1 signaling with limited levels of cell
death or, in the absence of cell death, hyperactivation. The release of IL-1 cytokines is mediated
by GSDMD, which forms pores in the cell membrane. (3) Pathogens that possess secretion
systems and toxins that disrupt barrier tissues and membranes, or perturb host cellular
processes, lead to robust inflammasome activation (ii), resulting in cell lysis and release of
intracellular DAMPs (for example, HMGB1, calreticulin and ATP, together with IL-1). Notably,
both pathogenic and sterile events that alter cellular homeostasis can trigger these immune
responses. An alternative framework for thinking about these types of responses is as factors that
indicate disruption of cellular homeostasis or HAMPs. These checkpoints allow the host to
modulate the immune response based on the level of threat posed by a microorganism or other
cellular stresses.

1.2 Recognition of microbial activity
While PAMP sensing is necessary for innate immune responses to infection and innate
instruction of adaptive immunity, PRR activation is insufficient to distinguish between invasive
pathogens and commensal bacteria because both possess PAMPs; added layers of immune
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recognition must therefore be engaged to distinguish between commensals and harmful microbes
(Iwasaki & Medzhitov, 2015; Pasare & Medzhitov, 2003, 2004, 2005).

1.2.1 Recognition of DAMPs
One of the mechanisms that enable the host to specifically detect pathogens involves
sensing of host molecules that are uniquely present or altered in the presence of a bona-fide
pathogen. This mechanism includes detection of damage-associated molecular patterns
(DAMPs) that are normally located intracellularly, but are released into the extracellular milieu as
a result of microbial infection (Matzinger, 1994; Seong & Matzinger, 2004) (Fig. 1.3). DAMPs
include the nuclear protein HMGB1, ATP, and the ER protein calreticulin (Kono & Rock, 2008;
Vénéreau et al., 2015) (Fig. 1.3). The PRR and DAMP models are not mutually exclusive, and
likely both play a role in defense against microbial infections.

Figure 1.3: Host cells sense damage-associated molecular patterns (DAMPs) to detect
pathogens.
Certain intracellular molecules, termed DAMPs, are associated with damaged tissues or cells.
DAMPs are released as a consequence of microbial infection or other kinds of acute stress
stimuli. DAMPs are sensed by receptors on neighboring cells and contribute to immune
activation.
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1.2.2 Recognition of HAMPs
Another mechanism of pathogen-specific recognition is the recently proposed concept of
homeostasis-altering molecular processes (HAMPs), whereby the host detects perturbations of
central cellular processes, including manipulation of actin cytoskeleton or inappropriate ROS
production, either in the context of microbial infection or sterile inflammation (Liston & Masters,
2017). These concepts of pathogen-sensing mechanisms share the idea that appropriate
detection and clearance of pathogens requires not only sensing of microbial structures, but also
the sensing of pathogen-specific activity, allowing the host to assess the threat level and generate
appropriate responses to each threat (Blander & Sander, 2012) (Fig. 1.2).

1.2.3 Patterns of Pathogenesis
Additional mechanisms of pathogen-specific sensing involve detection of microbial
structures or pathogen-specific activities within host sites that normally exclude microbes.
Cytosolic invasion or delivery of microbe-derived molecules into the cytosol due to the activity of
pathogen-specific secretion systems has been termed “violation of cytosolic sanctity” (Lamkanfi &
Dixit, 2009). Such activities, which also include disruption of vacuolar trafficking, pathogen
replication within the cytosol, or disruption of other structures or processes such as the actin
cytoskeleton or cell-intrinsic immune signaling, constitute “patterns of pathogenesis” (Fig. 1.4)
that can be sensed by the host (Vance et al., 2009). These “patterns of pathogenesis” can be
sensed by PRRs, whereby the PAMPs are exposed to cytosolic receptors and immune defense
mechanisms that would otherwise not be engaged by non-invading microbes.
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Figure 1.4: ‘Patterns of pathogenesis’ provides an additional framework for understanding
immune sensing of microbial pathogens.
When pathogens manipulate cellular physiology to colonize the host, they provide specific signals
that enable the host to detect the pathogen. Such patterns include: (1) invasion of pathogens into
the host cell, (2) altered vacuole trafficking, (3) vacuole disruption or cytosolic escape of the
pathogen, (4) cytosolic replication of the pathogen and (5) disruption of host cellular processes by
microbial effectors.

1.2.4 Effector-triggered immunity
Pathogen sensing by means of Effector-Triggered Immunity (Chisholm et al., 2006;
Jones & Dangl, 2006), or ETI, is induced in response to the activities of pathogen virulence
factors (effectors) that are secreted during infection. These effectors modulate host cellular
processes to aid in infection and bacterial replication (Galan & Waksman, 2018). The concept of
Effector-Triggered Immunity refers to sensing of pathogen-specific virulence activities through
direct protein-protein interactions between a host target protein and a bacterial effector, or
through sensing pathogen-mediated disruption of cellular activities (Rajamuthiah & Mylonakis,
2014; Stuart et al., 3).
ETI was originally described in the setting of plant immunity in the form of the “guard
hypothesis,” which proposed that host resistance proteins “guard” cellular processes and
recognize their disruption by pathogen effectors (Dangl & Jones, 2001; Jones et al., 2016; Jones
& Dangl, 2006). The superfamily of nucleotide-binding domain, leucine-rich repeat (NLR) proteins
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is one example of plant resistance proteins that detect such disturbances (Chisholm et al., 2006;
Dangl & Jones, 2001; Jones & Dangl, 2006). The recently proposed HAMP model shares
conceptual similarity to the guard or ETI model, in that the host protein responsible for initiating a
response is sensitive to perturbances in cellular homeostasis (Fig. 1.2).
One example of NLR-mediated ETI is NOD signaling in response to pathogen modulation
of host GTPases. Targeting of host GTPases is a major virulence strategy used by pathogens to
promote infection. In particular, Rho GTPases such as Rac1, RhoA, and Cdc42, are frequently
hijacked due to their roles in various host cellular processes (Lemichez & Aktories, 2013). Rho
GTPases have essential functions in innate immunity, including regulating phagocytosis,
maintaining epithelial barrier integrity, and mediating the production of reactive oxygen species
(ROS) and antimicrobial peptides (Lemichez & Aktories, 2013). Thus, GTPases serve as key
sensors of cellular processes, due to their manipulation by a wide variety of pathogens. The
Salmonella effectors SopB, SopE, and SopE2 activate RhoGTPases and promote phagocytosis
of the bacteria into host cells. This activity leads to NF-κB signaling via NOD1, indicating that
inappropriate activation of Rho GTPases leads to induction of a host defense response (Bruno et
al., 2009; Keestra et al., 2013; H. Sun et al., 2018). Like Salmonella, the bacterial pathogen
Shigella interacts intimately with the actin cytoskeleton during invasion of intestinal epithelial cells,
but also intracellularly when it employs actin-based-motility. Shigella’s manipulation of the actin
cytoskeleton also induces NF-κB signaling via NOD1/2 (Bielig et al., 2014; Fukazawa et al., 2008;
Legrand-Poels et al., 2007). Collectively, these and other studies that link modulation of Rho
GTPase activity to NOD1/2 signaling (Eitel et al., 2008; Legrand-Poels et al., 2007) demonstrate
that actin-regulating Rho GTPases are central regulators of ETI responses and serve as
important guardians of actin cytoskeleton dynamics.

1.3 Inflammasomes – guardians of cytosolic sanctity
Inflammasomes are considered ‘guardians of cytosolic sanctity’ – they sense the
presence of PAMPs or pathogen activity in the cytosol (Lamkanfi & Dixit, 2009). Inflammasomes
therefore sit at the nexus of detection of microbial structures (e.g. detection of PAMPs), and the
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detection of microbial activity. Many inflammasomes, such as NLRP1, NLRP3, NLRP6,
NAIP/NLRC4, belong to the NLR family. Additionally, there are also NLR-independent
inflammasomes, such as the CASP4/5/11, AIM2, and Pyrin inflammasomes. Upon detection of
PAMPs or pathogen activity, these proteins form multimeric complexes that mediate downstream
processing and release of proinflammatory cytokines such as IL-1α, IL-1β, and IL-18.
Inflammasome activation also leads to an inflammatory form of cell death known as pyroptosis
(Lamkanfi & Dixit, 2014). Below, we describe the mechanism of activation of the most wellcharacterized inflammasomes (Fig. 1.5).

Figure 1.5: Pathogens that violate the ‘cytosolic sanctity’ activate inflammasomes.
(i) Excessive injection of the Yersinia translocon proteins YopB and YopD damages intracellular
endosomal membranes, leading to recruitment of GBPs and downstream activation of the
caspase-11 inflammasome. Caspase-11-induced GSDMD pores also trigger K+ efflux, thereby
secondarily activating the NLRP3 inflammasome. Yersinia suppresses this defense mechanism
by preventing hypertranslocation of YopB and YopD via another effector, YopK. (ii) The NLRP1B
inflammasome is activated by bacterial effectors such as B. anthracis LeTx or Shigella IpaH7.8,
which cleave or degrade its N terminus, respectively. (iii) Effectors, such as YopE and TcdB,
modulate the actin cytoskeleton by suppressing Rho GTPases and, consequently, trigger the
pyrin inflammasome by inactivating the PKNs, which are sensitive to GTPase activity.
Notably, Yersinia YopM overrides this sensing pathway by directly activating PKNs, thereby
maintaining pyrin suppression.

1.3.1 NLRP1 inflammasome
Bacterial pathogens produce diverse toxins and effectors that have detrimental effects on
the host. The host has evolved mechanisms to detect the activity of these bacterial products and
mount an immune response. The bacterial pathogen Bacillus anthracis produces a pore-forming
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toxin called lethal toxin (LeTx). LeTx is a bipartite toxin composed of a protective antigen (PA),
which binds to cellular receptors and forms an oligomeric pore within endosomal membranes,
and a lethal factor (LF) that is translocated through the pore. Once inside the host cell, LF cleaves
and inactivates MAPK kinases (MAPKKs), thereby disrupting innate immune signaling pathways
and triggering apoptosis (Friebe et al., 2016). Additionally, LeTx induces inflammatory cell death
in macrophages from certain strains of inbred mice, while other mouse strains are resistant to this
effect, suggesting a host-mediated mechanism of cell death (Friedlander et al., 1993) which was
mapped to polymorphisms in the Nlrp1b locus (Boyden & Dietrich, 2006).
NLRP1B is one of several members of the NLR family that assembles a caspase-1activating inflammasome complex (Martinon & Tschopp, 2005). NLRP1B contains a unique
function to find (FIIND) domain that undergoes autoproteolysis (Frew et al., 2012). While this
autoproteolysis is required for NLRP1B inflammasome activation in response to LF, the
autoprocessing of NLRP1B is independent of LF protease activity (Frew et al., 2012; Sandstrom
et al., 2019), making the mechanism of LF-dependent NLRP1B activation mysterious. Intriguingly,
recent findings revealed that upon being translated, the NLRP1B N-terminal FIIND domain
undergoes autoproteolysis, but remains non-covalently associated with the remaining C-terminal
portion of the NLRP1B protein (Okondo et al., 2018; Sandstrom et al., 2019). LF-dependent
proteolytic cleavage of the N-terminal NLRP1B fragment leads to its recognition by cellular
ubiquitin ligases, followed by its degradation via the N-end rule pathway. This releases the Cterminal portion of NLRP1B, which contains the CARD domain that recruits and activates
caspase-1 (Okondo et al., 2018; Sandstrom et al., 2019) (Fig. 1.5). Mouse strains containing
NLRP1B that is sensitive to LeTx are thus able to induce an inflammasome response to the
proteolytic activity of LF.
Interestingly, pathogen effectors that are not directly proteolytic can also activate
NLRP1B. The bacterial ubiquitin ligase IpaH7.8 is translocated via Shigella’s type III secretion
system and activates the NLRP1B inflammasome via its ubiquitin ligase activity (Frew et al.,
2012; Sandstrom et al., 2019) (Fig. 1.5). Given that LF activates the NLRP1B inflammasome by
inducing ubiquitin-dependent degradation of an auto-inhibitory fragment, it is attractive to
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speculate that NLRP1B has evolved to sense at least two distinct pathogen effector mechanisms
- proteolytic activity or ubiquitination, either of which can activate NLRP1B by causing
degradation of its auto-inhibitory fragment. Proteases or ubiquitin ligases of other pathogens may
also be sensed by this mechanism. The protozoan parasite Toxoplasma gondii also activates the
NLRP1 inflammasome in mice and rats via Toxoplasma gondii dense granule proteins (Cirelli et
al., 2014; Ewald et al., 2014; Gorfu et al., 2014; Y. Wang et al., 2019), but the mechanism of
activation is unknown.
Mice have two additional NLRP1 homologs, a functional NLRP1A and a putative
pseudogene NLRP1C, whereas humans have a single NLRP1 (Martinon & Tschopp, 2005). The
signals that engage murine NLRP1A are currently unknown. While human NLRP1 is not cleaved
or activated by lethal toxin (Moayeri et al., 2012), in vitro proteolytic cleavage of the human
NLRP1 N-terminus induces inflammasome activation, suggesting that human NLRP1 can be
activated via a similar proteolytic mechanism (Chavarría-Smith & Vance, 2013). Recently, human
NLRP1 was shown to directly bind dsRNA and therefore serves as a sensor of RNA virus
infection (Bauernfried et al., 2021). The inability of human NLRP1 to be cleaved by lethal toxin
could in part account for the susceptibility of humans to anthrax. Additionally, human NLRP1
polymorphisms are associated with a variety of autoimmune diseases, suggesting that such
mutations may destabilize human NLRP1 and induce inflammasome activation through a
cleavage or degradation mechanism analogous to murine NLRP1B (Jin et al., 2007; Zhong et al.,
2016).

1.3.2 NLRP3 and CASP4/5/11 inflammasomes
NLRP3 is activated in response to a variety of endogenous and exogenous stimuli,
leaving the specific cellular pathway or process that NLRP3 might guard unclear. A common
theme for NLRP3 activation is a drop in intracellular potassium concentration below a critical
threshold (Muñoz-Planillo et al., 2013) and/or mitochondrial dysfunction, leading to excessive
mitochondrial ROS production (Leemans et al., 2011). Whether a specific link exists between
mitoROS and potassium efflux is unclear, although NLRP3-activating stimuli that only induce
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mitoROS or potassium efflux have been reported (Iyer et al., 2013; Muñoz-Planillo et al., 2013).
Upon activation, NLRP3 recruits the adaptor protein ASC via its PYD domain. NLRP3 does not
contain its own CARD domain, and therefore requires ASC to recruit and activate caspase-1 and
mediate downstream consequences of inflammasome activation (Fig. 1.5). Recent studies also
suggest that NLRP3 activation requires NIMA-related kinase 7 (NEK7). NEK7 binds NLRP3 and
regulates NLRP3 oligomerization (Broz & Dixit, 2016). Overactivation of the NLRP3
inflammasome can lead to cryopyrin-associated periodic fever syndromes (CAPS). Patients with
CAPS suffer from skin rashes and episodes of fever. Many CAPS patients have gain-of-function
mutation in NLRP3, which may cause conformational changes to NLRP3 that render it
constitutively active (Lamkanfi & Dixit, 2014).
Formation of pores at the plasma membrane induces potassium efflux, which is proposed
to be a general mechanism of NLRP3 activation (Muñoz-Planillo et al., 2013). Pore-forming toxins
(PFTs) that permeabilize the plasma membrane, such as aerolysin toxin from Aeromonas
spp.(Abrami et al., 2000) and α-hemolysin from Staphylococcus aureus (Bhakdi & TranumJensen, 1991), cause a potassium efflux that triggers activation of the NLRP3 inflammasome
(Fig. 1.5). NLRP3 may thus serve as a guard of cytosolic potassium levels, and a drop in
potassium below a key threshold may serve as a HAMP for NLRP3 activation.
Viral proteins that disrupt intracellular membranes also activate NLRP3. The influenza
virus M2 protein forms a proton-specific ion channel that pumps H+ ions out of the lumen of the
Golgi, thereby neutralizing the pH of the trans-Golgi network (Sakaguchi et al., 1996). This activity
is sufficient to activate the NLRP3 inflammasome in macrophages and dendritic cells (Ichinohe et
al., 2010), suggesting that NLRP3 may serve as a general guard of ion homeostasis within the
cell. Intriguingly, NLRP3 inflammasome activators can induce dispersal of the trans-Golgi network
(TGN), resulting in recruitment of NLRP3 to dispersed TGN (dTGN) membranes via ionic
interactions between a poly-basic region of NLRP3 and negatively-charged PI(4)P on TGN
membranes (J. Chen & Chen, 2018). Whether this is the mechanism by which influenza M2
protein triggers NLRP3 activation is not yet known.
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The NLRP3 inflammasome can also be secondarily activated downstream of the noncanonical inflammasome, which refers to the caspase-4/5 inflammasome in humans, and the
caspase-11 inflammasome in mice (Fig. 1.5). Caspases-4, -5, and -11 all detect cytosolic
intracellular LPS and directly bind the lipid A moiety from LPS (Kayagaki et al., 2015; Shi et al.,
2014). In addition to LPS, caspase-4 has also been shown to be activated by Shiga toxin 2
(Stx2)/LPS complex from pathogenic Escherichia coli, while caspase-11 can detect
lipophosphoglycan from Leishmania (R. V. H. de Carvalho et al., 2019; Platnich et al., 2018).
Upon activation, these caspases cleave the pore-forming protein GSDMD, leading to potassium
efflux (Shi et al., 2015). This potassium efflux secondarily activates the NLRP3 inflammasome.
Bacteria employ virulence factors that have the capacity to activate the NLRP3
inflammasome through disruption of intracellular membranes, which may also disturb cellular
homeostasis. A variety of Gram-negative bacteria utilize type III secretion systems (T3SS) to
inject effectors that modulate cellular signaling pathways and enable evasion of immune
clearance (Viboud & Bliska, 2005). Yersinia species that possess a functional T3SS, but no
secreted effector proteins, still inject the integral membrane proteins Yersinia outer proteins B and
D (YopB and YopD) that form the T3SS translocation complex. This activity induces both the noncanonical caspase-11 and the NLRP3 inflammasomes (Fig. 1.5) (Brodsky et al., 2010; Casson et
al., 2013; Neyt & Cornelis, 1999; Nordfelth & Wolf-Watz, 2001; Rosqvist et al., 1995; Zwack et al.,
2015). Importantly, inflammasome activation by YopB and YopD was due to their elevated
injection into the host cell in the absence of the effector protein, YopK, which normally limits
translocation of YopB and YopD and other Yop proteins, and thus serves as an important
mechanism of inflammasome evasion by Yersinia (Brodsky et al., 2010; Holmström et al., 1997;
Thorslund et al., 2011). YopB and YopD hypertranslocation in the absence of YopK thus activates
a host immune response (Casson et al., 2013; Zwack et al., 2015).
YopD colocalizes with markers of damaged membranes, as well as guanylate binding
protein 2 (GBP2) (Zwack et al., 2017). GBPs are a family of IFN-inducible GTPases involved in
cell-intrinsic immunity to a variety of intracellular pathogens, including bacteria, viruses, and
protozoa (Kim et al., 2016; Man et al., 2017; Meunier & Broz, 2016; Pilla et al., 2014; Pilla-Moffett
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et al., 2016). GBPs are recruited to pathogen-containing vacuoles, where it is thought that they
deliver a variety of cargo important for host defense (Kim et al., 2016). Precisely how GBPs target
pathogen-containing vacuoles is unclear, but GBPs are specifically recruited when bacterial
secretion systems are inserted into vacuolar membranes, such as in the case of the Yersinia
YopB and YopD translocon proteins or the Legionella type IV secretion system (Feeley et al.,
2017). GBPs also contribute to activation of the noncanonical caspase-11 inflammasome, in part
through disruption of pathogen-containing vacuoles, lysis of cytosolic bacteria, and release of
LPS into the cytosol (Coers, 2017; Finethy et al., 2015; Man et al., 2016; Meunier et al., 2014;
Pilla et al., 2014; Rühl & Broz, 2015). GBPs are therefore poised to act both as sensors of
intracellular membrane integrity as well as direct effectors of vacuole membrane damage in
response to bacteria-induced alteration of intracellular vacuole membranes.
The non-canonical inflammasome can also be activated by bacterial outer membrane
vesicles (OMVs) which can deliver LPS into the cytosol of host cells. GBPs have been shown to
be recruited to OMVs and induce inflammasome activation (Finethy et al., 2017; J. C. Santos et
al., 2018). Pathogenic bacteria often express a modified version of LPS that evades noncanonical inflammasome activation. However, it was recently shown that OMVs from Neisseria
gonorrhoeae, Pseudomonas aeruginosa, and uropathogenic E. coli can activate intrinsic
apoptosis and cause mitochondrial dysfunction, leading to downstream NLRP3 inflammasome
activation (Deo et al., 2020).

1.3.3 NAIP/NLRC4 inflammasome
Another subfamily of NLRs, the nucleotide-binding domain, leucine-rich repeat-containing
family, apoptosis inhibitory proteins (NAIPs) form an inflammasome in conjunction with the
adaptor NLR, NLRC4. NAIPs detect conserved microbial motifs such as the structural
components of bacterial T3SS. Upon sensing its cognate ligand, NAIP recruits the adaptor
protein NLRC4 to form a multimeric complex called the NAIP/NLRC4 inflammasome. Like other
inflammasomes, the NAIP/NLRC4 inflammasome recruits and activates caspase-1, leading to
downstream IL-1 cytokine release and pyroptosis (Kofoed & Vance, 2011; Rauch et al., 2016;
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Rayamajhi et al., 2013; J. Yang et al., 2013; Zhao et al., 2011, 2016). In the absence of caspase1, murine caspase-8 can be recruited to the NAIP/NLRC4 inflammasome during Salmonella
infection and mediate downstream responses (Man et al., 2013; Rauch et al., 2017). NLRC4
contains a CARD domain and can therefore recruit caspases directly without the need for an
additional adaptor protein like ASC. However, ASC may interact with the NAIP/NLRC4
inflammasome to potentiate inflammasome responses (Broz & Dixit, 2016).
Humans only have one functional copy of NAIP (Romanish et al., 2007, 2009), while
rodents have multiple copies of Naip (Growney et al., 2000; Growney & Dietrich, 2000). Each
murine NAIP detects a particular bacterial ligand. Specifically, NAIP1 recognizes the T3SS
needle protein (PrgI); NAIP2 recognizes the T3SS inner rod (PrgJ); NAIP5 and NAIP6 both
recognize flagellin, which is translocated through the T3SS (Kofoed & Vance, 2011; Rauch et al.,
2016; Rayamajhi et al., 2013; Y.-H. Sun et al., 2007; J. Yang et al., 2013; Zhao et al., 2011,
2016). In contrast to mice, humans only have one NAIP (hNAIP), that detects all three bacterial
ligands in human macrophages (Kortmann et al., 2015; Reyes Ruiz et al., 2017).
NAIP contains a nucleotide-binding domain (NBD). An internal region of this NBD is
thought to be responsible for conferring ligand specificity in mice (Tenthorey et al., 2014). Cryoelectron microscopy of the flagellin-NAIP5-NLRC4 demonstrates that a single flagellin monomer
is present per NAIP inflammasome and this monomer makes multiple contacts with the NAIP5
protein across NAIP’s various structural domains (Tenthorey et al., 2017; J. Yang et al., 2018).
Importantly, the bacterial ligand does not interact with NLRC4; rather, it directly interacts with
NAIP, confirming that NAIP is the sensor protein (Tenthorey et al., 2017). It is thought that the
flagellin monomer binding to NAIP5 results in NAIP5 unfurling and recruiting NLRC4, leading to
subsequent inflammasome oligomerization and activation (Tenthorey et al., 2017). The molecular
determinants of human NAIP’s broad recognition of bacterial ligands remains unknown.
The NAIP/NLRC4 inflammasome is important for immune defense against various
bacterial pathogens, including Salmonella enterica serovar Typhimurium, Pseudomonas
aeruginosa, Legionella pneumophila, Klebsiella pneumoniae, and Burkholderia pseudomallei
(Amer et al., 2006; Cai et al., 2012; F. A. Carvalho et al., 2012; Ceballos-Olvera et al., 2011;
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Franchi et al., 2012; Lara-Tejero et al., 2006; Man, Ekpenyong, et al., 2014; Miao, Leaf, et al.,
2010; Rauch et al., 2017; Sellin et al., 2014; Sutterwala et al., 2007; Vinzing et al., 2008; Zamboni
et al., 2006). NLRC4 also protects against the bacterial pathogen Anaplasma phagocytophilum
which induces NLRC4 via a distinct NAIP-independent mechanism involving eicosanoid
prostaglandin E2 production (Pedra et al., 2007; X. Wang et al., 2016).
The exact mechanisms by which inflammasome activation leads to control of infection
have not been fully elucidated. During Legionella infection of macrophages, NAIP5 activation
appears to promote phagosome-lysosome fusion, but the mechanism by which this occurs is not
clear (Amer et al., 2006; Fortier et al., 2007). Pyroptosis is a downstream consequence of
inflammasome activation that eliminates the pathogen’s replicative niche, the host cell. It has
been proposed that pyroptosis leads to the formation of cellular structures called pore-induced
intracellular traps (PITs) within which intracellular bacteria are trapped and susceptible to
efferocytosis by neutrophils, which are recruited to the site of infection (Jorgensen et al., 2016). It
has also been suggested that caspase-1 and caspase-11 enzymatic activity restricts cytosolic
Salmonella replication, and that this event occurs independent of or prior to the onset of cell
death (Thurston et al., 2016). Another consequence of NAIP/NLRC4 inflammasome activation in
mice during Salmonella infection is the production of prostaglandin E2, fluid accumulation in the
intestine, and eventual extrusion of infected intestinal epithelial cells from the intestinal epithelial
layer (Rauch et al., 2017). NAIP/NLRC4 inflammasome activation also prevents systemic
dissemination of Salmonella from the intestine to distal organs (Hausmann et al., 2020). These
events are thought to contribute to control of bacterial burdens in mice.
In addition to defense against pathogens, the NAIP/NLRC4 inflammasome has also been
implicated in protection against colorectal cancer, although there is some debate as to whether
this occurs and if so, the mechanism at play (Allam et al., 2015; B. Hu et al., 2010; Tenthorey et
al., 2020). On the flip side, inappropriate activation of the NAIP/NLRC4 inflammasome can also
lead to detrimental, pathological outcomes. In mice, NAIP/NLRC4 inflammasome activation in
response to a multidrug-resistant pathobiont triggers systemic inflammation, and the mice
succumb to a sepsis-like disease (Ayres et al., 2012). Additionally, human patients with gain-of-
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function mutations in NLRC4 suffer from autoinflammation and other debilitating symptoms,
including urticaria, arthritis, enterocolitis, and Macrophage Activation Syndrome (MAS) (Canna et
al., 2014; Kitamura et al., 2014; Romberg et al., 2014). Whether similar mutations in NAIP exist or
if they would have similar pathological consequences remains unknown.

1.3.4 NLRP6 inflammasome
Another NLR family member, NLRP6, can form an inflammasome in response to various
stimuli, including bacterial infection. Upon activation, NLRP6 recruits the adaptor protein ASC,
through which it interacts with caspase-1 and caspase-11 to mediate downstream IL-1 and IL-18
secretion (Venuprasad & Theiss, 2021). K63-linked ubiquitination of NLRP6 promotes its
association with ASC (Mukherjee et al., 2020). NLRP6 is activated in response to Citrobacter
rodentium, Staphylococcus aureus, and Listeria monocytogenes (Ghimire et al., 2018; Hara et al.,
2018; Mukherjee et al., 2020). Lipoteichoic acid (LTA) from Gram-positive bacteria such as
Listeria upregulates NLRP6 and caspase-11 expression. LTA also directly binds NLRP6 to induce
inflammasome activation. Other microbial ligands such as LPS, ATP, muramyl dipeptide (MDP),
and microbial metabolites taurine, histamine, and spermine can all modulate NLRP6
inflammasome activation (Venuprasad & Theiss, 2021; D. Zheng et al., 2020).
NLRP6 appears to play dual roles during infection – under certain circumstances, e.g.
during C. rodentium infection, NLRP6 is protective against colitis (Ghimire et al., 2018; Wlodarska
et al., 2014). Additionally, NLRP6 plays an important role in the clearance of
encephalomyocarditis virus (EMCV) infection (P. Wang et al., 2015). In contrast, in other
scenarios, NLRP6 activation may be detrimental to the host. NLRP6 inhibits host defense during
S. aureus infection of the lungs (Ghimire et al., 2018). Nlrp6-/- mice infected with L.
monocytogenes, S. Typhimurium, and E. coli have improved bacterial clearance relative to WT
mice. This is likely due to inflammasome-independent activity of NLRP6, as these mice
demonstrate enhanced NF-κB and mitogen-activated protein kinase (MAPK) signaling, but do not
exhibit any differences in IL-1β levels or caspase-1 activation (Anand et al., 2012).
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Outside of its role in innate immunity to infections, NLRP6 is also critical for many other
inflammasome-independent functions. It is highly expressed in the gut, and is thought to play a
role in gut homeostasis by regulating the gut microbiome, mucus production, goblet cell function,
and secretion of antimicrobial peptides (D. Zheng et al., 2021). NLRP6 expression is required for
preventing colorectal cancer in mice, but its role in human patients remains unclear. NLRP6 has
also been implicated in liver disease, rheumatoid arthritis, and platelet function (D. Zheng et al.,
2021).

1.3.5 AIM2 inflammasome
The absent in melanoma 2 (AIM2) inflammasome is activated by cytosolic DNA from
intracellular pathogens such as Francisella tularensis, cytomegalovirus, and vaccinia virus. Upon
activation, AIM2 recruits ASC to form an inflammasome. AIM2 activation is critical for host
defense against bacterial infections such as F. tularensis and L. monocytogenes (Lamkanfi &
Dixit, 2014). Other host factors such as GBPs and IRGs can potentiate AIM2 activation. Murine
GBP2 and GBP5 promote bacteriolysis of F. tularensis, which exposes dsDNA into the cytosol,
thereby activating the AIM2 inflammasome (Man et al., 2015; Meunier et al., 2015). IrgB10 also
release F. tularensis dsDNA into the cytosol by inducing bacterial cell lysis and trigger AIM2
activation (Man et al., 2016). Beyond host defense against pathogens, AIM2 has also been linked
to autoimmune disorders and tumor progression (Lamkanfi & Dixit, 2014).

1.3.6 Pyrin inflammasome
Pyrin, encoded by the MEFV gene, forms an inflammasome that recruits caspase-1,
leading to downstream processing of IL-1 family cytokines and pyroptotic cell death (Fig. 1.5).
Gain-of-function mutations in MEFV are associated with Familial Mediterranean Fever (FMF),
which is characterized by recurrent episodes of inflammation due to aberrant pyrin activation.
Pyrin activation is normally restrained by RhoA through the activity of Protein Kinase C-Related
Kinases (PKNs/PRKs). When RhoA is active, one of its targets, the PKNs, phosphorylate pyrin,
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creating binding sites for suppressive 14-3-3 regulatory proteins (Gao et al., 2016; Park et al.,
2016). Thus, under basal conditions, the pyrin inflammasome is maintained in an inactive state.
However, disruptions in these interactions due to pathogen inactivation of RhoA can trigger the
pyrin inflammasome. A number of pathogens are sensed via this detection mechanism.
Burkholderia cenocepacia inactivates RhoA via direct deamidation, thereby disrupting
macrophage effector functions (Aubert et al., 2016; Xu et al., 2014). The resulting de-repression
of pyrin leads to an inflammatory response that controls B. cenocepacia infection (Xu et al.,
2014). Similarly, other RhoA-inactivating toxins, such as Clostridium botulinum C3, Clostridium
difficile TcdB, Vibrio parahaemolyticus VopS, and Histophilus somni IbpA, also activate the pyrin
inflammasome (Xu et al., 2014). Only catalytically active bacterial effectors trigger this
inflammasome response, indicating that pyrin senses the activity of effectors and their disruption
of RhoA function (Xu et al., 2014).
Some bacterial pathogens have evolved to evade the pyrin inflammasome pathway in
response to manipulation of RhoA (Fig. 1.5). Yersinia effectors YopE and YopT inactivate the
Rho GTPases RhoA, Rac1, and Cdc42 to prevent phagocytosis of the bacteria (Viboud & Bliska,
2005), which triggers pyrin activation by disrupting its interactions with 14-3-3 proteins (Chung et
al., 2016; Medici et al., 2019; Ratner et al., 2016). However, Yersinia possesses another effector,
YopM, which specifically activates PRK/PKN kinases to phosphorylate pyrin, thereby maintaining
pyrin’s association with 14-3-3 proteins and masking YopE/T interference with Rho GTPases
(Chung et al., 2016). The YopE/M/RhoA/Pyrin circuit provides an elegant example of the interplay
between host sensing and pathogen evasion.

1.3.7 Atypical inflammasomes: NLRP7, NLRP9, NLRP12, NLRC5, IFI16
The function of several NLR family members remain unknown. Two additional members,
NLRP7 and NLRP9 have been implicated in inflammasome activation, although further studies
are needed to fully characterize their role in innate immunity. The NLRP7 inflammasome was
identified in human macrophages, where it gets activated in response to microbial acylated
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lipopeptides. Upon activation, NLRP7 recruits ASC and mediates downstream IL-1 and IL-18
release. It appears to work in concert with NLRP3 and mediates restriction of intracellular S.
aureus and L. monocytogenes replication (Khare et al., 2012). NLRP7 is also thought to
negatively regulate inflammasome responses, although the mechanisms by which it does so
remain unclear (Radian et al., 2013).
NLRP9 was originally thought to solely function in the reproductive system (Mullins &
Chen, 2021). Humans only have one NLRP9, while mice have three: mNLRP9a, mNLR9b,
mNLRP9c (Tian et al., 2009). Murine NLRP9 isoforms affect cell division during embryonic
development (Mullins & Chen, 2021). Recently, evidence of an NLRP9b inflammasome has
emerged. NLRP9b is highly expressed in the small intestine, but not in myeloid cells (Zhu et al.,
2017). During rotavirus infection, NLRP9b expression in the intestine was critical for caspase-1
activation, IL-1 release, and cell death. Nlrp9b-/- exhibited higher viral loads than WT mice,
indicating the NLRP9b inflammasome activation is critical for viral clearance. It is thought that this
protection is dependent on GSDMD-dependent cell death, as GSDMD-deficient mice were more
vulnerable to rotavirus infection. Although NLRP9b co-precipitates with short dsRNA stretches, it
does not directly bind viral RNA, making it unclear exactly what NLRP9b senses (Zhu et al.,
2017). The role of human NLRP9 remains unknown.
NLRP12 is a negative regulator of inflammation, specifically of non-canonical NF-κB
activation (Allen et al., 2012). NLRP12-deficient mice are more resistant to Salmonella infection
and have lower bacterial burdens (Zaki et al., 2014). NLRP12 is also hypothesized to form an
inflammasome with ASC and caspase-1 (Janowski & Sutterwala, 2016). NLRP12 inflammasome
activation is critical for control of Y. pestis infection, but is dispensable for control of K.
pneumoniae and Mycobacterium tuberculosis (Allen et al., 2013).
The main role of NLRC5 is as a regulator of MHC class I expression. Its function is
therefore critical for CD8 T cell responses to bacterial and viral infections (Janowski & Sutterwala,
2016). NLRC5 can also form an inflammasome and undergo activation in response to E. coli, S.
aureus, S. flexneri infections and stimulation with TLR ligands. Interestingly, only NLRP3 agonists
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appear to induce NLRC5 activation, suggesting that NLRC5 interacts with NLRP3 to modulate
inflammasome activation (Davis et al., 2011).
A non-NLR inflammasome, the interferon-inducible protein 16 (IFI16), is nuclear sensor
of viral DNA. IFI16 is present in humans, but not in mice. Upon activation, IFI16 migrates to the
cytoplasm, where it forms an inflammasome with the adaptor protein ASC (Janowski &
Sutterwala, 2016). IFI16 responds to viral pathogens such as Kaposi sarcoma-associated
herpesvirus (KSHV) (Kerur et al., 2011). It also plays an inflammasome-independent role in host
defense against viral infection. IFI16 can regulate type I IFN responses during viral infection by
interacting with stimulator of interferon genes (STING) and inducing the production of IFN-β
(Ishikawa et al., 2009; Stetson & Medzhitov, 2006; Unterholzner et al., 2010).

1.4 Salmonella
Enteric pathogens are a major public health concern due to their global burden of human
morbidity and mortality (WHO, 2015). Diarrheal diseases cause more than half of the global
burden of foodborne diseases (WHO, 2015). One of the causative agents of diarrheal disease is
the Gram-negative bacterial pathogen Salmonella enterica. There are over 2,500 serovars of S.
enterica, most of which cause self-limiting gastroenteritis in humans and are referred to as nontyphoidal Salmonella. Non-typhoidal Salmonella serovars are one of the leading causes of death
from diarrheal disease (WHO, 2015). In contrast, typhoidal Salmonella serovars S. Paratyphi and
S. Typhi cause systemic disease and are human adapted (LaRock et al., 2015). The nontyphoidal S. enterica serovar Typhimurium strain causes systemic disease in mice and is often
used to model typhoidal Salmonella infection (Monack et al., 2004).

1.4.1 Salmonella pathogenesis
S. Typhimurium (hereafter referred to as Salmonella) is a zoonotic pathogen and can
infect a variety of different animals. Transmission occurs via the fecal-oral route, and humans are
infected upon ingesting contaminated food or water that has come into contact with feces from
infected animals or pets (LaRock et al., 2015) (Fig. 1.6). To colonize the intestinal epithelium,
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Salmonella use molecular syringes known as type III secretion systems (T3SSs) to inject
effectors into the host cell cytosol as part of its virulence strategy. It has two T3SSs encoded on
two Salmonella pathogenicity islands (SPI): SPI-1 and SPI-2 (Crowley et al., 2016). Salmonella
uses the SPI-1 T3SS to invade host cells such as intestinal epithelial cells (IECs) and the SPI-2
T3SS to reside and replicate within the cell in a compartment called the Salmonella-containing
vacuole (SCV) (Hensel et al., 1998; Mills et al., 2006; Shea et al., 1996). Collectively, these
secretion systems inject over 30 effector proteins into the host cell cytosol, all of which play
important roles in Salmonella’s virulence strategy (Crowley et al., 2016).
The SPI-1 T3SS effectors are required for invasion of non-phagocytic cells such as IECs,
colonization of the intestine, and induction of intestinal inflammatory responses, including
inflammatory diarrhea (Haraga et al., 2008). Salmonella uses several SPI-1 T3SS effectors
including SopB, SopE, and SopE2 to invade cells. SopB/E/E2 activate the RhoGTPases Rac1
and Cdc42, resulting in host actin cytoskeleton remodeling and membrane ruffling (Bakshi et al.,
2000; Hardt et al., 1998; Stender et al., 2002). SipA and SipC also contribute to actin remodeling
and polymerization but they do so independent of RhoGTPases (Hayward, 1999; McGhie, 2001;
Zhou, 1999; Zhou et al., 1999). Collectively, these effectors promote internalization of the
Salmonella. Once the Salmonella is inside the host cell, SptP inactivates RhoGTPases and
reverses the membrane ruffling (Fu & Galán, 1999). Aside from invasion, SPI-1 effectors are also
involved in SCV biogenesis and preventing lysosomal fusion of the SCV (e.g. SopB), inducing
inflammation, and inducing transmigration of polymorphonuclear neutrophils (PMNs) into the
intestinal lumen (SipA, SopA) (Bakowski et al., 2010; Dai et al., 2007; Hernandez, 2004; Lee et
al., 2000, p. 200; Mallo et al., 2008; McIntosh et al., 2017; Norris et al., 1998; Silva et al., 2004;
Srikanth et al., 2010; Terebiznik et al., 2002; Y. Zhang et al., 2006).
Inside the host cell, Salmonella resides within the Salmonella phagosome which
eventually becomes the SCV. The internal environment of the phagosome down-regulates
expression of the SPI-1 T3SS and flagellin, and induces the expression of the SPI-2 T3SS
(Haraga et al., 2008). Expression of the SPI-1 and SPI-2 T3SS is regulated by the PhoPQ two
component regulatory system (Bijlsma & Groisman, 2005; Miller et al., 1989; Soncini et al., 1996).
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The sensor kinase PhoQ is activated by low pH and low Mg2+ in the phagosome (Groisman,
2001; Groisman et al., 1997). PhoQ then activates the response regulator PhoP. PhoP represses
the expression of several prg genes (PhoP-repressed gene) such as the SPI-1 T3SS inner rod
prgJ and needle prgI, as well as flagellar genes. PhoP also activates the expression of pag genes
(PhoP-activated genes) (Crowley et al., 2016). Thus, PhoPQ downregulates expression of the
SPI-1 T3SS and flagellin, and upregulates expression of the SPI-2 T3SS. The SPI-2 T3SS
effectors enable Salmonella to establish the SCV (e.g. SseF, SseG), inhibit phagosomal
maturation (e.g. SifA), and maintain the SCV (e.g. SifA, SseJ) (Boucrot, 2005; Brumell et al.,
2002; Jackson et al., 2008; McGourty et al., 2012; Ruiz-Albert et al., 2002; Stein et al., 1996; Yu
et al., 2016). Some effectors (e.g. SifA, SopD2, PipB2, SseF, SseG) also lead to the formation of
Salmonella-induced filaments (SIFs), which are thought to be important for nutrient acquisition
and maintaining membrane integrity of the SCV (Beuzon, 2000; Dumont et al., 2010; Garcia-del
Portillo, Zwick, et al., 1993; Jiang et al., 2004; Knodler & Steele-Mortimer, 2005; Krieger et al.,
2014; Kuhle & Hensel, 2002; Liss et al., 2017; Stein et al., 1996). SPI-2 effectors SpvB and SteC
remodel the actin cytoskeleton to enable intracellular survival of Salmonella (Odendall et al.,
2012; Otto et al., 2000; Poh et al., 2007; Tezcan-Merdol et al., 2001).
While Salmonella’s T3SS and its effectors are critical for its virulence strategy, the use of
these molecular machines can also facilitate detection of Salmonella by the host immune system.
Some of these mechanisms of detection and Salmonella interplay with the host immune system
are described in the next section.
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Figure 1.6: Salmonella transmits through the fecal-oral route and colonizes the intestinal
epithelium.
Humans are infected with Salmonella upon ingesting contaminated food or water. Salmonella
must first overcome the acidic pH of the stomach, after which it enters and colonizes the small
intestine. Salmonella can infect a variety of cell types, including macrophages and intestinal
epithelial cells. Image created with BioRender.com.

1.4.2 Overview of Salmonella’s interaction with the host immune system
Salmonella’s first barriers to infection are physical (Fig. 1.6). It must survive the acidic pH
of the stomach to enter the intestinal epithelium. Salmonella is thought to have adaptive acid
tolerance that promotes its survival in the stomach (Garcia-del Portillo, Foster, et al., 1993). Once
inside the small intestine, Salmonella encounters the host microbiota, which serve as a microbial
barrier between the invading pathogen and the submucosal layers beneath. To successfully
colonize, Salmonella must compete with the microbiota for nutrients and resources. Mice used for
Salmonella research studies are often pretreated with the antibiotic streptomycin to promote
Salmonella colonization, as untreated mice can be resistant to colonization (Barthel et al., 2003;
Stecher et al., 2005). Another physical barrier Salmonella encounters is the thick mucus layer
lining the intestinal epithelium, which it traverses using its flagellar motility (Patel & McCormick,
2014).
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Once Salmonella overcomes these physical barriers, it must contend with the host innate
immune system. Host cell TLRs detect Salmonella amyloid fibrils, flagellin, and LPS and induce
activation of NF-κB and MAPK pathways, which lead to upregulation of pro-inflammatory
cytokines (Gewirtz et al., 2001; Siegemund et al., 2008; Tükel et al., 2005). Salmonella infection
also induces inflammasome activation (described in detail in a later section), leading to release of
IL-18 and IL-1β (R. L. Santos et al., 2009). IL-18 leads to production of IFN-γ by T cells and
natural killer (NK) cells, which in turn activates macrophages (Srinivasan et al., 2007). IL-1β
recruits neutrophils to the site of infection (Raffatellu et al., 2008; Winter et al., 2009).
Innate immune cells activated by Salmonella can in turn facilitate adaptive immune
responses to infection. Specialized luminal M-fold cells and dendritic cells (DCs) sample the
lumen and transport Salmonella antigen from the lumen to the lamina propria. Dendritic cells
(DCs) in the lamina propria migrate to the mesenteric lymph nodes where they present antigen to
B and T cells (Patel & McCormick, 2014). Infected host cells also produce IL-23, which induces T
cells to produce IL-17, leading to Th17 responses and further neutrophil recruitment (Godinez et
al., 2009; Raffatellu et al., 2008). Th17 responses drive the production of IL-22 by NK cells, DCs,
and T cells (Cella et al., 2009; Godinez et al., 2008; Satoh-Takayama et al., 2008; Y. Zheng et al.,
2008). IL-22 triggers the production of antimicrobial peptides (AMPs) which sequester metals
such as iron and zinc from bacteria (Godinez et al., 2009; Raffatellu et al., 2009; Y. Zheng et al.,
2008). IL-22 also induces the production of reactive oxygen and nitrogen species (Raffatellu et
al., 2009). However, these mechanisms are not specific to Salmonella, and can kill commensal
microbes as well. Salmonella may exploit intestinal inflammation; the inflamed gut enables
Salmonella to use tetrathionate as an alternative electron acceptor during respiration, providing it
with a competitive advantage over other commensal microbes (Winter et al., 2010).

1.5 Dissertation Aims
As an intracellular pathogen, Salmonella violates the ‘cytosolic sanctity’ of cells and
induces multiple inflammasome pathways. Most studies on inflammasome responses to
Salmonella have been conducted in mice, but differences in innate immune genes between mice
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and humans make it unclear whether humans induce similar responses to Salmonella. In this
dissertation, we investigated the role of inflammasomes in sensing and responding to Salmonella
in human cells.
In mice, Salmonella induces the NAIP/NLRC4 inflammasome early in infection. Mice
contain multiple NAIPs, each specific to a particular bacterial ligand. The Salmonella SPI-1 T3SS
inner rod PrgJ, needle PrgI, and flagellin proteins activate NAIP2, NAIP1, and NAIP5/6
inflammasomes respectively (Kofoed & Vance, 2011; Rayamajhi et al., 2013; J. Yang et al., 2013;
Zhao et al., 2011). Upon activation, the NAIP/NLRC4 inflammasome recruits and activates
caspase-1, and in the absence of caspase-1, can activate caspase-8 (Man et al., 2013; Rauch et
al., 2017) (Fig. 1.7). Active caspases mediate secretion of proinflammatory cytokines and cell
death. The NAIP/NLRC4 inflammasome is critical for control of Salmonella infection in mice
(Lara-Tejero et al., 2006; Rauch et al., 2017; Sellin et al., 2014). Intriguingly, expression of
NAIP/NLRC4 only in IECs is sufficient to mediate protection (Rauch et al., 2017; Sellin et al.,
2014). NAIP/NLRC4 activation in IECs restricts bacterial replication, extrudes infected cells from
the intestinal epithelial layer, and prevents systemic dissemination of Salmonella to distal organs
(Hausmann et al., 2020; Rauch et al., 2017; Sellin et al., 2014). In mice, the NLRP3
inflammasome is also activated, but later in infection (Broz et al., 2010). Additionally, the
caspase-11 inflammasome is activated in the absence of caspase-1 during Salmonella infection
(Crowley et al., 2020).
In humans, the role of the NAIP/NLRC4 inflammasome has thus far only been
investigated in macrophages. Unlike mice, humans only have one NAIP, which broadly
recognizes all three bacterial ligands that the murine NAIPs recognize (Kortmann et al., 2015;
Reyes Ruiz et al., 2017) (Fig. 1.8). Inflammasome activation in human macrophages in response
to Salmonella is dependent on the presence of the SPI-1 T3SS (Reyes Ruiz et al., 2017).
However, it was unknown whether human NAIP itself is necessary to mediate this inflammasome
response or if other inflammasomes play a role.
In human IECs, the CASP4/5 inflammasome is critical for control of Salmonella infection
(Holly et al., 2020; Knodler, Crowley, et al., 2014). CASP4/5 is activated by cytosolic LPS, and it
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is thought that populations of cytosolic Salmonella in human IECs trigger activation of this
inflammasome at late timepoints of infection (Holly et al., 2020; Knodler, Crowley, et al., 2014).
The role of the NAIP/NLRC4 inflammasome or other inflammasomes during Salmonella infection
of human IECs was unknown.

Figure 1.7: Salmonella infection of murine cells induces NAIP/NLRC4 inflammasome
activation.
Murine NAIP1 recognizes the Salmonella T3SS needle, NAIP2 recognizes the T3SS inner rod,
and NAIP5/6 recognize flagellin. Upon sensing its corresponding bacterial ligand, the NAIPs
recruit the adaptor protein NLRC4 and form an inflammasome. The NAIP/NLRC4 inflammasome
can recruit and activate caspases-1 and -8, which in turn activate IL-1 cytokines, and the poreforming protein GSDMD. Inflammasome activation results in cell death and release of
proinflammatory cytokines. Image created with BiorRender.com.
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Figure 1.8: Bacterial T3SS ligands and flagellin activate the NAIP/NLRC4 inflammasome in
human macrophages.
Humans only have one NAIP, which senses the T3SS inner rod, needle, and flagellin proteins.
This leads to formation of the NAIP/NLRC4 inflammasome and downstream caspase-1 activation,
cell death, and IL-1 release. Image created with BiorRender.com.

1.5.1 Aim 1: What is the contribution of the NAIP/NLRC4 inflammasome in sensing and
responding to Salmonella infection of human macrophages?
In Chapter 2, we interrogated the requirement of the NAIP/NLRC4 inflammasome in
sensing and responding to Salmonella infection of human macrophages. We found that
Salmonella infection induces NAIP- and NLRP3-dependent inflammasome activation in human
macrophages. In addition, the CASP4/5-inflammasome is also activated. Intriguingly, we
observed NAIP/NLRC4- and NLRP3-dependent restriction of Salmonella replication in human
macrophages. These results demonstrate that the NAIP/NLRC4 inflammasome, in conjunction
with other inflammasomes, sense, respond, and restrict Salmonella infection in human
macrophages.
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1.5.2 Aim 2: What is the contribution of the NAIP/NLRC4 inflammasome in sensing and
responding to Salmonella infection of human intestinal epithelial cells?
In Chapter 3, we investigated the role of the NAIP/NLRC4 inflammasome in sensing
Salmonella in human IECs. Although we observed inflammasome activation in IECs, in contrast
to macrophages, we found that Salmonella T3SS ligands do not activate the inflammasome in
human IECs. Additionally, we found both the NAIP/NLRC4 and the NLRP3 inflammasomes to be
dispensable for inflammasome responses to Salmonella in human IECs. The inflammasome
adaptor protein ASC was also not required. Instead, we observed a partial requirement for
caspase-1, and complete necessity of caspase-4 and GSDMD for inflammasome responses to
Salmonella in human IECs. Collectively, these results highlight that caspase-4 is the main
inflammasome pathway activated in human IECs during Salmonella infection.
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CHAPTER 2
Human NAIP/NLRC4 and NLRP3 inflammasomes detect Salmonella type III secretion
system activities to restrict intracellular bacterial replication

This chapter contains unpublished data from a submitted manuscript by Nawar Naseer*, Marisa
Egan*, Valeria M. Reyes Ruiz*, Igor E. Brodsky, and Sunny Shin. *indicates co-first authorship
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2.1 Abstract
Salmonella enterica serovar Typhimurium is a Gram-negative pathogen that uses two
distinct type III secretion systems (T3SSs), termed Salmonella pathogenicity island (SPI)-1 and
SPI-2, to deliver virulence factors into the host cell. The SPI-1 T3SS enables Salmonella to
invade host cells, while the SPI-2 T3SS facilitates Salmonella’s intracellular survival. In mice, a
family of cytosolic immune sensors, including NAIP1, NAIP2, and NAIP5/6, recognizes the SPI-1
T3SS needle, inner rod, and flagellin proteins, respectively. Ligand recognition triggers assembly
of the NAIP/NLRC4 inflammasome, which mediates caspase-1 activation, IL-1 family cytokine
secretion, and pyroptosis of infected cells. In contrast to mice, humans encode a single NAIP that
broadly recognizes all three ligands. The role of NAIP/NLRC4 or other inflammasomes during
Salmonella infection of human macrophages is unclear. We find that although the NAIP/NLRC4
inflammasome is essential for detecting SPI-1 T3SS ligands in human macrophages, it is partially
required for responses to infection, as Salmonella also activated the NLRP3 and CASP4/5
inflammasomes. Importantly, we demonstrate that combinatorial NAIP/NLRC4 and NLRP3
inflammasome activation restricts Salmonella replication in human macrophages. In contrast to
SPI-1, the SPI-2 T3SS inner rod is not sensed by human or murine NAIPs, which is thought to
allow Salmonella to evade host recognition and replicate intracellularly. Intriguingly, we find that
human NAIP detects the SPI-2 T3SS needle protein. Critically, in the absence of both flagellin
and the SPI-1 T3SS, the NAIP/NLRC4 inflammasome still restricted intracellular Salmonella
replication. These findings reveal that recognition of Salmonella SPI-1 and SPI-2 T3SSs and
engagement of both the NAIP/NLRC4 and NLRP3 inflammasomes control Salmonella infection in
human macrophages.

2.2 Author Summary
Salmonella enterica serovar Typhimurium is a gastrointestinal bacterial pathogen that
causes diarrheal disease and is a major cause of morbidity and mortality worldwide. Salmonella
uses molecular syringe-like machines called type III secretion systems (T3SSs) to inject virulence
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factors into host cells. These T3SSs enable Salmonella to infect and survive within host cells
such as macrophages. However, host cells contain a family of cytosolic immune receptors,
termed NAIPs, that recognize T3SS and flagellin components. Upon detecting these components,
NAIPs recruit the adaptor protein NLRC4 to form signaling complexes called inflammasomes.
Inflammasomes activate host proteases called caspases that mount robust immune responses
against the invading pathogen. While mice encode multiple NAIPs that have been extensively
studied, much remains unknown about how the single human NAIP mediates inflammasome
responses to Salmonella in macrophages. Our study reveals that while NAIP is necessary to
detect individual T3SS ligands in human macrophages, it is only partially required for
inflammasome responses to Salmonella infection. We found that the NLRP3 and CASP4/5
inflammasomes are also activated, and the combination of NAIP- and NLRP3-mediated
recognition limits intracellular Salmonella replication in human macrophages. Our results
demonstrate that human macrophages employ multiple inflammasomes to mount robust host
defense against Salmonella infection.

2.3 Introduction
Salmonella enterica serovar Typhimurium (referred to hereafter as Salmonella) is a
Gram-negative bacterial pathogen that causes self-limiting gastroenteritis in immune-competent
humans. Transmission of Salmonella typically occurs upon ingestion of contaminated food or
water. Once inside the host, Salmonella uses specialized nanomachines known as type III
secretion systems (T3SSs) to inject effectors into the host cell cytosol (Crowley et al., 2016).
Subsequently, these effectors remodel host cellular processes to facilitate bacterial colonization.
Thus, Salmonella’s T3SSs enable the enteric pathogen to successfully colonize the intestinal
tract and infect a variety of cell types, including intestinal epithelial cells (IECs) and macrophages
(Crowley et al., 2016). Specifically, Salmonella uses its first T3SS, located on Salmonella
Pathogenicity Island 1 (SPI-1), to invade host cells, and its second T3SS, located on a second
pathogenicity island, SPI-2, to persist and replicate within host cells (Galán, 1999; Galán &
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Collmer, 1999; Galán & Curtiss, 1989; Galan & Zhou, 2000; Hensel et al., 1998; Mills et al., 2006;
Shea et al., 1996). Numerous other Gram-negative bacterial pathogens also use these
evolutionarily conserved T3SSs to colonize the host (Zhao & Shao, 2015). While T3SSs are
required for these bacterial pathogens to cause disease, they also translocate structural
components of the T3SS or the flagellar apparatus into the cytosol, thus enabling the host to
detect the invading pathogen (Sun et al., 2007). Unlike effectors, which display significant
diversity across bacterial species, structural components of the T3SS or the flagellar apparatus
retain significant structural homology across Gram-negative bacteria (Miao et al., 2010; Zhao &
Shao, 2015). Thus, these ligands serve as ideal targets of host immune sensors.
The mammalian innate immune system is armed with pattern recognition receptors
(PRRs) that detect pathogens by recognizing pathogen-associated molecular patterns (PAMPs)
(Janeway, 1989; Medzhitov & Janeway, 2002). A subfamily of cytosolic PRRs, known as NAIPs
(the NLR [nucleotide-binding domain, leucine-rich repeat-containing] family, apoptosis inhibitory
proteins), recognize the structurally related SPI-1 T3SS needle protein, SPI-1 T3SS inner rod
protein, and flagellin, which are translocated into the host cell cytosol by the SPI-1 T3SS (Kofoed
& Vance, 2011; Sun et al., 2007; Zhao et al., 2011). Mice have multiple NAIPs, each specific to a
particular ligand: NAIP1 recognizes the T3SS needle protein, NAIP2 recognizes the T3SS inner
rod protein, and NAIP5 and NAIP6 both recognize flagellin (Kofoed & Vance, 2011; Rauch et al.,
2016; Rayamajhi et al., 2013; J. Yang et al., 2013; Zhao et al., 2011, 2016). Upon sensing a
ligand, NAIPs recruit the adaptor protein NLRC4 (nucleotide-binding domain, leucine-rich repeatcontaining family, CARD domain-containing protein 4) to form multimeric signaling complexes
called inflammasomes (Diebolder et al., 2015; Hu et al., 2015; Zhang et al., 2015). The
NAIP/NLRC4 inflammasome then recruits and activates the cysteine protease caspase-1
(Martinon et al., 2002). Active caspase-1 cleaves downstream substrates, including pro-IL-1 and
pro-IL-18, as well as the pore-forming protein gasdermin-D (GSDMD) (Kuida et al., 1995; Li et al.,
1995; Shi et al., 2015). Cleaved GSDMD creates pores in the host plasma membrane, leading to
the release of proinflammatory cytokines and an inflammatory form of cell death known as
pyroptosis, which effectively eliminates the infected cell. The NAIP/NLRC4 inflammasome is
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critical for the control of Salmonella infection in mice (Rauch et al., 2017; Sellin et al., 2014).
However, whether the NAIP/NLRC4 inflammasome recognizes or controls Salmonella infection in
humans has not been thoroughly investigated.
While mice express several different NAIPs that each respond to a particular ligand,
humans only express one functional NAIP (Romanish et al., 2007, 2009). In human
macrophages, this single NAIP is sufficient to respond to the cytosolic delivery of bacterial
flagellin as well as the SPI-1 T3SS inner rod (PrgJ) and needle (PrgI) proteins (Kortmann et al.,
2015; Reyes Ruiz et al., 2017). Interestingly, the SPI-2 T3SS inner rod protein (SsaI) fails to
induce inflammasome activation in both murine and human macrophages (Miao et al., 2010;
Reyes Ruiz et al., 2017), suggesting that the Salmonella SPI-2 T3SS evades NAIP detection to
enable Salmonella replication within macrophages. However, whether the SPI-2 T3SS needle
protein (SsaG) is recognized by NAIP or whether NAIP contributes to the restriction of Salmonella
replication within macrophages is unknown.
In this study, we found that while human macrophages require NAIP and NLRC4 for
inflammasome responses to T3SS ligands, NAIP and NLRC4 are only partially required for the
inflammasome response during Salmonella infection. Rather, we found that Salmonella infection
of human macrophages also activates both the CASP4/5 inflammasome, which senses cytosolic
LPS (Shi et al., 2014), and the NLRP3 inflammasome. Importantly, both the NAIP/NLRC4 and
NLRP3 (NLR pyrin domain-containing protein 3) inflammasomes played a functional role in
restricting Salmonella’s intracellular replication, indicating that they contribute to host defense in a
cell-intrinsic manner, as well as via release of inflammatory mediators. Finally, we found that the
NAIP/NLRC4 inflammasome recognizes the SPI-2 T3SS needle protein SsaG, and that SPI-1
T3SS and flagellin-independent, NAIP/NLRC4-dependent recognition of Salmonella mediates
restriction of bacterial replication within human macrophages. Our findings highlight the
multifaceted inflammasome response to Salmonella infection in human macrophages, and yield
important insight into how human macrophages use inflammasomes to sense and respond to
intracellular bacterial pathogens.
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2.4 Materials and Methods
2.4.1 Ethics statement
All studies involving primary human monocyte-derived macrophages (hMDMs) were
performed in compliance with the requirements of the US Department of Health and Human
Services and the principles expressed in the Declaration of Helsinki. hMDMs were derived from
samples obtained from the University of Pennsylvania Human Immunology Core. These
samples are considered to be a secondary use of deidentified human specimens and are exempt
via Title 55 Part 46, Subpart A of 46.101 (b) of the Code of Federal Regulations.

2.4.2 Bacterial strains and growth conditions
Targeted deletion strains used in this study were made on the Salmonella enterica
serovar Typhimurium SL1344 strain background. The ΔprgIfliCfljB strain was engineered using
the ΔfliCfljB background (Wynosky-Dolfi et al., 2014), in which the SPI-1 T3SS needle, prgI, was
deleted through a chloramphenicol resistance cassette insertion into prgI (fliCfljBprgI::CmR) using
standard methods (Datsenko & Wanner, 2000).
WT, ΔsipB (Lawley et al., 2006), and ΔprgIfliCfljB isogenic strains were routinely grown
overnight in Luria-Bertani (LB) broth with streptomycin (100 μg/ml) at 37°C. For infection of
cultured cells, overnight cultures were diluted in LB containing 300 mM NaCl and grown standing
for 3 hours at 37°C to induce SPI-1 expression (Lee & Falkow, 1990).
Listeria monocytogenes WT and isogenic strains on the 10403S background were
cultured in brain heart infusion (BHI) medium (Sauer et al., 2011). The Listeria strain encoding the
heterologous bacterial ligand S. Typhimurium PrgJ translationally fused to the truncated Nterminus of ActA and under the control of the actA promoter was used (Sauer et al., 2011). The
Listeria strains expressing S. Typhimurium SsaI and SsaG were constructed using codonoptimized gene fragments (IDT) cloned into the pPL2 vector and introduced into Listeria as
previously described (Lauer et al., 2002; Sauer et al., 2011).
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2.4.3 Cell culture of THP-1s
THP-1 cells (TIB-202; American Type Culture Collection) were maintained in RPMI
supplemented with 10% (vol/vol) heat-inactivated FBS, 0.05 nM β-mercaptoethanol, 100 IU/mL
penicillin, and 100 μg/mL streptomycin at 37°C in a humidified incubator. Two days before
experimentation, the cells were replated in media without antibiotics in a 48-well plate at a
concentration of 2 × 105 cells/well and incubated with phorbol 12-myristate 13-acetate (PMA) for
24 hours to allow differentiation into macrophages. Macrophages were primed with 100 ng/mL
Pam3CSK4 (Invivogen) for 16 hours prior to bacterial infections or anthrax toxin treatments. For
experiments involving LPS, cells were pretreated with 500 ng/mL LPS (Sigma-Aldrich) for 3
hours. For experiments involving Nigericin, cells were treated with 10 μM Nigericin (EMD
Millipore) for 6 hours. For experiments involving MCC950, cells were treated with 1 μM MCC950
(Sigma Aldrich) 1 hour prior to infection.

2.4.4 Cell culture of primary human monocyte-derived macrophages (hMDMs)
Purified human monocytes from de-identified healthy human donors were obtained from
the University of Pennsylvania Human Immunology Core. Monocytes were cultured in RPMI
supplemented with 10% (vol/vol) heat-inactivated FBS, 2 mM L-glutamine, 100 IU/mL penicillin,
100 μg/ml streptomycin, and 50 ng/ml recombinant human M-CSF (Gemini Bio-Products) for 6
days to promote differentiation into hMDMs. One day prior to infection, adherent hMDMs were
replated in media with 25 ng/ml human M-CSF lacking antibiotics at 1.0 × 105 cells/well in a 48well plate.
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2.4.5 Bacterial infections
Overnight cultures of Salmonella were diluted into LB broth containing 300 mM NaCl and
grown for 3 hours standing at 37°C to induce SPI-1 expression (Lee & Falkow, 1990). Overnight
cultures of L. monocytogenes were diluted and grown for 3 hours in BHI. All cultures were
pelleted at 6,010 × g for 3 minutes, washed once with PBS, and resuspended in PBS. THP-1
cells were infected with S. Typhimurium or L. monocytogenes at a multiplicity of infection (MOI) of
20. hMDMs were infected with L. monocytogenes at an MOI of 5. Infected cells were centrifuged
at 290 × g for 10 min and incubated at 37°C. 1 hour post-infection, cells were treated with 100
ng/mL or 50 ng/mL of gentamicin to kill any extracellular S. Typhimurium or L. monocytogenes
respectively. Salmonella and Listeria infections in THP-1s proceeded at 37°C for 6 hours. Listeria
infection of hMDMs proceeded at 37°C for 16 hours. For all experiments, control cells were mockinfected with PBS.

2.4.6 Anthrax toxin-mediated delivery of bacterial ligands
Recombinant proteins (PA, LFn-FlaA310-475, LFn-PrgJ, and LFn-YscF) were kindly
provided by Russell Vance (Rauch et al., 2016). PA and LFn doses for in vitro delivery were: 1
μg/ml PA for FlaTox; 4 μg/ml PA for PrgJTox and YscFTox; 500 ng/ml LFn-FlaA310-475; 8 ng/ml
LFn-PrgJ; and 200 ng/mL LFn-YscF.

2.4.7 siRNA-mediated knockdown of genes
All Silencer Select siRNA oligos were purchased from Ambion (Life Technologies). For
CASP4, siRNA ID# s2412 was used. For CASP5, siRNA ID# s2417 was used. The two Silencer
Select negative control siRNAs (Silencer Select Negative Control No. 1 siRNA and Silencer
Select Negative Control No. 2 siRNA) were used as a control. Two days before infection, 30 nM
of siRNA was transfected into macrophages using Lipofectamine RNAiMAX transfection reagent
(Thermo Fisher Scientific) following the manufacturer’s protocol. 16 hours before infection, the
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media was replaced with fresh antibiotic-free media containing 100 ng/ml Pam3CSK4. In parallel,
siRNA-transfected cells were also transfected with 2 μg/ml of E. coli LPS strain W3110 (kindly
provided by Robert Ernst) using FuGENE HD transfection reagent (Promega) for 6 hours.

2.4.8 Bacterial intracellular replication assay
Cells were infected with WT or ΔprgIfliCfljB S. Typhimurium as usual at an MOI of 20. 1
hour post-infection, cells were treated with 100 μg/ml of gentamicin to kill any extracellular
bacteria. 2 hours post-infection, the media was replaced with fresh media containing 10 μg/ml of
gentamicin. At the indicated time points, cells were lysed with PBS containing 0.5% Triton to
collect all intracellular bacteria. Harvested bacteria were serially diluted in PBS and plated on LB
agar with streptomycin (100 μg/ml) plates to enumerate colony forming units (CFUs). Plates were
incubated at 37°C overnight and then CFUs were counted.

2.4.9 ELISAs
Harvested supernatants from infected cells were assayed using ELISA kits for human IL1α (R&D Systems), IL-18 (R&D Systems), IL-1β (BD Biosciences), and TNF-α (R&D Systems).

2.4.10 LDH cytotoxicity assays
Harvested supernatants from infected cells were assayed for cytotoxicity by measuring
loss of cellular membrane integrity via lactate dehydrogenase (LDH) activity. LDH release was
quantified using an LDH Cytotoxicity Detection Kit (Clontech) according to the manufacturer’s
instructions and normalized to mock-infected cells.
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2.4.11 Quantitative RT-PCR analysis
RNA was isolated using the RNeasy Plus Mini Kit (Qiagen) following the manufacturer’s
instructions. Cells were lysed in 350 μL RLT buffer with β-mercaptoethanol and centrifuged
through a QIAshredder spin column (Qiagen). cDNA was synthesized from isolated RNA using
SuperScript II Reverse Transcriptase (Invitrogen) following the manufacturer’s protocol.
Quantitative PCR was conducted with the CFX96 real-time system from Bio-Rad using the
SsoFast EvaGreen Supermix with Low ROX (Bio-Rad). For analysis, mRNA levels of siRNAtreated cells were normalized to housekeeping gene HPRT and control siRNA-treated cells using
the 2−ΔΔCT (cycle threshold) method (Livak & Schmittgen, 2001) to calculate knockdown efficiency.
The following primers from PrimerBank were used. The PrimerBank identifications are CASP4
(73622124c1), and CASP5 (209870072c2), and HPRT (164518913c1); all 5′–3′:
CASP4 forward: CAAGAGAAGCAACGTATGGCA
CASP4 reverse: AGGCAGATGGTCAAACTCTGTA
CASP5 forward: TTCAACACCACATAACGTGTCC
CASP5 reverse: GTCAAGGTTGCTCGTTCTATGG
HPRT forward: CCTGGCGTCGTGATTAGTGAT
HPRT reverse: AGACGTTCAGTCCTGTCCATAA

2.4.12 Generation of CRISPR Cas9 knockouts in THP-1 cells
To knockout NAIP and NLRC4 in THP-1 cells, plasmids encoding the desired guide RNA
(gRNA) and Cas9 in the pLentiCRISPR v2 plasmid were purchased from GenScript. The
following target sequences were used:
NAIP: gRNA 1 (ACATTGCCAAGTACGACATA)
NLRC4: gRNA 1 (AAACATCATTTGCTGCGAGA)
For the production of lentiviral particles, pCMV-VSV-G and psPAX2 plasmids were kindly
provided by Paul Bates at the University of Pennsylvania. HEK293T cells were plated at 2.5 × 106
cells per 10 cm dish in 10 ml of DMEM supplemented with 10% (vol/vol) heat-inactivated FBS, 2
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mM L-glutamine, 100 IU/ml penicillin, and 100 μg/ml streptomycin. After 24 hours, plasmids were
transfected using the Lipofectamine 2000 protocol. The amounts of plasmids used were 1 μg of
pCMV-VSV-G, 2.5 μg of psPAX2, and 8 μg of pLentiCRISPR v2 encoding the appropriate gRNA.
50 μl of Lipofectamine 2000 was used per dish. Transfected HEK293T cells were incubated for
18 hours at 37°C, and the media was then aspirated and replaced with 6 ml of fresh growth
media. After 16 - 18 hours, the supernatant containing lentiviral particles was harvested and
filtered using a 0.22 μM filter. THP-1 cells were infected in 1 ml of viral-containing media with 8
μg/ml of polybrene. The cells were spin-infected at 1250 ́× g for 90 min at 25°C, then incubated at
37°C for 48 hours. After 48 hours, puromycin was added to a final concentration of 1 μg/ml. The
cells were maintained in puromycin for 3 weeks and then harvested for Western Blot analysis and
clonal selection. For clonal selection, cells were plated in 96-well plates at 0.5 cell per well or 2
cells per well in 200 μl of growth media and were incubated for 4-8 weeks until single clones were
visible in the bottom of the well. Single cell clones were then expanded from a 96-well plate
through a series of multi-well plates ending in 10 cm dishes. Cells were then plated in 48-well
plates at a concentration of 2 × 105 cells per well in 500 μl of media and harvested for purification
of RNA, DNA, and Western Blot assays.

2.4.13 Validation of CRISPR Cas9 THP-1 single clones for knockouts
To validate single cell clones after CRISPR Cas9 editing, DNA was purified using the
DNeasy Blood and Tissue kit (Qiagen). The genomic region containing the target sequence was
then amplified by PCR using the following primers (all 5’ to 3’):
NAIP forward: CCGTACAGCTCATGGATACCACAG
NAIP reverse: GTACCTGTAAAGACAAAGCCAGCC
NLRC4 forward: CCCAGCCGGATATGCACATT
NLRC4 reverse: TCTGCCATGGGGAAGATGGAT
The PCR product was purified using the PCR Cleanup kit (Qiagen). A poly A-tail was
added to the purified PCR product by adding together 7 μl of PCR product, 5 Units of Taq DNA
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polymerase, 1X PCR Buffer containing MgCl2, and 0.2mM dATP. The reaction was then
incubated at 70°C for 30 minutes. 2 μl of this product was then ligated into the pGEM-T vector
and transformed into DH5α competent cells using the protocol in the pGEM-T Vector System
Protocol (A1360; Promega). Positive colonies were sequenced using a T7 Promoter Primer (5′
TAATACGACTCACTATAGGG 3′).

2.4.14 Quantitative RT-PCR Analysis of NAIP-/- THP-1s
Cells were lysed and RNA was isolated using the RNeasy Plus Kit (Qiagen). Synthesis of
the first strand cDNA was performed using Superscript II reverse transcriptase and oligo (dT)
primer (Invitrogen). Quantitative PCR was performed with the CFX96 real-time system (Bio-Rad)
using the SsoFast EvaGreen Supermix with LOW ROX kit (Bio-Rad). The following primers were
used (all 5’-3’):
NAIP forward: GCATTCTCCTCTATTAGACTAG
NAIP reverse: GCCAACTGAACTGCATCTAG
HPRT forward: CCTGGCGTCGTGATTAGTGAT
HPRT reverse: AGACGTTCAGTCCTGTCCATAA
For analysis, mRNA levels of CRISPR-modified THP-1 cells were normalized to control
THP-1 cells using the 2−ΔΔCT (cycle threshold) method (Livak & Schmittgen, 2001) to calculate fold
induction.

2.4.15 Immunoblotting of NLRC4-/- THP-1s
Cells were lysed directly with 1X SDS-PAGE sample buffer. Protein samples were boiled
for 5 minutes, separated by SDS-PAGE, and transferred to a PVDF Immobilon-P membranes
(Millipore). Samples were then probed with antibody specific for NLRC4 (12421S; Cell Signaling).
As a loading control, the blot was probed with anti-β-actin (4967L; Cell Signaling). Detection was
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performed with HRP-conjugated anti-mouse IgG (F00011; Cell Signaling) or anti-rabbit IgG
(7074S; Cell Signaling).

2.4.16 Three-dimensional structure prediction using PHYRE2
The PHYRE2 server was used for protein modeling, prediction, and analysis of the
published protein sequence for SsaG from Salmonella Typhimurium SL1344. The sequence is
shown below (N terminus to C terminus):
MDIAQLVDMLSHMAHQAGQAINDKMNGNDLLNPESMIKAQFALQQYSTFINYESSLIKMI
KDMLSGIIAKI
PHYRE2 is a powerful and inexpensive bioinformatics tool to that uses homology-based
modeling to predict the three-dimensional structure of proteins (Kelley et al., 2015; Phyre2:
Protein Homology/Analogy Recognition Engine V 2.0, n.d.). For the structural modeling of SsaG,
the confidence score was 98% and the coverage was 96%. Thus, the structure predicted for
SsaG is considered to be highly confident with high coverage.

2.4.17 Statistical analysis
Prism 9.1.1 (GraphPad Software) was utilized for the graphing of data and all statistical
analyses. Statistical significance for experiments with THP-1 cells was determined using the
appropriate test and are indicated in each figure legend. Differences were considered statistically
significant if the p value was <0.05.

2.5 Results
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2.5.1 NAIP and NLRC4 are necessary for inflammasome responses to T3SS
ligands in human macrophages
In murine macrophages, multiple NAIPs are required for inflammasome responses to the
Salmonella SPI-1 T3SS inner rod protein (PrgJ), the SPI-1 T3SS needle protein (PrgI), and
flagellin (Kofoed & Vance, 2011; Rauch et al., 2016; Rayamajhi et al., 2013; J. Yang et al., 2013;
Zhao et al., 2011, 2016). In addition, the murine NAIPs and NLRC4 contribute to the
inflammasome response during in vivo Salmonella infection (Miao et al., 2010; Zhao et al., 2016).
In human macrophages, PrgJ, PrgI, and flagellin all activate the inflammasome, while the
Salmonella SPI-2 inner rod protein (SsaI) does not (Kortmann et al., 2015; Reyes Ruiz et al.,
2017). Using siRNA-mediated silencing of NAIP in human macrophages, we have previously
shown that human NAIP is important for maximal inflammasome responses to PrgJ and flagellin
(Reyes Ruiz et al., 2017). However, siRNA-mediated knockdown of NAIP did not completely
abrogate inflammasome activation, either due to incomplete knockdown, or the potential
contribution of other inflammasomes. Therefore, it remained unclear whether human NAIP or
NLRC4 is absolutely required for inflammasome responses to these bacterial ligands or whether
additional host sensors also mediate sensing of these ligands.
To test the requirement of the NAIP/NLRC4 inflammasome in human macrophages, we
used the Clustered Regularly Interspersed Palindromic Repeat (CRISPR) system, in conjunction
with the RNA-guided exonuclease Cas9, to disrupt the NAIP and NLRC4 genes in the human
monocytic cell line, THP-1 (Fig. 2.1A, 2.2A). We selected one independent single cell clone of
NAIP-/- THP-1s (NAIP-/- Clone 12) that exhibited reduced NAIP mRNA expression by qRT-PCR
compared to WT THP-1s (Fig. 2.1C). Sequence validation confirmed that this clone contained a
deletion of 1 or 2 nucleotides in both NAIP alleles, resulting in premature stop codons (Fig. 2.1B).
We selected two independent single cell clones of NLRC4-/- THP-1s (NLRC4-/- Clone 4 and Clone
7), both of which showed complete loss of NLRC4 protein expression compared to WT THP-1s
(Fig. 2.1D). Both clones were sequence-validated and both alleles of each clone contained
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mutations that resulted in premature stop codons (Fig. 2.2B, 2.2C). These sequence-validated
NAIP-/- and NLRC4-/- THP-1 clones were used throughout this study.
To test if NAIP and NLRC4 are necessary for sensing and responding to bacterial T3SS
ligands, we compared inflammasome responses in wild type (WT), NAIP-/-, and NLRC4-/- THP-1
macrophages to T3SS ligands delivered directly into the host cell cytosol. We used the Bacillus
anthracis toxin system to deliver these bacterial ligands into the cytosol of THP-1s (von Moltke et
al., 2012). This system contains two subunits: a protective antigen (PA) that creates a pore in the
host endosomal membrane and a truncated lethal factor (LFn) that is delivered through the PA
pore into the cytosol. Our T3SS ligands of interest are fused to the N-terminal domain of the B.
anthracis LFn. When the LFn is added to eukaryotic cells in conjunction with PA (collectively
referred to as Tox), the bacterial ligand is delivered directly into the host cell cytosol. Using this
system, we delivered a truncated version of Legionella flagellin (FlaTox), the Salmonella SPI-1
T3SS inner rod protein (PrgJTox), and the Burkholderia T3SS needle protein (YscFTox) into
THP-1s. We then measured the release of the inflammasome-dependent IL-1 family cytokines IL1α, IL-1β, and IL-18 and cell death as markers of inflammasome activation. Cells left untreated
(Mock) or treated with the PA alone or the LFn fused to the bacterial ligand alone released
negligible levels of IL-1β, IL-18, and IL-1α and exhibited minimal cell death (Fig. 2.3A, 2.3C, 2.4AC, 2.5A-C). In agreement with previous findings (Reyes Ruiz et al., 2017), WT THP-1s treated
with both the PA and LFn subunits exhibited robust inflammasome activation, and released
substantial levels of IL-1β, IL-18, and IL-1α and exhibited considerable cytotoxicity (Fig. 2.3A,
2.3C, 2.4A-C, 2.5A-C), indicating that robust inflammasome activation requires cytosolic delivery
of the ligands. In contrast, both NAIP-/- THP-1s and NLRC4-/- THP-1s released negligible levels of
inflammasome-dependent cytokines and did not undergo cell death when treated with FlaTox,
PrgJTox, or YscFTox (Fig 2.3A, 2.3C, 2.4A-C, 2.5A-C). Importantly, the NAIP-/- and NLRC4-/THP-1s released IL-1β at levels comparable to those released by WT THP-1s in response to the
NLRP3 stimulus LPS + nigericin (Fig. 2.3B, 2.3D), indicating that CRISPR/Cas9 editing was
specific to the NAIP/NLRC4 inflammasome pathway (Mariathasan et al., 2006). In addition,
release of the inflammasome-independent cytokine TNF-α was unaffected in NAIP-/- or NLRC4-/-
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THP-1s (Fig. 2.4D, 2.5D). Consistent with our prior results (Reyes Ruiz et al., 2017) and in
agreement with recent studies (Gram et al., 2021), these results collectively demonstrate that
NAIP and NLRC4 are required for inflammasome activation in response to the T3SS inner rod,
T3SS needle, and flagellin proteins in human macrophages.
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Figure 2.1: Validation of NAIP mutant THP-1 single cell clone generated with CRISPR/Cas9
genome editing.
(A) Schematic representation of the NAIP gene with exons (filled boxes) and introns (filled lines).
gRNA target sequence is highlighted in red. (B) Sequence alignments of WT THP-1 and NAIP-/-
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clone 12 are shown for both alleles. Red boxes represent the mutated region. Purple text
represents the predicted impact of the mutation on the amino acid sequence. (C) qRT-PCR was
performed to quantitate NAIP mRNA levels in WT THP-1 and NAIP-/- THP-1 cells. For the NAIP-/THP-1 cells, NAIP mRNA levels were normalized to human HPRT mRNA levels and WT THP-1
cells.
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Figure 2.2: Validation of NLRC4 mutant THP-1 single cell clones generated with
CRISPR/Cas9-mediated genome editing.
(A) Schematic representation of the NLRC4 gene with exons (filled boxes) and introns (lines).
gRNA target sequence is highlighted in red. (B-C) Sequence alignments of WT THP-1 and
NLRC4-/- clones are shown for both alleles per clone. Red boxes highlight the mutated region.
Purple text represents the predicted impact of the mutation on the amino acid sequence. (D)
Immunoblot analysis was performed on cell lysates for human NLRC4, and β-actin as a loading
control.

Figure 2.3: NAIP and NLRC4 are necessary for inflammasome responses to T3SS ligands
in human macrophages.
WT, NAIP-/- clone, or two independent clones of NLRC4-/- THP-1 monocyte-derived macrophages
were primed with 100 ng/mL Pam3CSK4 for 16 hours. Cells were then treated with PBS (Mock),
PA alone, LFnFlaA310–475 alone, LFnPrgJ alone, LFnYscF alone, PA+LFnFlaA310–475 (FlaTox),
PA+LFnPrgJ (PrgJTox), or PA+LFnYscF (YscFTox) for 6 hours (A, C). As a control, cells were
primed with 500 ng/mL LPS for 4 hours and treated with 10 µM nigericin for 6 hours (B, D).
Release of IL-1β into the supernatant was measured by ELISA. ns – not significant, *p < 0.05, **p
< 0.01, ****p < 0.0001 by Šídák’s multiple comparisons test (A), or by unpaired t-test (B), or by
Dunnett’s multiple comparisons test (C, D). Data shown are representative of at least three
independent experiments.
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Figure 2.4: NAIP is necessary for inflammasome responses to T3SS ligands in human
macrophages.
WT or NAIP-/- THP-1 monocyte-derived macrophages were primed with 100 ng/ml Pam3CSK4 for
16 hours. Cells were then treated with PBS (Mock), PA alone, LFn FlaA310–475 alone, LFn PrgJ
alone, LFn YscF alone, PA+LFn FlaA310–475 (FlaTox), PA+LFn PrgJ (PrgJTox), or PA+LFn YscF
(YscFTox) for 6 hours. (A, B, D) Release of cytokines IL-18, IL-1α, and TNF-α into the
supernatant were measured by ELISA. (C) Cell death (percentage cytotoxicity) was measured by
lactate dehydrogenase release assay and normalized to Mock-treated cells. ns – not significant,
**p < 0.01, ****p < 0.0001 by Šídák’s multiple comparisons test. Data shown are representative of
at least three independent experiments.
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Figure 2.5: NLRC4 is necessary for inflammasome responses to T3SS ligands in human
macrophages.
WT or two independent clones of NLRC4-/- THP-1 monocyte-derived macrophages were primed
with 100 ng/mL Pam3CSK4 for 16 hours. Cells were then treated with PBS (Mock), PA alone,
LFn FlaA310–475 alone, LFn PrgJ alone, LFn YscF alone, PA+LFn FlaA310–475 (FlaTox), PA+LFn
PrgJ (PrgJTox), or PA+LFn YscF (YscFTox) for 6 hours. (A, B, D) Release of cytokines IL-18, IL1α, and TNF-α into the supernatant were measured by ELISA. (C) Cell death (percentage
cytotoxicity) was measured by lactate dehydrogenase release assay and normalized to Mocktreated cells. ns – not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by Dunnett’s
multiple comparisons test (A-C). Data shown are representative of at least three independent
experiments.
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2.5.2 NAIP and NLRC4 are partially required for inflammasome activation during
Salmonella infection of human macrophages
Human macrophages undergo SPI-1 T3SS-dependent inflammasome activation during
Salmonella infection (Reyes Ruiz et al., 2017). To test whether this inflammasome activation
requires NAIP/NLRC4, we infected WT, NAIP-/-, or NLRC4-/- THP-1 macrophages with WT
Salmonella (WT Stm) or Salmonella lacking its SPI-1 T3SS (ΔsipB Stm) and assayed for
subsequent inflammasome activation (Fig. 2.6, 2.7). WT THP-1s infected with WT Stm released
high levels of IL-1β, IL-18, and IL-1α and underwent cell death (Fig. 2.6, 2.7A-D). This response
was dependent on SPI-1 T3SS translocation into host cells, as cells infected with ΔsipB Stm,
which lack a component of the translocon, failed to undergo robust inflammasome activation (Fig.
2.6, 2.7A-D). In NAIP-/- or NLRC4-/- THP-1 macrophages infected with WT Stm, we observed a
significant decrease but not complete abrogation of secreted IL-1β and IL-18 levels (Fig. 2.6),
whereas levels of IL-1α and cell death were largely unaffected (Fig. 2.7A–D). WT and NAIP-/- or
NLRC4-/- THP-1s released similar levels of the inflammasome-independent cytokine TNF-α (Fig.
2.7E, F). Overall, these data indicate that NAIP and NLRC4 are partially required for
inflammasome responses to Salmonella infection in human macrophages, in contrast to what we
observe with individual T3SS ligand delivery (Fig. 2.3 – 2.5), where NAIP/NLRC4 is absolutely
required for inflammasome activation. Thus, our data indicate that in addition to the NAIP/NLRC4
inflammasome, Salmonella also induces a NAIP/NLRC4-independent inflammasome response, in
agreement with a recent study (Gram et al., 2021).
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Figure 2.6: NAIP and NLRC4 are partially required for inflammasome activation during
Salmonella infection in human macrophages.
WT, NAIP-/- clone, or two independent clones of NLRC4-/- THP-1 monocyte-derived macrophages
were primed with 100 ng/mL Pam3CSK4 for 16 hours. Cells were then infected with PBS (Mock),
WT S. Typhimurium, or ΔsipB S. Typhimurium for 6 hours. Release of IL-1β and IL-18 into the
supernatant were measured by ELISA. ns – not significant, ***p < 0.001, ****p < 0.0001 by
Šídák’s multiple comparisons test (A, C) or Dunnett’s multiple comparisons test (B, D). Data
shown are representative of at least three independent experiments.
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Figure 2.7: NAIP and NLRC4 are partially required for inflammasome activation during
Salmonella infection in human macrophages.
WT, NAIP-/-, or two independent clones of NLRC4-/- THP-1 monocyte-derived macrophages were
primed with 100 ng/µL Pam3CSK4 for 16 hours. Cells were then infected with PBS (Mock), WT
S. Typhimurium, or ΔsipB S. Typhimurium for 6 hours. As a control, cells were primed with 500
ng/mL LPS for 4 hours and treated with 10 µM nigericin for 6 hours. (A, C, E, F) Release of
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cytokines IL-1α and TNF-α into the supernatant were measured by ELISA. (B, D) Cell death
(percentage cytotoxity) was measured by lactate dehydrogenase release assay and normalized
to Mock-treated cells. ns – not significant, *p < 0.05, ***p < 0.001 by Šídák’s multiple comparisons
test (A, B, E) or by Dunnett’s multiple comparisons test (C, D, F). Data shown are representative
of at least three independent experiments.

2.5.3 Salmonella induces NAIP/NLRC4- and NLRP3-dependent inflammasome
activation in human macrophages
In murine macrophages, Salmonella infection activates both the NAIP/NLRC4 and
NLRP3 inflammasomes (Broz et al., 2010). The NAIP/NLRC4 inflammasome is important for
early responses to Salmonella in the setting of SPI-1 activation, while the NLRP3 inflammasome
is important at later timepoints following bacterial replication (Man et al., 2014). In human THP-1s,
Salmonella infection triggers recruitment of both NLRC4 and NLRP3 to the same macromolecular
complex (Man et al., 2014). The NLRP3 inflammasome can be activated by diverse stimuli during
bacterial infection, such as potassium efflux (Muñoz-Planillo et al., 2013). To determine if the
NAIP/NLRC4-independent inflammasome response we observed in our Salmonella-infected
human macrophages is NLRP3-dependent, we infected WT, NAIP-/-, or NLRC4-/- THP-1s with
Salmonella in the presence of MCC950, a potent chemical inhibitor of the NLRP3 inflammasome
(Coll et al., 2015), or the vehicle control DMSO. We subsequently assayed for inflammasome
activation by measuring IL-1α, IL-1β, and IL-18 secretion (Fig. 2.8, 2.9). WT THP-1s treated with
DMSO control released substantial amounts of IL-1α, IL-1β, and IL-18 when infected with WT
Stm. In contrast, infected WT THP-1s treated with MCC950 secreted decreased levels of IL-1α,
IL-1β, and IL-18, which are comparable to levels observed in WT Stm-infected NAIP-/- or NLRC4-/THP-1s. (Fig. 2.8, 2.9A-D). Interestingly, WT Stm-infected NAIP-/- or NLRC4-/- THP-1s treated
with MCC950 largely had significantly decreased IL-1α, IL-1β, and IL-18 secretion compared to
infected NAIP-/- or NLRC4-/- THP-1s treated with DMSO or infected WT THP-1s treated with
MCC950 (Fig. 2.8, 2.9A-D). Furthermore, NAIP-/- or NLRC4-/- THP-1s treated with MCC950
secreted negligible levels of IL-1α, IL-1β, and IL-18, similar to those observed during ΔsipB Stm
infection (Fig. 2.8, 2.9A-D). WT, NAIP-/-, and NLRC4-/- THP-1s demonstrated robust IL-1α, IL-1β,
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and IL-18 secretion in response to LPS + nigericin that was significantly reduced by MCC950
treatment, indicating that this inhibitor effectively blocked NLRP3 inflammasome activation, as
expected (Fig. 2.8, 2.9A-D). Release of the inflammasome-independent cytokine TNF-α was
similar across the various THP-1 genotypes and treatments following infection (Fig. 2.9E, F).
Altogether, these data indicate that Salmonella infection induces both NAIP/NLRC4- and NLRP3dependent inflammasome activation in human macrophages.
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Figure 2.8: Salmonella induces NAIP/NLRC4- and NLRP3-dependent inflammasome
activation in human macrophages.
WT, NAIP-/-, or NLRC4-/- THP-1 monocyte-derived macrophages were primed with 100 ng/mL
Pam3CSK4 for 16 hours. One hour prior to infection, cells were treated with 1 µM MCC950, a
chemical inhibitor of the NLRP3 inflammasome or DMSO as a control. Cells were then infected
with PBS (Mock), WT S. Typhimurium, or ΔsipB S. Typhimurium for 6 hours. As a control, cells
were primed with 500 ng/mL LPS for 4 hours and treated with 10 µM nigericin for 6 hours.
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Release of IL-1β into the supernatant was measured by ELISA. ns – not significant, *p < 0.05, **p
< 0.01, ***p < 0.001, ****p < 0.0001 by Tukey’s multiple comparisons test (A, C) or by Šídák’s
multiple comparisons test (B, D). Data shown are representative of at least three independent
experiments.

60

Figure 2.9: Salmonella induces NAIP/NLRC4- and NLRP3-dependent inflammasome
activation in human macrophages.
WT, NAIP-/-, or NLRC4-/- THP-1 monocyte-derived macrophages were primed with 100 ng/uL
Pam3CSK4 for 16 hours. One hour prior to infection, cells were treated with 1 µM MCC950, a
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chemical inhibitor of the NLRP3 inflammasome. Cells were then infected with PBS (Mock), WT S.
Typhimurium, or ΔsipB S. Typhimurium for 6 hours. (B) As a control, cells were primed with 500
ng/mL LPS for 4 hours and treated with 10 µM nigericin for 6 hours. (A-F) Release of cytokines
IL-18, IL-1α, TNF-α into the supernatant were measured by ELISA. ns – not significant, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 by Tukey’s multiple comparisons test.

2.5.4 Salmonella induces NAIP/NLRC4- and CASP4/5-dependent inflammasome
activation in human macrophages
In mice, in addition to the NAIP/NLRC4 and NLRP3 inflammasomes, Salmonella infection
can also activate the caspase-11 inflammasome (Broz et al., 2012). Caspase-11 detects cytosolic
LPS and forms the noncanonical inflammasome, which secondarily activates the NLRP3
inflammasome (Schmid-Burgk et al., 2015; Shi et al., 2014). Caspases-4 and 5 are human
orthologs of murine caspase-11 (Shi et al., 2014), and they can also sense cytosolic LPS to form
the noncanonical inflammasome in human cells. We have previously observed caspase-4dependent inflammasome activation in response to Salmonella infection in primary human
macrophages (Casson et al., 2015), and caspases-4 and 5 also contribute to inflammasome
responses to Salmonella infection in THP-1s and human intestinal epithelial cells (Baker et al.,
2015; Knodler et al., 2014). To test the relative contribution of both caspases-4 and 5 to NAIPindependent inflammasome responses during Salmonella infection of THP-1 macrophages, we
treated WT or NAIP-/- THP-1s with siRNAs targeting CASP4, CASP5, or both, achieving ~70-90%
knockdown efficiency at the mRNA level (Fig. 2.10), and subsequently assayed for IL-1β
secretion in response to WT Stm. WT THP-1s treated with either CASP4 or CASP5 siRNAs
exhibited significantly decreased IL-1β secretion following WT Stm infection relative to WT THP1s treated with control siRNA (Fig. 2.11A & B), in agreement with our previous observations in
primary human macrophages (Casson et al., 2015). NAIP-/- THP-1s treated with CASP5 siRNA
showed a slight but significant decrease in IL-1β secretion following CASP5 siRNA treatment, but
not CASP4 siRNA treatment, compared to control siRNA-treated cells following WT Stm infection
(Fig. 2.11A & B). WT and NAIP-/- THP-1s treated with both CASP4 and CASP5 siRNAs displayed
significantly reduced IL-1β secretion relative to THP-1s treated with a scrambled control siRNA,
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although inflammasome activation was not completely abrogated when both CASP4 and CASP5
were knocked down in NAIP-/- THP-1 cells (Fig. 2.11C). As a control, we assessed inflammasome
activation in response to transfected E. coli LPS, which activates the caspase-4/5 inflammasome.
Both WT and NAIP-/- cells transfected with LPS displayed significantly decreased IL-1β secretion
when CASP4 was silenced, either alone or in conjunction with CASP5 (Fig. 2.11A & C), whereas
knockdown of CASP5 alone did not significantly affect IL-1β secretion, as expected (Baker et al.,
2015) (Fig. 2.11B). Taken together, these data suggest that the caspase-4/5 inflammasome is
involved in the NAIP-independent response to Salmonella.
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Figure 2.10: Salmonella induces NAIP- and CASP4/5-dependent inflammasome activation
in human macrophages.
WT or NAIP-/- THP-1 monocyte-derived macrophages were treated with siRNA targeting a control
scrambled siRNA, siRNA targeting CASP4 or CASP5, or siRNA targeting both CASP4 and
CASP5 for 48 hours. Cells were primed with 100 ng/mL Pam3CSK4 for 16 hours. Cells were then
infected with PBS (Mock) or WT S. Typhimurium for 6 hours. Release of IL-1β into the
supernatant were measured by ELISA. As a control, cells were transfected with LPS. ns – not
significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by Tukey’s multiple comparisons
test. Data shown are representative of at least three independent experiments.

Figure 2.11: Knockdown efficiencies of siRNA-mediated silencing of CASP4 and CASP5 in
human macrophages.
Knockdown efficiencies following siRNA treatment were measured by qRT-PCR and normalized
to housekeeping gene HPRT, and calculated relative to control-siRNA-treated cells. (A) siRNA
targeting CASP4 or CASP5. (B) siRNA targeting CASP4 and CASP5. Data shown are averages
of at least three independent experiments.

2.5.5 The NAIP/NLRC4 and NLRP3 inflammasomes restrict Salmonella replication
within human macrophages
One of the mechanisms by which inflammasome activation leads to control of bacterial
infection is by restricting intracellular bacterial replication. In mice, the NAIP/NLRC4
inflammasome is important for controlling Salmonella replication in the intestine (Rauch et al.,
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2017), whereas the NLRP3 inflammasome is dispensable for control of Salmonella infection in
vivo (De Jong et al., 2014; Hausmann et al., 2020). Caspases-1 and 11 restrict cytosolic
Salmonella replication within murine macrophages (Thurston et al., 2016). Whether
inflammasome activation restricts WT Salmonella replication in human macrophages is unknown.
To test the hypothesis that inflammasome activation restricts Salmonella replication within human
macrophages, we infected WT or NAIP-/- THP-1 macrophages with WT Stm in the presence or
absence of the NLRP3 inhibitor MCC950 and determined the bacterial colony forming units (CFU)
at various timepoints post-infection to assay bacterial replication (Fig. 2.12, 2.13). At 2 hours
post-infection, we did not observe any differences in bacterial uptake between the different
conditions (Fig. 2.13A). At 6 or 24 hours post-infection, the bacterial burden was the lowest in WT
THP-1s, whereas NAIP-/- THP-1s harbored significantly higher bacterial burdens (Fig. 2.12A,
2.13B). WT THP-1s treated with MCC950 also contained a significantly higher number of
bacterial CFUs, comparable to those in NAIP-/- THP-1s (Fig. 2.12A, 2.13B). NAIP-/- THP-1s
treated with MCC950 had the highest bacterial burdens, which were significantly higher than the
bacterial burdens in DMSO control-treated NAIP-/- THP-1s or WT THP-s treated with MCC950
(Fig. 2.12A). We then examined the fold-change in bacterial replication at 6 and 24 hours relative
to 2 hours post-infection. The fold-change in bacterial replication was restricted the most
effectively in WT THP-1s, moderately restricted in NAIP-/- THP-1s or WT THP-1s treated with
MCC950, and the least restricted in NAIP-/- THP-1s treated with MCC950 (Fig. 2.12B).
Collectively, these data suggest that both the NAIP/NLRC4 and NLRP3 inflammasomes restrict
intracellular Salmonella replication within human macrophages at both early (6 hours postinfection) and late (24 hours post-infection) timepoints.
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Figure 2.12: The NAIP and NLRP3 inflammasomes restrict Salmonella replication within
human macrophages.
WT or NAIP-/- THP-1 monocyte-derived macrophages were primed with 100 ng/mL Pam3CSK4
for 16 hours. One hour prior to infection, cells were treated with 1 µM MCC950, a chemical
inhibitor of the NLRP3 inflammasome or DMSO as a control. Cells were then infected with PBS
(Mock) or WT S. Typhimurium. Cells were lysed at the indicated time points and bacteria were
plated to calculate CFU. (A) CFU/well of bacteria at 6 hpi (B) Fold change in CFU/well of bacteria
at indicated time point, relative to 2 hpi CFU/well. ns – not significant, ***p < 0.001, ****p < 0.0001
by Dunnett’s multiple comparisons test (A) or Tukey’s multiple comparisons test (B). Data shown
are representative of at least three independent experiments.

66

Figure 2.13: NAIP and NLRP3 restrict replication of Salmonella in human macrophages.
WT or NAIP-/- THP-1 monocyte-derived macrophages were primed with 100 ng/ml Pam3CSK4 for
16 hours. One hour prior to infection, cells were treated with 1 µM MCC950 or DMSO as a
control. Cells were then infected with WT S. Typhimurium. Cells were lysed at the indicated time
points and bacterial were plated to calculate CFU. (A) CFU/well of bacteria at 2 hpi (B) CFU/well
of bacteria at 24 hpi. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by Tukey’s multiple
comparisons test. Data shown are representative of at least three independent experiments.
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2.5.6 Salmonella SPI-2 needle protein SsaG activates the NAIP/NLRC4
inflammasome in human macrophages
The Salmonella flagellin, SPI-1 T3SS inner rod (PrgJ), and needle (PrgI) proteins all
activate NAIP in primary human macrophages, whereas the Salmonella SPI-2 T3SS inner rod
protein (SsaI) is not sensed by NAIP (Kortmann et al., 2015; Reyes Ruiz et al., 2017). Similarly in
mice, SsaI is not sensed by NAIP2 (Miao et al., 2010). These findings have led to models
proposing that the SPI-2 T3SS evades inflammasome detection to allow Salmonella to replicate
or persist in both murine and human cells (Miao et al., 2010; Reyes Ruiz et al., 2017). However,
our data indicate that the NAIP/NLRC4 inflammasome restricts Salmonella replication within
macrophages even at late timepoints, when the SPI-1 T3SS and flagellin are thought to be
downregulated (Adams et al., 2001; Boddicker & Jones, 2004; Lou et al., 2019). As Salmonella
utilizes the SPI-2 T3SS to replicate within macrophages (Haraga et al., 2008), we asked whether
the human NAIP/NLRC4 inflammasome detects the SPI-2 T3SS needle SsaG. To address this
question, we delivered bacterial ligands into the cytosol of primary human monocyte-derived
macrophages (hMDMs) derived from anonymous healthy human donors using the Gram-positive
bacterium Listeria monocytogenes, which, upon infection, escapes from its vacuole into the
cytosol where it expresses the protein ActA on its surface. Fusing bacterial ligands of interest to
the N-terminus of truncated ActA allows these ligands to be delivered into the host cytosol, where
they trigger NAIP/NLRC4 inflammasome activation (Reyes Ruiz et al., 2017; Sauer et al., 2011).
We infected hMDMs with WT Listeria (Lm) or Listeria expressing PrgJ, SsaI, or SsaG and
assayed for inflammasome activation (Fig. 2.14A, 2.15). hMDMs infected with Listeria expressing
the SPI-1 T3SS inner rod protein PrgJ induced robust inflammasome activation, indicated by
significantly increased IL-18 secretion as well as robust IL-1α and IL-1β secretion compared to
mock infection or WT Lm infection alone (Fig. 2.14A, 2.15), in agreement with our previous
findings (Reyes Ruiz et al., 2017). In contrast, and as we previously observed (Reyes Ruiz et al.,
2017), Listeria expressing the SPI-2 inner rod protein SsaI failed to induce IL-1β, IL-18, and IL-1α
secretion or cell death in hMDMs (Fig. 2.14A, 2.15). Intriguingly, we observed that Listeria
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expressing the SPI-2 needle protein SsaG induced significantly increased IL-18 and robust IL-1α
and IL-1β secretion compared to mock infection or WT Lm infection alone (Fig. 2.14A, 2.15).
To test whether NAIP or NLRC4 are required for inflammasome responses to SsaG, we
infected WT, NAIP-/-, and NLRC4-/- THP-1s with WT Listeria (Lm) or Listeria expressing PrgI or
SsaG and assayed for subsequent inflammasome activation by measuring levels of IL-1β, IL-18,
and IL-1α secretion and cell death (Fig. 2.14B, 2.16). Infection of WT THP-1s with Listeria
expressing PrgI or SsaG led to robust release of IL-1 cytokines and cytotoxicity. In contrast,
NAIP-/- and NLRC4-/- THP-1s infected with Listeria expressing PrgI or SsaG released significantly
reduced levels of IL-1 cytokines and cell death relative to WT THP-1s that were comparable to
the background levels secreted by THP-1s infected with WT Lm (Fig. 2.14B, 2.16). Altogether,
these data demonstrate that the SPI-2 needle protein activates the human NAIP/NLRC4
inflammasome, providing evidence that human NAIP can sense and respond to the Salmonella
SPI-2 T3SS.

Figure 2.14: Salmonella SPI-2 needle protein SsaG activates the NAIP/NLRC4
inflammasome in human macrophages.
(A) Primary hMDMs from four healthy human donors were infected with PBS (Mock), WT Listeria
(WT Lm), Listeria expressing PrgJ (Lm + PrgJ), SsaI (Lm + SsaI), or SsaG (Lm + SsaG) for 16
hours at MOI=5. Release of IL-18 into the supernatant was measured by ELISA. Each dot
represents the mean of individual donors derived from triplicate wells. The grey bar represents
the mean of all donors. (B) WT or NAIP-/-, NLRC4-/- THP-1 monocyte-derived macrophages were
primed with 100 ng/mL Pam3CSK4 for 16 hours. Cells were treated with PBS (Mock), WT Listeria
(WT Lm), Listeria expressing PrgI (Lm + PrgI), or SsaG (Lm + SsaG) for 6 hours at MOI=20.
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Release of IL-1β into the supernatant was measured by ELISA. ns – not significant, ***p < 0.001,
****p < 0.0001 paired t-test (A) or by Tukey’s multiple comparisons test (B). Data shown are
representative of at least three independent experiments.

Figure 2.15: Salmonella SPI-2 needle protein SsaG activates the inflammasome in human
macrophages.
Primary hMDMs from four healthy human donors was infected with PBS (Mock), WT Listeria (WT
Lm), Listeria expressing PrgJ (Lm + PrgJ), SsaI (Lm + SsaI), or SsaG (Lm + SsaG) for 16 hours
at MOI=5. Each dot represents the triplicate mean of one donor. The grey bar represents the
mean of all donors. Release of cytokines IL-1β and IL-1α, was measured by ELISA. p values
based on paired t-tests.
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Figure 2.16: NAIP/NLRC4 are necessary for inflammasome responses to the Salmonella
SPI-2 needle protein SsaG in human macrophages.
WT, NAIP-/-, or NLRC4-/- THP-1 monocyte-derived macrophages were primed with 100 ng/ml
Pam3CSK4 for 16 hours. Cells were then treated with PBS (Mock), WT Listeria (WT Lm), Listeria
expressing PrgI (Lm + PrgJ) or SsaG (Lm + SsaG) for 6 hours at MOI=20. (A, B) Release of
cytokines IL-18, and IL-1α was measured by ELISA. (C) Cell death was measured by lactate
dehydrogenase (LDH) release. ns – not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p <
0.0001 by Dunnett’s multiple comparisons test. Data shown are representative of at least three
independent experiments.
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2.5.7 NAIP/NLRC4 inflammasome recognition of the SPI-2 T3SS restricts
Salmonella replication in human macrophages
To determine if NAIP/NLRC4-mediated recognition of the SPI-2 T3SS needle restricts
Salmonella intracellular replication, we generated a Salmonella mutant strain (ΔprgIfliCfljB)
lacking flagellin and the SPI-1 T3SS needle protein, PrgI. This strain is therefore unable to
assemble a functional SPI-1 T3SS, but still expresses a functional SPI-2 T3SS. We infected WT
or NAIP-/- THP-1 macrophages with ΔprgIfliCfljB and determined the CFUs at various timepoints
to assay bacterial replication (Fig. 7, S11). Bacterial replication of ΔprgIfliCfljB over a 24-hour
post-infection time course was restricted the most effectively in WT THP-1s and was significantly
less restricted in NAIP-/- THP-1s (Fig. 7, S11). Collectively, our data suggest that there is SPI-1
T3SS/flagellin-independent, NAIP/NLRC4 inflammasome-dependent control of Salmonella
replication in human macrophages, and that NAIP/NLRC4 recognition of the SPI-2 T3SS needle
SsaG mediates such restriction of Salmonella replication in human macrophages.

Figure 2.17: NAIP/NLRC4 inflammasome recognition of the SPI-2 T3SS restricts
Salmonella replication in human macrophages.
WT or NAIP-/- THP-1 monocyte-derived macrophages were primed with 100 ng/mL Pam3CSK4
for 16 hours. Cells were then infected with PBS (Mock) or ΔprgIfliCfljB S. Typhimurium. Cells
were lysed at the indicated time points and bacteria were plated to calculate CFU. Fold change in
CFU/well of bacteria at indicated time point, relative to 2 hpi CFU/well. ns – not significant, ***p <
0.001, ****p < 0.0001 by Tukey’s multiple comparisons test.
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Figure 2.18: NAIP/NLRC4 inflammasome recognition of the SPI-2 T3SS restricts
Salmonella replication in human macrophages.
WT or NAIP-/- THP-1 monocyte-derived macrophages were primed with 100 ng/ml Pam3CSK4 for
16 hours. Cells were then infected with a SPI-1 T3SS/flagellin-deficient strain of S. Typhimurium,
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ΔprgIfliCfljB. (A) CFU/well of bacteria at 2 hpi (B) CFU/well of bacteria at 6 hpi. (C) CFU/well of
bacteria at 24 hpi. **p < 0.01, ***p < 0.001, by unpaired t-test. Data shown are representative of
at least three independent experiments.

2.6 Discussion
Our data show that human macrophages engage multiple inflammasome pathways to
sense and respond to Salmonella infection. Using NAIP-/- and NLRC4-/- THP-1s (Fig. 2.1, 2.2), we
found inflammasome activation in response to individual SPI-1 T3SS ligands to be entirely
dependent on the NAIP/NLRC4 inflammasome in human macrophages (Fig. 2.3 – 2.5). In
contrast, Salmonella infection induced activation of inflammasome responses that depended
partially on NAIP/NLRC4, NLRP3, and CASP4/5 (Fig. 2.6 – 2.10). Our findings are in agreement
with a recent study demonstrating that both NLRC4 and NLRP3 are required for inflammasome
responses to Salmonella in human macrophages (Gram et al., 2021). Importantly, our data also
reveal that both the NAIP/NLRC4 and NLRP3 inflammasomes contribute to restriction of
Salmonella replication in human macrophages (Fig. 2.7, 2.12, 2.13). Furthermore, contrary to the
prevailing model that the SPI-2 T3SS evades NAIP detection, we show that the NAIP/NLRC4
inflammasome can recognize the Salmonella SPI-2 T3SS needle SsaG (Fig. 2.14 – 2.16), and
that NAIP/NLRC4-dependent recognition of the SPI-2 T3SS restricts bacterial replication within
human macrophages (Fig. 2.14, 2.17, 2.18).
Many Gram-negative bacteria use evolutionarily conserved T3SSs to deliver virulence
factors, or effectors, into host cells. We have previously shown that T3SS inner rod proteins from
various Gram-negative bacteria activate the inflammasome in human macrophages (Reyes Ruiz
et al., 2017). In this study, we used T3SS inner rod, needle, or flagellin proteins from three
different Gram-negative bacteria, Salmonella, Burkholderia, and Legionella, and observed that
inflammasome activation in response to an isolated ligand is entirely dependent on NAIP/NLRC4
(Fig. 2.3 – 2.5, 2.14B). How the single human NAIP senses and responds to these diverse
bacterial structures remains an open question. The Salmonella SPI-1 T3SS inner rod (PrgJ), SPI1 T3SS needle (PrgI), and flagellin proteins exhibit low total sequence conservation, but they all
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retain several conserved hydrophobic amino acid residues within their structurally homologous Cterminal helices (Kubori et al., 2000; Miao et al., 2010). In particular, both PrgJ and flagellin
contain C-terminal leucine residues, specifically in their LLR motifs, which are critical for
recognition by mNAIP2 and mNAIP5, respectively (Halff et al., 2012; Lightfield et al., 2008;
Tenthorey et al., 2017; J. Yang et al., 2018; X. Yang et al., 2018). Instead of the LLR motif, PrgI
has other hydrophobic amino acids, including valine and isoleucine residues, within its C-terminal
helical domain. These terminal hydrophobic residues within PrgI are important for mediating
inflammasome activation in human macrophages (J. Yang et al., 2013). Interestingly, an
alignment of the amino acid sequences of the SPI-2 T3SS needle protein (SsaG), PrgJ, and PrgI
using Clustal Omega revealed that SsaG also contains conserved hydrophobic amino acid
residues in its C-terminus (Fig. 2.19A). Specifically, SsaG has C-terminal isoleucine residues like
PrgI. To further compare these ligands at the structural level, we examined published threedimensional structures of PrgJ and PrgI and used PHYRE2 Protein Fold Recognition Server to
predict the structure of SsaG. Similar to PrgJ and PrgI, SsaG also displays an alpha-helical
structure at its C-terminus (Fig. 2.19B). Thus, SsaG displays secondary structural and sequence
motifs similar to those retained by the other T3SS ligands recognized by human NAIP. Unlike
these T3SS ligands, the Salmonella SPI-2 inner rod protein, SsaI, does not retain such conserved
C-terminal residues. Perhaps this is why SsaI is not detected by human NAIP. Still, the specific
ligand residues recognized by human NAIP remain unknown. Murine NAIPs use their nucleotidebinding domain (NBD)-associated domains to detect these conserved residues of their respective
cognate bacterial ligand (Halff et al., 2012; Lightfield et al., 2008; Tenthorey et al., 2014, 2017; J.
Yang et al., 2018; X. Yang et al., 2018). It remains to be determined if the single human NAIP
uses a similar mechanism to broadly detect its bacterial ligands.
Human NAIP is a generalist, as it detects multiple bacterial ligands, while the murine
NAIPs are specialists, as they each recognize a particular ligand. The functional consequences of
being a generalist NAIP is unclear. It is possible that recognizing a broad array of structures
diminishes the affinity with which human NAIP binds its ligands. Alternatively, human NAIP may
recognize its bacterial ligands with varying affinities. Furthermore, under physiological conditions,
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all bacterial ligands may not be delivered to the cytosol to the same extent or recognized with the
same sensitivity. Varying levels of inflammasome activation with the different ligands may have
distinct downstream consequences. It would be interesting to determine whether restriction of
bacterial replication varies depending on which bacterial ligand is sensed.
Salmonella infection induces NAIP/NLRC4-, CASP4/5-, and NLRP3-dependent
inflammasome activation in human macrophages (Fig. 2.6 – 2.10). This suggests that there is
redundancy in the inflammasome pathways when sensing and responding to Salmonella
infection, such that loss of just one inflammasome does not result in severe loss of inflammasome
activation in human macrophages. Given our observations with individual ligand delivery (Fig. 2.3
– 2.5), it is likely that the NAIP/NLRC4 inflammasome is sensing the Salmonella SPI-1 T3SS
inner rod, SPI-1 and SPI-2 needle, and flagellin proteins during infection. However, it remains
unknown how NLRP3 and CASP4/5 inflammasomes are activated in human macrophages during
Salmonella infection. CASP4/5 detects intracellular LPS (Shi et al., 2014), but given that
Salmonella is normally a vacuolar pathogen in macrophages, it is unclear how CASP4/5 may be
accessing LPS. In murine macrophages, a small percentage of Salmonella-containing vacuoles
rupture, allowing bacteria to escape into the host cell cytosol (Meunier et al., 2014). In human
intestinal epithelial cells, a subpopulation of Salmonella that escape the vacuole and replicates in
the cytosol activates the CASP4/5 inflammasome at late timepoints of infection (Knodler et al.,
2014). Moreover, other host immune factors can potentiate inflammasome signaling by promoting
the release of PAMPs, such as LPS, into the host cell cytosol. For example, a family of host
immune factors called guanylate binding proteins (GBPs) can localize to pathogen-containing
vacuoles (Kim et al., 2011). Murine GBPs promote rupture of the Salmonella-containing vacuole
(SCV) (Meunier et al., 2014). Human GBP-1 can localize to the SCV in macrophages (Fisch et
al., 2019), and in human epithelial cells, GBP1 binds to bacterial LPS on the surface of cytosolic
Salmonella and promotes the recruitment and activation of caspase-4 (Santos et al., 2020;
Wandel et al., 2020). Another mechanism by which LPS can access the cytosol is through
bacterial outer membrane vesicles (OMVs), and this mechanism has been shown to activate the
caspase-11 inflammasome in murine models (Santos et al., 2018; Vanaja et al., 2016). Future
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studies will explore if the CASP4/5-dependent inflammasome activation we have observed in
human macrophages is facilitated by Salmonella escape into the host cell cytosol, GBP1 activity,
OMVs, or other mechanisms.
The NLRP3 inflammasome can be activated by a variety of different stimuli, including
potassium efflux. It can also be activated downstream of the CASP4/5 inflammasome (Baker et
al., 2015; Schmid-Burgk et al., 2015), leading to non-canonical NLRP3 inflammasome activation.
Given that we observed only partial loss of inflammasome activation in the NAIP-/- THP-1s treated
with siRNA targeting CASP4 and CASP5, we hypothesize that at least part of the NLRP3dependent response is due to canonical activation (Fig. 2.11), although this partial loss may also
be due to incomplete knockdown of CASP4 and CASP5. A recent study also found that
Salmonella infection induces NLRC4- and NLRP3-dependent inflammasome activation in human
macrophages, and observed that full-length Salmonella flagellin can activate the NLRP3
inflammasome (Gram et al., 2021). In contrast, we found the response to flagellin to be entirely
dependent on the NAIP/NLRC4 inflammasome (Fig. 2.3 – 2.5). The reason for this apparent
discrepancy is unclear, but in our studies, we used a truncated flagellin that only contains the Cterminal D0 domain and thus does not stimulate TLR5 signaling (Lightfield et al., 2008, 2011). It is
possible that full-length flagellin, in addition to activating the NAIP/NLRC4 inflammasome, also
stimulates TLR5 signaling, perhaps potentiating NLRP3-dependent responses.
We observed NAIP/NLRC4- and NLRP3-dependent restriction of Salmonella (Fig. 2.12,
2.13), but the mechanism by which inflammasome activation promotes bacterial restriction is
unclear. Inflammasome activation often triggers host cell death, thereby eliminating the
pathogen’s intracellular replicative niche. In vivo, pyroptosis can trigger formation of pore-induced
intracellular traps (PITs). These PITs can trap intracellular bacteria that can subsequently be
efferocytosed by neutrophils (Jorgensen et al., 2016). However, in murine macrophages,
inhibition of Salmonella replication by caspase-1 and caspase-11 occurs prior to host cell death,
indicating that caspase-1 and caspase-11 restrict Salmonella through a mechanism distinct from
cell death (Thurston et al., 2016). Another mechanism of inflammasome-dependent restriction
may be through promoting phagolysomal maturation. In murine macrophages infected with
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Legionella, NAIP5 activation results in increased colocalization of Legionella-containing vacuoles
with the lysosomal markers cathepsin-D and Lamp-1 (Amer et al., 2006; Fortier et al., 2007).
Perhaps a similar process occurs during Salmonella infection of human macrophages.
The current model is that the SPI-2 T3SS subverts inflammasome activation to facilitate
Salmonella’s intracellular survival, based on the observation that the SPI-2 T3SS inner rod SsaI is
not detected in murine or human macrophages (Miao et al., 2010; Reyes Ruiz et al., 2017).
Moreover, the SPI-2 T3SS effectors are critical for biogenesis and maintenance of the SCV
(Haraga et al., 2008). Thus, evasion of inflammasome activation by the SPI-2 T3SS was thought
to confer an advantage to the pathogen. However, our findings indicate that the NAIP/NLRC4
inflammasome detects the Salmonella SPI-2 T3SS needle protein SsaG. Furthermore, we find
that SPI-1-independent, flagellin-independent, NAIP-dependent detection of Salmonella mediates
restriction of intracellular bacterial replication in human macrophages. Perhaps the NAIP/NLRC4mediated detection of SsaG is a consequence of a functional constraint placed upon SsaG’s role
as a T3SS needle protein. It is thus possible that SsaG is unable to evade immune detection due
to such functional constraints.
While we focused here primarily on inflammasome responses in human macrophages,
Salmonella’s first cellular encounters are with intestinal epithelial cells. In mice, NAIP/NLRC4
inflammasome activation in intestinal epithelial cells results in extrusion of infected cells from the
epithelial layer (Rauch et al., 2017; Sellin et al., 2014). It has been proposed that this mechanism
eliminates Salmonella from the host and helps control bacterial burdens. Whether similar
NAIP/NLRC4-dependent mechanisms are engaged in human intestinal epithelial cells remains to
be elucidated.
Overall, these data indicate that Salmonella infection of human macrophages triggers
activation of multiple inflammasomes, and at least two of these inflammasomes, the
NAIP/NLRC4, and the NLRP3 inflammasomes, appear to be essential for controlling bacterial
replication within macrophages. Furthermore, our data indicate that the human NAIP/NLRC4
inflammasome detects the SPI-2 needle protein SsaG, and that NAIP/NLRC4-mediated detection
of the SPI-2 T3SS restricts Salmonella replication within macrophages. Collectively, our findings
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provide fundamental insight into how Salmonella is sensed and restricted by human
macrophages. Moreover, these results offer a foundation for further understanding of how each of
these pathways is activated and how these inflammasomes interact to mediate downstream
responses that promote control of Salmonella infection in human macrophages.

Figure 2.19: Sequence alignment and three-dimensional structural prediction of SsaG.
(A) The primary sequences of PrgJ, PrgI, and SsaG were aligned using Multiple Sequence
Alignment by Clustal Omega. * indicates single, fully conserved residue, : indicates conservation
between groups of strongly similar properties, and . indicates conservation between groups of
weakly similar properties. Small, hydrophobic residues are indicated in red (AVFPMILW). Acidic
residues are indicated in blue (DE). Basic residues are indicated in magenta (RK). The remaining
residues are indicated in green (STYHCNGQ). (B) The three-dimensional structure of SsaG was
predicted with high confidence and high coverage using the PHYRE2 server. The structure is
colored from N to C terminus using the colors of the rainbow (red, orange, yellow, green, and
blue).
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CHAPTER 3

Salmonella Typhimurium induces NAIP/NLRC4-independent, caspase-4-dependent
inflammasome activation in human intestinal epithelial cells

This chapter contains unpublished data from a manuscript in preparation by Nawar Naseer,
Renate Bauer, Jenna Zhang, Igor E. Brodsky, Isabella Rauch, and Sunny Shin.
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3.1 Abstract
Salmonella enterica serovar Typhimurium is a gram-negative, facultative intracellular
pathogen that causes gastrointestinal disease. Salmonella uses type III secretion systems
(T3SSs) to inject effectors into the host cell cytosol. These effectors are important for invasion
and intracellular survival of Salmonella. However, these secretion systems also enable host
detection of Salmonella by cytosolic immune sensors. Upon detecting Salmonella ligands, these
sensors form multimeric complexes called inflammasomes, which activate caspases and lead to
downstream release of proinflammatory cytokines and pyroptosis. One inflammasome that is
formed upon detection of Salmonella T3SS structural components or flagellin is the NAIP/NLRC4
inflammasome. NAIP/NLRC4 activation specifically in murine intestinal epithelial cells (IECs)
leads to restriction of bacterial replication, extrusion of infected IECs, and prevents systemic
dissemination of Salmonella to distal organs. In mice, activity of the NAIP/NLRC4 inflammasome
in IECs is therefore critical for host immune defense. However, the role of the NAIP/NLRC4
inflammasome in human IECs is unknown. Here, we found the NAIP/NLRC4 inflammasome is
dispensable for inflammasome activation, and Salmonella T3SS ligands are not sufficient to
induce inflammasome activation in human IECs. Additionally, the NLRP3 inflammasome and its
adaptor protein ASC are not required for inflammasome activation in human IECs. Instead, we
observed partial requirement of caspase-1, and necessity of caspase-4 and the pore-forming
protein GSDMD for inducing inflammasome activation in human IECs. These findings suggest
that unlike murine IECs, human IECs do not rely on NAIP/NLRC4 for sensing Salmonella
infection, and instead primarily use caspases-1 and -4 for mediating inflammasome responses to
IECs.

3.2 Introduction
Enteric bacterial pathogens such as Salmonella enterica serovar Typhimurium (hereafter
referred to as Salmonella) are leading causes of global morbidity and mortality from diarrheal
diseases (Majowicz et al., 2010). Contracted upon ingestion of contaminated food or water,
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Salmonella colonizes the intestinal tract, where it uses evolutionarily conserved molecular
syringes called type III secretion systems (T3SS) to inject effectors, or virulence factors, into the
host cell cytosol (Crowley et al., 2016). Salmonella contains two T3SS: the first, the SPI-1 T3SS
is expressed early in infection, and enables Salmonella to invade host cells, while the second, the
SPI-2 T3SS, is expressed at later timepoints of infection, and allows Salmonella to replicate
within host cells such as intestinal epithelial cells (IECs) (Crowley et al., 2016). IECs thus serve
both as targets of, as well as the first line of physical and innate immune defense against enteric
pathogens like Salmonella. Most studies of Salmonella’s interactions with the innate immune
system have been conducted in mice. However, key differences in innate immune genes
encoded by mice and humans make it unclear whether mice fully recapitulate how humans
respond to Salmonella. Here, we interrogate how human IECs sense and respond to Salmonella
infection.
The mammalian immune system can recognize invading intracellular pathogens like
Salmonella through cytosolic sensors such as Nod-like receptors. Upon detecting a bacterial
ligand or activity, these receptors oligomerize to form multimeric signaling complexes called
inflammasomes (Lamkanfi & Dixit, 2014). Inflammasomes recruit and activate cysteine proteases
such as caspase-1 and caspase-8 (Lamkanfi & Dixit, 2014; D. Zheng et al., 2020). Some
inflammasomes require an adaptor protein called ASC to mediate their interaction with caspases
(Lamkanfi & Dixit, 2014). Active caspases can process proinflammatory cytokines IL-1α, IL-1β,
and IL-18 (Lamkanfi & Dixit, 2014), and the pore-forming protein GSDMD (Shi et al., 2015). This
leads to release of the processed cytokines and an inflammatory form of cell death known as
pyroptosis (Lamkanfi & Dixit, 2014). Release of these proinflammatory cytokines alerts nearby
cells of the infection, while cell death eliminates the pathogen’s replicative niche within the
infected host cell.
Various cellular insults during infection can trigger activation of different inflammasomes.
Inflammasome activation is critical for control of Salmonella infection in mice (Raupach et al.,
2006). In both murine and human macrophages, Salmonella infection activates the NAIP/NLRC4
inflammasome, which detects Salmonella SPI-1 T3SS components and flagellin (Kofoed &
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Vance, 2011; Rauch et al., 2016; Rayamajhi et al., 2013; J. Yang et al., 2013; Zhao et al., 2011,
2016). Activation of the NAIP/NLRC4 inflammasome specifically in murine intestinal epithelial
cells restricts bacterial replication, causes extrusion of infected cells from the intestinal epithelial
layer, and prevents dissemination of Salmonella to systemic sites (Hausmann et al., 2020; Rauch
et al., 2017; Sellin et al., 2014). However, the role of the NAIP/NLRC4 inflammasome during
Salmonella infection in human IECs remains unknown.
Salmonella infection can also induce activation of another inflammasome called the
NLRP3 inflammasome, which can be activated by a variety of stimuli during infection, including
potassium efflux (Muñoz-Planillo et al., 2013). In murine macrophages, the NLRP3
inflammasome is thought to be important for late timepoints during Salmonella infection (Broz et
al., 2010). In both murine and human intestinal epithelial cells, a third inflammasome, the
caspase-11 (mice) or caspase-4/5 (humans) inflammasome is activated late in Salmonella
infection (Broz et al., 2010; Knodler, Crowley, et al., 2014; Crowley et al., 2020; Holly et al.,
2020). Caspase-4/5/11 detect cytosolic LPS and forms the noncanonical inflammasome, which
can secondarily activate the NLRP3 inflammasome (Schmid‐Burgk et al., 2015; Shi et al., 2014). In
human macrophages, Salmonella infection triggers recruitment of both NLRC4 and NLRP3 to the
same macromolecular complex (Man, Hopkins, et al., 2014). However, whether the NLRP3
inflammasome plays a functional role during Salmonella infection of human IECs has not been
previously tested.
In this study, using a combination of pharmacological inhibitors and CRISPR/Cas9
technology, we have found that although human IECs undergo inflammasome activation in
response to SPI-1-expressing Salmonella, Salmonella SPI-1 T3SS ligands are not sufficient to
activate the inflammasome in human IECs. Additionally, we found that the NAIP/NLRC4
inflammasome, the NLRP3 inflammasome, and the adaptor protein ASC are all dispensable for
early inflammasome responses to SPI-1-expressing Salmonella in human IECs. Instead, we
observed that caspase-1 is partially required, and caspase-4 is necessary for inflammasome
activation in human IECs in response to Salmonella infection. Finally, we found GSDMDmediated pore formation is necessary to observe release of IL-18 and cell death. Our findings
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delineate the role of several inflammasomes in human IECs during early Salmonella infection.
Importantly, these results demonstrate how widely inflammasome responses to infection can vary
between species (i.e. mice versus humans) as well as cell types (i.e. macrophages and IECs).

3.3 Materials and Methods
3.3.1 Ethics statement
All studies involving human peripheral blood mononuclear cells (PBMCs) and human
intestinal organoids were performed in compliance with the requirements of the US Department of
Health and Human Services and the principles expressed in the Declaration of Helsinki. Both
human PBMCs and organoids are considered to be a secondary use of deidentified human
specimens and are exempt via Title 55 Part 46, Subpart A of 46.101 (b) of the Code of Federal
Regulations. All experiments performed with murine organoids were done so in compliance with
the regulatory standards of, and were approved by the Oregon Health & Science University
Institutional Animal Care and Use Committee.

3.3.2 Bacterial strains and growth conditions
Salmonella enterica serovar Typhimurium SL1344 WT and ΔsipB (Lawley et al., 2006)
isogenic strains were routinely grown shaking overnight at 37°C in Luria-Bertani (LB) broth with
streptomycin (100 μg/ml). Cells were infected with Salmonella grown under SPI-1 inducing
conditions (Lee & Falkow, 1990).
Listeria monocytogenes WT and isogenic strains on the 10403S background were
routinely grown shaking overnight at 30°C in brain heart infusion (BHI) broth (Sauer et al., 2011).
S. Typhimurium ligands PrgJ or PrgI were translationally fused to the truncated N-terminus of
ActA and under the control of the actA promoter (Sauer et al., 2011). The Listeria strain
expressing S. Typhimurium SsaI was constructed using a codon-optimized gene fragment (IDT)
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cloned into the pPL2 vector and introduced into Listeria as previously described (Lauer et al.,
2002; Sauer et al., 2011).

3.3.3 Bacterial infections
Where indicated, cells were primed with 100 ng/ml or 400 ng/ml of Pam3CSK4
(Invivogen) for 3 hours prior to infection. To induce SPI-1 expression, overnight cultures of
Salmonella were diluted into LB broth containing 300 mM NaCl and grown for 3 hours standing at
37°C (Lee & Falkow, 1990). Overnight cultures of Listeria were diluted and grown shaking for 3
hours in BHI. All cultures were pelleted at 6,010 × g for 3 minutes, washed once with PBS, and
resuspended in PBS. Cells were infected with Salmonella at a multiplicity of infection (MOI) of 60
or Listeria at the indicated MOI for each experiment in the figure legend. Infected cells were
centrifuged at 290 × g for 10 minutes and incubated at 37°C. 1 hour post-infection, cells were
treated with 100 ng/ml or 50 ng/ml of gentamicin to kill any extracellular Salmonella or Listeria
respectively. Infections proceeded at 37°C for the indicated length of time for each experiment.
Control cells were mock-infected with PBS for all experiments.

3.3.4 Cell culture of intestinal epithelial cell lines
All cell lines were obtained from American Type Culture Collection (ATCC). Caco-2 cells
(HTB-37; ATCC) were maintained in DMEM supplemented with 10% (vol/vol) heat-inactivated
FBS, 100 IU/ml penicillin, and 100 μg/ml streptomycin. T84 cells (CCL-248; ATCC) were
maintained in DMEM F-12 supplemented with 5% (vol/vol) heat-inactivated FBS, 100 IU/ml
penicillin, and 100 μg/ml streptomycin. C2Bbe1 cells (CRL-2102; ATCC) were maintained in
DMEM supplemented with 0.01 mg/ml human transferrin, 10% (vol/vol) heat-inactivated FBS, 100
IU/ml penicillin, and 100 μg/ml streptomycin. Cells were maintained at 37°C in a humidified
incubator.
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One day prior to infection or treatment, cells were dissociated with 0.25% Trypsin-EDTA
(Gibco) diluted 1:1 with 1X PBS. Cells were incubated with trypsin at 37°C for 15 minutes, after
which the trypsin was neutralized with serum containing media. Cells were replated in media
without antibiotics in a 24-well plate at a concentration of 3 × 105 cells/well. Where indicated, cells
were primed with 100 ng/ml or 400 ng/ml Pam3CSK4 (Invivogen) or 500 ng/ml LPS (SigmaAldrich) for 3h or 16h prior to anthrax toxin treatment or bacterial infections.

3.3.5 Culture of intestinal organoids in spheroid culture
Spheroids derived from human duodenum or colon were kindly provided by Jared Fisher
at Oregon Health & Science University. Human and murine organoids were cultivated in special
conditioned medium as described (Miyoshi & Stappenbeck, 2013). Briefly, spheroids were grown
in Corning® Matrigel® Basement Membrane Matrix (VWR). Spheroids were dissociated with
Trypsin-EDTA (1X PBS, 0.25% trypsin, 0.5 mM EDTA) at 37°C for 5 minutes. Subsequently
washing medium (DMEM/F12 with HEPES (Sigma), 10% FBS (ia), 1X P/S) was added to stop
trypsinization. After washing the cells with washing medium at 200 × g for 5 minutes at room
temperature, the supernatant was completely aspirated and the cell pellet resuspended in
Matrigel®. 20 µL matrigel-cell drops were placed into 24-well plates and polymerized for 5
minutes at 37°C upside down. Afterwards, cells were cultured in organoid medium consisting of
50% primary culture medium (Advanced DMEM/F12 (Gibco), 20% FBS, 1X P/S, 1X L-Glu) and
50% conditioned medium (L-WRN supernatant) supplemented with 10 µM of rock-inhibitor
Y27632 (Sigma) and 10 µM TGF-β-inhibitor SB431542 (Millipore).

3.3.6 Polarization of intestinal epithelial cells
Transparent membrane (PET) 1 μm pore size cell culture inserts (Greiner Bio-One
662610) in a 24-well plate were coated with collagen coating solution containing 30 µg/ml
collagen, 10 µg/ml fibronectin, and 10 µg/ml BSA in DMEM and incubated overnight at 37°C.
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Caco-2 cells were plated in growth medium containing Corning MITO+ serum extender (Fisher
Scientific CB-50006). After 24 hours, the growth medium was replaced with Corning enterocyte
differentiation medium (Fisher Scientific 355357) containing MITO+ serum extender. The media
was replaced daily and after three days of incubation in differentiation medium, the transepithelial
electrical resistance was measured using an Epithelial Volt/Ohm (TEER) Meter (World Precision
Instruments) to ensure that it is ≥250 Ω.cm2 prior to infection or treatments. All treatments were
administered on the apical side of the cells.

3.3.7 ELISAs
Supernatants harvest from infected cells were assayed using ELISA kits for human IL-18
(R&D Systems) and IL-8 (R&D Systems).

3.3.8 Immunoblot analysis
Cell lysates were harvested for immunoblot analysis by adding 1X SDS/PAGE sample
buffer to cells following infection. Cells were incubated and infected in serum-free media to collect
supernatant samples. Supernatant samples were centrifuged at 200 × g to pellet any cell debris.
The supernatant was then treated with trichloroacetic acid (TCA) (25 µL of TCA for 500 µL of
supernatant) overnight at 4°C. The next day, the samples were centrifuged at maximum speed
(15871 × g) for 15 minutes at 4°C. Precipitated supernatant pellets were washed with ice-cold
acetone, centrifuged at maximum speed (15871 × g) for 10 minutes at 4°C, and resuspended in
1X SDS/PAGE sample buffer. All protein samples (lysates and supernatants) were boiled for 5
minutes. Samples were separated by SDS/PAGE on a 12% (vol/vol) acrylamide gel and
transferred to PVDF Immobilon-P membranes (Millipore). Primary antibodies specific for human
IL-18 (PM014; MBL International), human caspase-1 (2225S; Cell Signaling), human caspase-4
(4450S; Cell Signaling), human ASC (D086-3, MBL International) and β-actin (4967L; Cell
Signaling), and HRP-conjugated secondary antibody anti-rabbit IgG (7074S; Cell Signaling) were
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used. ECL Western Blotting Substrate or SuperSignal West Femto (both from Pierce Thermo
Scientific) were used as the HRP substrate for detection.

3.3.9 Propidium iodide (PI) uptake assay
0.75 × 105 Caco-2 cells per well were plated in a black, flat-bottom 96-well plate
(Cellstar) in PI uptake media containing 1X HBSS without phenol red, 20 mM HEPES, and 10%
(vol/vol) heat-inactivated FBS. Cells were infected at an MOI=60 and triton wells were treated
with 1% Triton. After infection, cells were centrifuged at 290 × g for 10 minutes following infection.
5 μM propidium iodide (PI, P3566, Invitrogen) diluted in PI uptake media was added to the cells.
The plate was sealed with adhesive optical plate sealing film (Microseal, Bio-Rad) and placed in a
Synergy H1 microplate reader (BioTek) pre-heated to 37°C. PI fluorescence was measured every
10 minutes for the indicated number of hours.

3.3.10 Anthrax toxin-mediated delivery of bacterial ligands into human intestinal
epithelial cell lines
Cells were primed with 400 ng/ml Pam3CSK4 (Invivogen) for 4 hours prior to treatment.
Recombinant proteins (PA, LFn-PrgJ, and LFn-PrgI) were kindly provided by Russell Vance
(Rauch et al., 2016). PA and LFn doses for in vitro delivery were: 4 μg/ml PA; 8 ng/ml LFn-PrgJ;
and 200 ng/ml LFn-PrgI. Cells were incubated at 37°C for 16 hours.

3.3.11 Anthrax toxin-mediated delivery of bacterial ligands into organoids
Organoids were seeded in 96-well plates with transparent bottom and opaque walls in 5
µl matrigel domes. After two days in organoid media, organoids were grown for an additional 3
days in differentiation media: DMEM/F12 supplemented with 20% murine R-Spondin1
supernatant, 10% murine Noggin supernatant, 50 ng/ml recombinant murine EGF (Fisher
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Scientific), 1X P/S, 1X L-Glu, 10 mM HEPES (Himedia), 1X N2 (Life Technologies), 1X B27 (Life
Technologies), 1 mM N-Acetylcysteine (Fisher Scientific). 5 µM DAPT was added for the last 24h.
Differentiated organoids were then treated with 16 µg/ml PA and 8 µg/ml LFn-FlaA or 0.1 µg/ml
LFn-PrgJ in differentiation media containing 10 µg/ml propidium iodide for 4h. Total lysis wells
were treated with 1% Triton.

3.3.12 Expression of inflammasome genes in human small intestinal organoids
To analyze inflammasome expression under different media conditions, spheroids were
cultured in differentiation medium: DMEM/F12 supplemented with 20% murine R-Spondin1
supernatant, 10% murine Noggin supernatant, 50 ng/ml recombinant murine EGF (Fisher
Scientific), 1X P/S, 1X L-Glu, 10 mM HEPES (Himedia), 1X N2 (Life Technologies), 1X B27 (Life
Technologies), 1 mM N-Acetylcysteine (Fisher Scientific) and 5 µM DAPT. After 4 days of
incubation at 37°C, matrigel domes were dissolved in PBS-EDTA (5 mM) for 1 hour at 4°C on an
orbital shaker. After centrifugation at 300 × g for 5 minutes at 4°C, the cell pellet was
resuspended in TRIzolTM to analyze mRNA expression.

3.3.13 Isolation of peripheral blood mononuclear cells (PBMCs)
To compare expression levels of inflammasome components in human intestinal
epithelial cells with immune cells, cDNA of PBMCs was kindly provided by William Messer at
Oregon Health & Science University. These cells were isolated using density gradient
centrifugation. After overlay of LymphoprepTM (Alere Technologies AS) with blood mixed 1:2 with
1X PBS (pH 7.4, Gibco), the sample was centrifuged at 800 × g for 20 minutes at room
temperature. Residual erythrocytes were lysed with 1X RBC lysis buffer (10X, BioLegend),
followed by three washing steps with fresh PBS for 10 minutes at 250 × g. Subsequently cells
were harvested in TRIzolTM Reagent (Thermo Fisher Scientific) for mRNA analysis.
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3.3.14 RNA extraction, cDNA synthesis, and real-time quantitative polymerase
chain reaction (RT-qPCR) of organoid and PBMC samples
After thawing the TRIzolTM samples, chloroform was added and the tubes centrifuged for
15 minutes at 12,000 × g at 4°C. The aqueous phase was transferred to a new tube containing
linear polyacrylamide (Gene-EluteTM LPA, Sigma). To allow RNA precipitation, the samples were
incubated with isopropanol for 10 minutes and subsequently centrifuged for 10 minutes at 12,000
× g. After aspiration of the supernatant, the RNA pellet was washed once with 75% ethanol for 5
minutes at 7,500 × g at 4°C. The supernatant was aspirated and the dried pellet resuspended in
Molecular Biology Grade Water (Corning). After determination of RNA content and quality
(260/280 and 260/230 ratios), 1 µg of RNA was reversely transcribed into cDNA. Reaction steps
were performed in Biorad T100 Cycler. First, residual DNA was removed using RQ1 RNAse free
DNase (Promega) in RQ1 DNase 1X Reaction buffer (Promega) for 30 minutes at 37°C. After
stopping the reaction with RQ1 DNase Stop Solution (Promega) for 10 minutes at 65°C, OligodTs
(Sigma) and dNTPs (Sigma) were added for 5 minutes at 65°C. Reverse transcription was
performed with SuperScriptTM IV Reverse Transcriptase (Invitrogen), 5 mM DTT and
SuperScriptTM IV Reaction Buffer (Invitrogen) for 10 minutes at 50-55°C. Subsequently the
enzyme was inactivated at 80°C for 10 minutes.
To analyze RNA expression, cDNA was mixed with 10 µM forward and reverse primers
and PowerUpTM SYBRTM Green Master Mix (Applied Biosystems) according to manufacturer’s
instructions. The following primers were used:
RPLP0

NAIP

NLRC4

CASP1

Forward:

5’- GGCACCATTGAAATCCTGAGTGATGTG -3‘

Reverse:

5’- TTGCGGACACCCTCCAGGAAG -3‘

Forward:

5’- AAGCATCCGCCCAGCTCTTGA -3‘

Reverse:

5’- TATTGCCCTCCAGATCCACAGACAGTTC -3‘

Forward:

5’- CATAGTCAAGTCTCTGTCAAGTGAACCCTGT -3‘

Reverse:

5’- GCTGTTCTAGCACGTTCATCCTGTCG -3‘

Forward:

5’- GAGGCATTTGCACACCGCCC -3‘
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Reverse:

5’- GGATCTCTTCACTTCCTGCCCACA -3‘

Amplification was analyzed in real-time with StepOne Software v2.3. In brief, samples
were incubated for 10 minutes at 95°C, followed by 40 cycles of heating to 95°C for 15 seconds
and cooling to 60°C for 1 minute. To monitor specificity of the run, the melt curves were
determined by keeping the samples at 95°C for 15 seconds, cooling to 60°C for 1 min and then
increasing the temperature every 15 seconds by 0.3°C up to 95°C. Expression levels relative to
the house keeping gene (RPLP0) were calculated using the formula x = 2-Δct.

3.3.15 RNA extraction, cDNA synthesis, and RT-qPCR of Caco-2, T84, and THP-1
samples
RNA was isolated using the RNeasy Plus Mini Kit (Qiagen) following the manufacturer’s
instructions. Cells were lysed in 350 μl RLT buffer with β-mercaptoethanol and centrifuged
through a QIAshredder spin column (Qiagen). cDNA was synthesized from isolated RNA using
SuperScript II Reverse Transcriptase (Invitrogen) following the manufacturer’s protocol.
Quantitative PCR was conducted with the CFX96 real-time system from Bio-Rad using the
SsoFast EvaGreen Supermix with Low ROX (Bio-Rad). To calculate relative gene expression,
mRNA levels of target genes were normalized to housekeeping gene HPRT and the formula x =
2−ΔCT was used. The following primers from PrimerBank (PrimerBank identification listed within
parentheses) were used (Spandidos et al., 2008, 2010; X. Wang, 2003):
HPRT (164518913c1)

NAIP (119393877c3)

NLRC4 (312433959c2)

NLRP3 (208879435c1)

Forward:

5’- CCTGGCGTCGTGATTAGTGAT -3’

Reverse:

5’ - AGACGTTCAGTCCTGTCCATAA -3’

Forward:

5’ - CCCATTAGACGATCACACCAGA -3’

Reverse:

5’ - GGAGTCACTTCCGCAGAGG -3’

Forward:

5’ - TGCATCATTGAAGGGGAATCTG -3’

Reverse:

5’ - GATTGTGCCAGGTATATCCAGG -3’

Forward:

5’ - GATCTTCGCTGCGATCAACAG -3’

Reverse:

5’ - CGTGCATTATCTGAACCCCAC -3’

92

PYCARD (313482805c1)

CASP1 (380254454c1)

CASP4 (73622124c1)

Forward:

5’ - TGGATGCTCTGTACGGGAAG -3’

Reverse:

5’ - CCAGGCTGGTGTGAAACTGAA -3’

Forward:

5’ - TTTCCGCAAGGTTCGATTTTCA -3’

Reverse:

5’ - GGCATCTGCGCTCTACCATC -3’

Forward:

5’- CAAGAGAAGCAACGTATGGCA -3’

Reverse:

5’- AGGCAGATGGTCAAACTCTGTA -3’

3.3.16 Generation of CRISPR Cas9 knockouts in Caco-2 cells
To knockout genes in Caco-2 cells, plasmids encoding the desired guide RNA (gRNA)
and Cas9 in the pLentiCRISPR v2 plasmid were purchased from GenScript. The sequences of
these gRNAs are listed below:
NAIP

gRNA 1 : ACATTGCCAAGTACGACATA

PYCARD

gRNA 1 : CATGTCGCGCAGCACGTTAG

CASP1

gRNA 1 : GACAGTATTCCTAGAAGAAC

CASP4

gRNA 1 : TCCTGCAGCTCATCCGAATA
Paul Bates at the University of Pennsylvania kindly provided pCMV-VSV-G and psPAX2

plasmids to produce lentiviral particles. Lentiviral particles were generated in HEK293T cells.
HEK293T cells were plated at 2 × 106 cells per 10 cm dish in 10 mL of DMEM supplemented with
10% (vol/vol) heat-inactivated FBS, 2 mM L-glutamine, 100 IU/ml penicillin, and 100 μg/ml
streptomycin. After 24 hours, plasmids were transfected using Lipofectamine 2000 according to
manufacturer’s instructions. 1 μg of pCMV-VSV-G, 2.5 μg of psPAX2, and 5 μg of pLentiCRISPR
v2 encoding the appropriate gRNA, and 50 μl of Lipofectamine 2000 was used per dish.
Transfected HEK293T cells were incubated for 18 hours at 37°C, and the media was then
aspirated and replaced with 6mL of fresh growth media. After an additional 24 hours, the
supernatant containing lentiviral particles was harvested and filtered using a 0.22μM filter. 5 × 105
Caco-2 cells were infected in 1 ml of virus-containing media with 8 μg/ml of polybrene in a 12-well
plate. The cells were then spun at 1250 × g for 90 minutes at 30°C, and subsequently incubated
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at 37°C for 24 hours. After 24 hours, the virus-containing media was replaced with Caco-2 growth
media and incubated at 37°C. After an additional 24 hours, puromycin was added to a final
concentration of 10 μg/ml. The cells were maintained in puromycin for approximately 4 weeks
and gradually expanded from a 12-well plate to larger dishes, ending in a T175 flask. Cells were
then harvested for clonal selection.
For clonal selection, cells were plated in 96-well plates at 0.5 cell per well or 2 cells per
well in 200 μl of growth media and were incubated for 4-8 weeks until single clones were visible
in the bottom of the well. 10-12 single cell clones for each gene were selected and gradually
expanded from a 96-well plate to larger dishes, ending in a T175 flask. Cells were then plated in
24-well plates at a concentration of 3 × 105 cells per well in 500 μl of media and harvested for
RNA isolation, western blot analysis, and purification of DNA for validation.

3.3.17 Validation of CRISPR Cas9 Caco-2 single clones for knockouts
DNA was harvested from cells and purified using the DNeasy Blood and Tissue kit
(Qiagen). The following primers were used to amplify the genomic region containing the gRNA
target sequence via PCR:
NAIP

forward : 5’- CCGTACAGCTCATGGATACCACAG -3’

NAIP

reverse : 5’- GTACCTGTAAAGACAAAGCCAGCC -3’

PYCARD

forward : 5’- GACCTCACCGACAAGCTG -3’

PYCARD

reverse : 5’- GGGGTAGGAGGAACAGAAAG -3’

CASP1

forward : 5’- GGGCATTTGCAATGTCCATGCA -3’

CASP1

reverse : 5’- CCAGGCTTGTGCTGCATGAC -3’

CASP4

forward : 5’- GGAAAGGCCAAATTTAACCCCAAC -3’

CASP4

reverse : 5’- ATGGTTACTGTCATCCCCACCC -3’
The PCR product was purified using the PCR Cleanup kit (Qiagen). A poly A-tail was

added to the purified PCR product by combining 7 μl of PCR product, 5 Units of Taq DNA
polymerase, 1X PCR Buffer containing MgCl2, and 0.2 mM dATP. The reaction was then
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incubated at 70°C for 30 minutes. 2 μl of this product was then ligated into the pGEM-T Vector
System and transformed into DH5α competent cells according to manufacturer’s instructions
(A1360; Promega). Blue-white screening was used to select approximately 15 colonies that were
PCR-screened using the same primers shown above and run on an agarose gel to confirm that
they contained the insert. At least 10 positive colonies were sequenced using one of the following
primers:
M13/pUC

forward : 5’- CCCAGTCACGACGTTGTAAAACG -3’

M13/pUC

reverse : 5’- AGCGGATAACAATTTCACACAGG -3’

3.3.18 Inhibitor experiments
Cells were treated 1 hour prior to infection at the indicated concentrations with inhibitors:
varying concentrations of MCC950 (Sigma Aldrich PZ0280), 20 μM of pan-caspase inhibitor ZVAD(OMe)-FMK (SM Biochemicals SMFMK001), 25 μM of caspase-1 inhibitor Ac-YVAD-cmk
(Sigma Aldrich SML0429), 20 μM of caspase-8 inhibitor Z-IETD-FMK (SM Biochemicals
SMFMK004), 30 μM of disulfiram (Sigma).

3.3.19 siRNA-mediated knockdown of genes
The following Silencer Select siRNA oligos were purchased from Ambion (Life
Technologies): CASP4 (s2412), CASP5 (s2417), two Silencer Select negative control siRNAs
(Silencer Select Negative Control No. 1 siRNA and Silencer Select Negative Control No. 2
siRNA). Three days before infection, 30 nM of siRNA was transfected into Caco-2s using
Lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientific) following the
manufacturer’s protocol. Cells were primed with 400 ng/ml of Pam3CSK4 (Invivogen) for 3 hours
prior to infection.
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To calculate knock-down efficiency, RNA was extracted and cDNA synthesized as
described in main body. The following primers from PrimerBank (identification numbers within
parenthesis) (Spandidos et al., 2008, 2010; X. Wang, 2003) were used:
CASP4 (73622124c1)

CASP5 (209870072c2)

Forward:

5’- CAAGAGAAGCAACGTATGGCA -3’

Reverse:

5’- AGGCAGATGGTCAAACTCTGTA -3’

Forward:

5’- TTCAACACCACATAACGTGTCC -3’

Reverse:

5’- GTCAAGGTTGCTCGTTCTATGG -3’

mRNA levels of siRNA-treated cells were normalized to housekeeping gene HPRT and
control siRNA-treated cells using the 2−ΔΔCT (cycle threshold) method (Livak & Schmittgen, 2001).

3.3.20 Statistical analysis
Prism 9.1.1 (GraphPad Software) was used to graph all data and for all statistical
analyses. Statistical significance for experiments was determined using the appropriate test and
are indicated in each figure legend. Differences were considered statistically significant if the p
value was <0.05.

3.4 Results
3.4.1 Salmonella infection induces inflammasome activation in human intestinal
epithelial cells
Once inside the host, Salmonella upregulates expression of its SPI-1 T3SS (Crowley et
al., 2016). Effectors of the SPI-1 T3SS enable Salmonella to invade intestinal epithelial cells
(Crowley et al., 2016). Human IECs infected with Salmonella grown under non-SPI-1-inducing
conditions undergo inflammasome activation at late time points following infection (10hpi) (Holly
et al., 2020; Knodler, Crowley, et al., 2014). However, early inflammasome responses to SPI-1expressing Salmonella have not been previously investigated. To test if human IECs undergo
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inflammasome activation in response to Salmonella grown under SPI-1-inducing conditions (Lee
& Falkow, 1990), we infected WT Caco-2 cells, a human colorectal cell line, with WT Salmonella
(WT Stm) or Salmonella lacking its SPI-1 T3SS (∆sipB Stm) and assayed for subsequent
inflammasome activation by measuring release and cleavage of the inflammasome-dependent
cytokine IL-18 at 6hpi, an early time point following Salmonella infection (Fig. 3.1A, B). Cells
infected with WT Stm released significantly increased levels of cleaved IL-18 into the supernatant
compared to mock-infected cells (Fig. 3.1A, B). In contrast, cells infected with ∆sipB Stm, which is
unable to invade cells, failed to release cleaved IL-18 (Fig. 3.1A, B). We measured cell death as
another readout of inflammasome activation by assaying for uptake of the cell-impermeable dye
propidium iodide (PI), which is taken up into cells as they form pores in their plasma membrane
and undergo cell death. In cells infected with WT Stm, PI uptake began to occur between 4-6hpi,
and gradually increased over time, indicating that infected cells begin to undergo cell death as
early as 4-6hpi (Fig. 3.1C). As expected, cells infected with ∆sipB Stm, which cannot enter the
host cell, did not uptake any PI (Fig. 3.1C). We confirmed that inflammasome activation in
response to Salmonella also occurs in another human colorectal cell line, T84 cells (Fig. 3.1D).
T84 cells infected with SPI-1-expressing WT Stm also released IL-18 into the supernatant at 6hpi
(Fig. 3.1D). As a control, we measured release of an inflammasome-independent cytokine, IL-8
(Fig. 3.1E, F). In both Caco-2 cells and T84 cells, the inflammasome-independent cytokine, IL-8,
is released in response to WT Stm and ∆sipB Stm (Fig. 3.1E, F). The level of IL-8 release is
slightly lower in cells infected with ∆sipB Stm, likely due to the role of Salmonella SPI-1 effectors
in inducing IL-8 secretion (Huang et al., 2004). Thus, as early as 4-6hpi, human IECs infected
with WT Stm grown under SPI-1-inducing conditions undergo inflammasome activation.
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Figure 3.1: Salmonella infection induces inflammasome activation in human intestinal
epithelial cells.
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WT Caco-2 cells (A – C, E) or WT T84 cells (D, F) were infected with PBS (Mock), WT S.
Typhimurium, or ΔsipB S. Typhimurium. (A, D – F) Release of IL-18 and IL-8 into the supernatant
were measured by ELISA at 6hpi. (B) Lysates and supernatants collected 6hpi were
immunoblotted for IL-18 and β-actin. (C) Cell death was measured as percentage uptake of
propidium iodide, normalized to cells treated with 1% Triton. ns – not significant, ** p < 0.01, ****
p < 0.0001 by Dunnett’s multiple comparisons test (A, E), or by unpaired t-test (D, F). Data shown
are representative of at least three independent experiments.

3.4.2 Bacterial T3SS ligands do not activate the inflammasome in human intestinal
epithelial cells
We next sought to determine what bacterial ligands activate the inflammasome in human
IECs. The Salmonella SPI-1 T3SS inner rod protein (PrgJ), the SPI-1 T3SS needle protein (PrgI),
and flagellin activate the NAIP/NLRC4 inflammasome in both murine and human macrophages,
(Rauch et al., 2016; Zhao et al., 2016). Given that Salmonella grown under SPI-1-inducing
conditions triggered inflammasome activation in human IECs (Fig. 3.1), we hypothesized that this
inflammasome activation is due to NAIP-mediated recognition of Salmonella T3SS ligands. First,
we asked whether Salmonella T3SS ligands are sufficient to activate the inflammasome in human
IECs. We used the Gram-positive bacterium Listeria monocytogenes to deliver Salmonella T3SS
ligands into IECs. We have previously successfully used the Listeria system to deliver Salmonella
T3SS ligands into the cytosol of human macrophages to examine NAIP inflammasome activation
(Reyes Ruiz et al., 2017). Upon infecting host cells, Listeria escapes from its pathogen-containing
vacuole into the host cell cytosol, where it expresses the protein ActA on its surface. Our
Salmonella ligands of interest are translationally fused to the N-terminus of a truncated ActA so
that upon infection with Listeria, the Salmonella ligand is delivered into the host cell cytosol
(Reyes Ruiz et al., 2017; Sauer et al., 2011). Human macrophages infected with Listeria
expressing the Salmonella SPI-1 T3SS inner rod PrgJ or needle PrgI undergo robust
inflammasome activation (Reyes Ruiz et al., 2017). In contrast, human macrophages infected
with Listeria expressing the Salmonella SPI-2 T3SS inner rod SsaI fail to undergo inflammasome
activation (Reyes Ruiz et al., 2017). To determine if these bacterial ligands can activate the

99

inflammasome in human IECs, we infected Caco-2 and T84 cells with WT Listeria (Lm) or Listeria
expressing PrgJ, PrgI, or SsaI (Fig. 3.2A, B). Surprisingly, IECs infected with low or high MOIs of
Listeria expressing the bacterial ligands failed to induce inflammasome activation that was above
that observed with WT Lm infection, as measured by IL-18 release (Fig. 3.2A, B; Fig. 3.3A, B).
Polarized Caco-2 cells and C2Bbe1 cells, a Caco-2 subtype infected with Listeria expressing the
SPI-1 inner rod PrgJ also cells failed to undergo inflammasome activation above that observed in
cells infected with WT Lm (Fig. 3.3C, D). Collectively, we failed to observe inflammasome
activation in a variety of different human IEC lines in response to bacterial T3SS ligands delivered
using Listeria.
As we did not observe inflammasome activation by bacterial T3SS ligands delivered
using Listeria, we tested a second delivery method, the Bacillus anthracis toxin system, to deliver
these bacterial ligands into the cytosol of IECs (von Moltke et al., 2012). The anthrax toxin
delivery system contains two subunits: a protective antigen (PA) that creates a pore in the host
endosomal membrane and a truncated lethal factor (LFn) that is delivered through the PA pore
into the cytosol. Our T3SS ligands of interest are translationally fused to the N-terminal domain of
the B. anthracis LFn and are delivered into the host cell cytosol upon treatment with both PA and
LFn (collectively referred to as Tox). Using this system, we delivered the Salmonella SPI-1 T3SS
inner rod protein (PrgJTox) into Caco-2 cells (Fig. 3.4A), polarized Caco-2 cells (Fig. 3.4B),
C2Bbe1 cells (Fig. 3.4C), and T84 cells (Fig. 3.4D) and measured the release of the
inflammasome-dependent cytokine IL-18. In all cell types, we failed to observe IL-18 secretion in
response to PrgJTox that was above the PA alone control (Fig. 3.4). Thus, our data indicate that
human IEC lines did not undergo inflammasome activation in response to bacterial T3SS ligands
delivered with the anthrax toxin system.
To determine if this absence of inflammasome responses to T3SS ligands was limited to
immortalized IECs, we delivered flagellin (FlaTox) or the SPI-1 T3SS inner rod PrgJ (PrgJTox)
into human intestinal organoids and measured levels of cell death (Fig. 3.4C). Both human small
intestinal organoids and colonoids failed to undergo cell death when treated with FlaTox or Inner
Rod Tox. As a control, we treated murine organoids with FlaTox or PrgJTox, and in both
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instances, murine organoids underwent robust cell death. Thus, even in human organoids, we
failed to observe inflammasome activation in response to bacterial T3SS ligands. Collectively
these data suggest that under the conditions tested, bacterial T3SS ligands fail to activate the
inflammasome in human IECs.

Figure 3.2: Bacterial T3SS ligands do not activate the inflammasome in human intestinal
epithelial cells.
(A, B) WT Caco-2 (A) or T84 cells (B) were primed for 3h with 100 ng/ml of Pam3CSK4 and
infected with PBS (Mock), WT L. monocytogenes (WT Lm), or L. monocytogenes expressing S.
Typhimurium SPI-1 inner rod (Lm + PrgJ), SPI-1 needle (Lm + PrgI), or SPI-2 inner rod (Lm +
SsaI) at an MOI of 100. Release of IL-18 into the supernatant was measured by ELISA at 16hpi.
L.O.D indicates the limit of detection of the assay. (C) Differentiated intestinal organoids were
treated with FlaTox (PA + LFn-Fla) or PrgJTox (PA + LFn-PrgJ) in media containing propidium
iodide for 4h. Cell death was measured as percentage uptake of propidium iodide, normalized to
organoids treated with 1% Triton. ns – not significant, * p < 0.05, **** p < 0.0001 by Dunnett’s
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multiple comparisons test. Data shown are representative of at least three independent
experiments.
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Figure 3.3: Bacterial T3SS ligands delivered using the Listeria system do not activate the
inflammasome in human intestinal epithelial cells.
WT Caco-2 cells (A), T84 cells (B), polarized Caco-2 cells (C) or C2Bbe1 cells (D) were primed
for 3h with 400 ng/ml of Pam3CSK4 and infected with PBS (Mock), WT L. monocytogenes (WT
Lm), or L. monocytogenes expressing S. Typhimurium SPI-1 inner rod (Lm + PrgJ), SPI-1 needle
(Lm + PrgI), or SPI-2 inner rod (Lm + SsaI) at the following MOIs: Caco-2 = 5; T84 = 25; polarized
Caco-2 = 100; C2Bbe1 = as indicated in graph. Release of IL-18 into the supernatant was
measured by ELISA at 16hpi. ns – not significant, ** p < 0.01, **** p < 0.0001 by Dunnett’s
multiple comparisons test. L.O.D indicates the limit of detection of the assay. (B) and (D) were
conducted in duplicate wells. Data shown represent one independent experiment.

Figure 3.4: Bacterial T3SS ligands delivered using the anthrax toxin system do not activate
the inflammasome in human intestinal epithelial cells.
WT Caco-2 cells (A), polarized Caco-2 cells (B), C2Bbe1 cells (C), or T84 cells (D) were primed
for 3h with 400 ng/ml of Pam3CSK4. Cells were then treated with PBS (Mock), PA alone,
LFnPrgJ alone, or PA+LFnPrgJ (PrgJTox) for 16 hours. Release of IL-18 into the supernatant
was measured by ELISA. For polarized Caco-2s (B), supernatants were collected from both
apical and basolateral compartments. L.O.D indicates the limit of detection of the assay. (A, C, D)
were conducted in duplicate wells. Data shown are from one independent experiment (A, D) or
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are representative of two independent experiments (B, C). ns – not significant, ** p < 0.01 by
Dunnett’s multiple comparisons test.

3.4.3 Human intestinal epithelial cells express low levels of NAIP and NLRC4
compared to human myeloid cells
Given the importance of the NAIP/NLRC4 inflammasome in detecting and responding to
Salmonella and bacterial T3SS ligands in murine IECs as well as murine and human
macrophages, our findings that human IECs do not respond to T3SS ligands in human IECs were
surprising. To determine if expression of NAIP and NLRC4 in human IECs is comparable to
human myeloid cells, we compared NAIP and NLRC4 mRNA levels in Caco-2 cells, T84 cells,
and human THP-1 macrophages (Fig. 3.5A, B). Both NAIP and NLRC4 mRNA expression were
very low in human IECs compared to human macrophages. To determine if this low expression
was limited to immortalized cell lines, we compared expression of NAIP and NLRC4 in human
peripheral blood mononuclear cells (PBMCs) and human small intestinal organoids (Fig. 3.5C, D).
We found that like human IEC lines, small intestinal organoids also express very low levels of
NAIP and NLRC4 compared to human PBMCs. Collectively, these data suggest that human IECs
express very low levels of NAIP/NLRC4, and this may partially explain why human IECs do not
mount inflammasome responses to T3SS ligands.
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Figure 3.5: Human intestinal epithelial cells express low levels of NAIP/NLRC4 compared
to human myeloid cells.
Relative mRNA expression of NAIP and NLRC4 compared to the housekeeping control HPRT or
RPLP0 as measured by qRT-PCR in (A, B) Caco-2 cells, T84 cells, and THP-1 macrophages,
and in (C, D) human peripheral blood mononuclear cells (PBMCs) and human small intestinal
organoids. Data shown are representative of at least three independent experiments.

3.4.4 NAIP is not required for inflammasome activation in response to Salmonella
infection of human intestinal cells
In mice and human macrophages, NAIP/NLRC4 contributes to inflammasome responses
during Salmonella infection (Miao, Mao, et al., 2010; Zhao et al., 2016). To formally test if the
inflammasome activation we observe in human IECs infected with Salmonella (Fig. 3.1) requires
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NAIP, we used the Clustered Regularly Interspersed Palindromic Repeat (CRISPR) system, in
conjunction with the RNA-guided exonuclease Cas9, to disrupt NAIP in Caco-2 cells (Fig. 3.6).
We sequenced two independent single cell clones of NAIP-/- Caco-2s (NAIP-/- #7, NAIP-/- #8) to
confirm that they contain mutant alleles (Fig. 3.6). Caco-2s are polyploid, and we therefore found
multiple mutant alleles for each CRISPR clone we sequenced (Fig. 3.6). For the two NAIP-/clones, all of the changes resulted in a premature stop codon (Fig. 3.6).
To test whether inflammasome activation during Salmonella infection of human IECs
requires NAIP, we infected WT or NAIP-/- Caco-2s with WT Stm or ∆sipB Stm and assayed for
inflammasome activation by measuring IL-18 release and PI uptake (Fig. 3.7). As expected, WT
Caco-2s infected with WT Stm released significantly increased levels of IL-18 and underwent cell
death (Fig. 3.7) and this response was dependent on the presence of the SPI-1 T3SS, as cells
infected with ∆sipB Stm failed to undergo inflammasome activation (Fig. 3.7). Surprisingly, in
NAIP-/- Caco-2s infected with WT Stm, we did not observe a decrease in inflammasome activation
compared to WT Caco-2s. Both WT and NAIP-/- Caco-2s secreted similar levels of the
inflammasome-independent cytokine IL-8 (Fig. 3.7). Overall, these data suggest that NAIP is not
required for inflammasome responses to Salmonella infection in human IECs.
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Figure 3.6: Validation of NAIP mutant Caco-2 cells generated with CRISPR/Cas9 genome
editing.
Sequence alignments of WT Caco-2s, NAIP-/- #7 Caco-2s, and NAIP-/- #8 Caco-2s are shown for
multiple alleles. Red text represents the target guide RNA sequence and red boxes represent the
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mutated region. Purple text represents the predicted impact of the mutation on the amino acid
sequence.

Figure 3.7: NAIP is not required for inflammasome activation in response to Salmonella
infection of human intestinal epithelial cells.
WT or two independent single cell clones of NAIP-/- Caco-2 cells were infected with PBS (Mock),
WT S. Typhimurium, or ΔsipB S. Typhimurium for 6hrs. (A, C) Release of IL-18 or IL-8 into the
supernatant was measured by ELISA. (C) Cell death was measured as percentage uptake of
propidium iodide, normalized to cells treated with 1% Triton. (A, C) ns – not significant, * p < 0.05,
** p < 0.01, *****p < 0.0001 by Dunnett’s multiple comparisons test. Data shown are
representative of at least three independent experiments.

3.4.5 NLRP3 and ASC are not required for inflammasome activation in response to
Salmonella in human intestinal epithelial cells
Since we did not observe a role for the NAIP/NLRC4 inflammasome in responding to
Salmonella grown under SPI-1-inducing conditions in human IECs, we sought to determine what
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other host cytosolic sensor could be responsible for inflammasome activation. One candidate is
the NLRP3 inflammasome, which can be activated by a variety of stimuli during infection,
including potassium efflux (Muñoz-Planillo et al., 2013). In murine macrophages, the NLRP3
inflammasome is thought to be important for late timepoints of Salmonella infection (Broz et al.,
2010). Salmonella infection also activates the NLRP3 inflammasome in human macrophages
(Gram et al., 2021; Man, Hopkins, et al., 2014). To determine if the inflammasome activation we
observed in human IECs is dependent on the NLRP3 inflammasome, we infected WT Caco-2s
that were pre-treated with MCC950, a potent chemical inhibitor of the NLRP3 inflammasome (Coll
et al., 2015) and measured IL-18 release (Fig. 3.8A). As expected, cells treated with the DMSO
control underwent robust inflammasome activation in response to WT Stm infection (Fig. 3.8A).
Interestingly, cells treated with varying concentrations of MCC950 also exhibited similar levels of
inflammasome activation as DMSO-control treated cells (Fig. 3.8A), suggesting that the NLRP3
inflammasome is not required for inflammasome responses to Salmonella in human IECs. We
found that like NAIP and NLRC4, mRNA expression of NLRP3 is also very low in Caco-2 cells
compared to THP-1 macrophages (Fig. 3.8B), which may explain why we do not observe a role
for the NLRP3 inflammasome in human IECs.
In addition to the NAIP/NLRC4 and NLRP3 inflammasomes, there are many other
inflammasomes that can get activated in response to bacterial infections. The majority of these
inflammasomes, including AIM2, IFI16, NLRP3, NLRP6, NLRP7, and pyrin, use an adaptor
protein called ASC to recruit and activate downstream caspases (D. Zheng et al., 2020). To
determine if ASC-dependent inflammasomes participate in the response to Salmonella in human
IECs, we tested if ASC is required for inflammasome activation. Using CRISPR/Cas9, we
disrupted PYCARD, the gene that encodes for ASC, in Caco-2s (Fig. 3.9). We sequence
validated two independent single cell clones of PYCARD-/- Caco-2s (PYCARD-/- #4, PYCARD-/#6) (Fig. 3.9). Most of the mutations resulted in a premature stop codon or the mutated protein
bore no resemblance to the WT protein sequence (Fig. 3.9). mRNA expression of PYCARD was
also significantly abrogated in the KO clones relative to WT Caco-2s (Fig. 3.10A). We did not
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detect any ASC protein expression even in WT Caco-2s, although protein expression was
detectable in THP-1 macrophages (Fig. 3.10B).
We next infected WT or PYCARD-/- Caco-2s with WT Stm or ∆sipB Stm and assayed for
inflammasome activation (Fig. 3.8C, D). As expected, WT Caco-2s infected with WT Stm
released significantly increased levels of IL-18 and underwent cell death (Fig. 3.8C, D). This
response was dependent on the presence of the SPI-1 T3SS, as cells infected with ∆sipB Stm
failed to undergo inflammasome activation (Fig. 3.8C, D). In PYCARD-/- Caco-2s infected with WT
Stm, we did not observe a decrease in inflammasome activation compared to WT Caco-2s.
Importantly, both WT and PYCARD-/- Caco-2s exhibited similar levels of IL-8 release, an
inflammasome-independent cytokine (Fig. 3.8E). Expression of PYCARD mRNA and ASC protein
in Caco-2 cells was very low compared to THP-1 macrophages (Fig. 3.8F, 3.10B). Collectively,
these data indicate that NLRP3 and ASC-dependent inflammasomes are not required for
inflammasome responses to Salmonella infection in human IECs.
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Figure 3.8: NLRP3 and ASC are not required for inflammasome activation in response to
Salmonella infection in human intestinal epithelial cells.
(A) WT Caco-2 cells were primed for 3hrs with 400 ng/ml of Pam3CSK4. One hour prior to
infection, cells were treated with the indicated concentrations of MCC950 or DMSO as a vehicle
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control. Cells were then infected with PBS (Mock) or WT S. Typhimurium for 6hrs. Release of IL18 into the supernatant was measured by ELISA. (B, F) Relative mRNA expression of NLRP3
and PYCARD compared to the housekeeping control HPRT as measured by qRT-PCR in Caco-2
cells and THP-1 macrophages. (C, D, E) WT or two independent single cell clones of PYCARD-/Caco-2 cells were infected with PBS (Mock), WT S. Typhimurium, or ΔsipB S. Typhimurium. (C,
D) Release of IL-18 or IL-8 into the supernatant were measured by ELISA at 6hpi. (E) Cell death
was measured as percentage uptake of propidium iodide, normalized to cells treated with 1%
Triton. (A, C, E) ns – not significant, ** p < 0.01, *** p < 0.001, **** p < 0.0001 by Dunnett’s
multiple comparisons test. Data shown are representative of at least three independent
experiments.
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Figure 3.9: Validation of PYCARD mutant Caco-2 cells generated with CRISPR/Cas9
genome editing.
Sequence alignments of WT Caco-2, PYCARD-/- #4, and PYCARD-/- #6 Caco-2 are shown for
multiple alleles. Red text represents the target guide RNA sequence and red boxes represent the
mutated region. Purple text represents the predicted impact of the mutation on the amino acid
sequence.
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Figure 3.10: Expression of ASC in PYCARD mutant Caco-2 cells generated with
CRISPR/Cas9 genome editing.
(A) Relative mRNA expression of PYCARD compared to the housekeeping control HPRT as
measured by qRT-PCR in WT and PYCARD-/- #4 Caco-2s and PYCARD-/- #6 Caco-2s. (B) WT
THP-1s, WT Caco-2s, PYCARD-/- #4 Caco-2s, and PYCARD-/- #6 Caco-2s lysates were
immunoblotted for ASC and β-actin.

3.4.6 Caspase-1 is partially required for inflammasome activation in response to
Salmonella in human intestinal epithelial cells
Inflammasomes recruit various caspases which can then cleave and process IL-1 and IL18 cytokines and mediate pyroptosis (von Moltke et al., 2013). For example, the murine
NAIP/NLRC4 inflammasome can recruit both caspase-1 and caspase-8 in response to
Salmonella infection of murine IECs (Rauch et al., 2017). In human macrophages, NAIP/NLRC4,
NLRP3, caspase-1, and caspase-8 are all recruited to the same macromolecular complex during
Salmonella infection (Man, Hopkins, et al., 2014). We compared expression of CASP1 mRNA in
human IECs to human myeloid cells (Fig. 3.11A). Although expression of CASP1 mRNA in Caco2 cells is lower than that in THP-1 macrophages, CASP1 expression in Caco-2 cells is still higher
than expression of other inflammasome genes we have assessed so far (e.g. compare axes in
Fig. 3.11A to Fig. 3.5A, 3.5B, 3.8B, 3.8F). Similarly, expression of CASP1 in small intestinal
organoids, although lower than that observed in human PBMCs, is higher than expression of
other inflammasome-related genes (e.g. compare axes in Fig. 3.11B to Fig. 3.5C, 3.5D).
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To test the contribution of caspases to inflammasome responses during Salmonella
infection in human IECs, we pretreated Caco-2 cells with pharmacological inhibitors targeting
caspases of interest (ZVAD: pan-caspase inhibitor; YVAD: inhibitor for caspase-1; and IETD:
inhibitor for caspase-8). We then infected cells with WT Stm or ∆sipB Stm and assayed for
inflammasome activation by measuring IL-18 release (Fig. 3.11C). DMSO-treated cells infected
with WT Stm released IL-18, whereas cells treated with the inhibitors had a significant defect in
IL-18 release. Treatment with ZVAD, the pan-caspase inhibitor, resulted in a lower level of IL-18
release compared to treatment with the caspase-1 inhibitor YVAD or the caspase-8 inhibitor IETD
(Fig. 3.11C). As expected, cells infected with ∆sipB Stm demonstrated no inflammasome
activation regardless of inhibitor treatment (Fig. 3.11C). These results suggest that caspases-1
and -8 are both important for inflammasome responses to Salmonella in human IECs.
Since pharmacological inhibitors targeting caspases can have cross-reactivity with other
caspases, we used CRISPR/Cas9 to disrupt CASP1 in Caco-2 cells (Fig. 3.12, 3.13). We
sequenced and validated two independent single cell clones of CASP1-/- Caco-2s (CASP1-/- #7,
CASP1-/- #12) (Fig. 3.12, 3.13). All mutations resulted in a premature stop codon (Fig. 3.12, 3.13).
We further confirmed decreased mRNA expression of CASP1 in CASP1-/- #7 Caco-2s (Fig.
3.12B). We were unable to detect protein expression in both WT Caco-2s and CASP1-/- #7 Caco2s by western blot (Fig. 3.12C)
To test whether inflammasome activation during Salmonella infection requires caspase-1
in human IECs, we infected WT or CASP1-/- Caco-2s with WT or ∆sipB Stm and assayed for
subsequent inflammasome activation (Fig. 3.11D, E). As expected, WT Caco-2s infected with WT
Stm released significant levels of IL-18 and underwent cell death (Fig. 3.11D, E). This response
was dependent on the presence of the SPI-1 T3SS, as cells infected with ∆sipB Stm failed to
undergo inflammasome activation (Fig. 3.11D). In CASP1-/- Caco-2s infected with WT Stm, we
observed a slight and statistically significant decrease, but not complete abrogation of IL-18
release at 6hpi (Fig. 3.11D). There was also a slight delay in uptake of PI in CASP1-/- #7 Caco-2s
relative to WT Caco-2s (Fig. 3.11E). However, both WT and KO Caco-2s exhibited similar levels
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of IL-8 release, an inflammasome-independent cytokine (Fig. 3.11F). Overall, these data suggest
that caspase-1 is partially required for the inflammasome response to Salmonella infection in
human IECs.
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Figure 3.11: Caspase-1 is partially required for inflammasome activation in response to
Salmonella in human intestinal epithelial cells.
(A, B) Relative mRNA expression of CASP1 compared to the housekeeping control HPRT or
RPLP0 as measured by qRT-PCR in Caco-2 cells, THP-1 macrophages, human peripheral blood
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mononuclear cells (PBMCs), and human small intestinal organoids. (C) WT Caco-2 cells were
primed with 400 ng/ml of Pam3CSK4 for 3h. One hour prior to infection, cells were treated with 20
μM of pan-caspase inhibitor Z-VAD(OMe)-FMK, 25 μM of caspase-1 inhibitor Ac-YVAD-cmk, 20
μM of caspase-8 inhibitor Z-IETD-FMK or DMSO as a vehicle control. Cells were then infected
with PBS (Mock), WT S. Typhimurium, or ΔsipB S. Typhimurium for 6hrs. Release of IL-18 into
the supernatant was measured by ELISA. (D – F) WT or two independent single cell clones of
CASP1-/- Caco-2 cells were infected with PBS (Mock), WT S. Typhimurium, or ΔsipB S.
Typhimurium. (D, F) Release of IL-18 or IL-8 into the supernatant were measured by ELISA at
6hpi. (E) Cell death was measured as percentage uptake of propidium iodide, normalized to cells
treated with 1% Triton. (C, D, F) ns – not significant, ** p < 0.01, **** p < 0.0001 by Dunnett’s
multiple comparisons test. Data shown are representative of at least three independent
experiments.
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Figure 3.12: Validation of CASP1 mutant Caco-2 Clone 7 generated with CRISPR/Cas9
genome editing.
(A) Sequence alignments of WT Caco-2s, and CASP1-/- #7 Caco-2s are shown for multiple
alleles. Red text represents the target guide RNA sequence and red boxes represent the mutated
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region. Purple text represents the predicted impact of the mutation on the amino acid sequence.
(B) Relative mRNA expression of CASP1 compared to the housekeeping control HPRT in WT
Caco-2s and CASP1-/- #7 Caco-2s, as measured by qRT-PCR. (C) WT THP-1s, WT Caco-2s,
CASP1-/- #7 Caco-2 lysates were immunoblotted for ASC and β-actin.

Figure 3.13: Validation of CASP1 mutant Caco-2 Clone 12 generated with CRISPR/Cas9
genome editing.
Sequence alignments of WT Caco-2, and CASP1-/- #12 Caco-2 are shown for multiple alleles.
Red text represents the target guide RNA sequence and red boxes represent the mutated region.
Purple text represents the predicted impact of the mutation on the amino acid sequence.
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3.4.7 Caspase-4 is required for inflammasome responses to Salmonella in human
intestinal epithelial cells
In mice, caspase-1 is thought to be the primary caspase that responds to Salmonella
infection, while a second caspase, caspase-11, serves as a back-up mechanism (Broz et al.,
2010; Crowley et al., 2020). Caspase-11 and its human orthologs caspases-4/5 detect cytosolic
LPS and form the noncanonical inflammasome (Schmid‐Burgk et al., 2015; Shi et al., 2014).
Caspases-4/5 are important for late inflammasome responses to Salmonella infection of human
intestinal epithelial cells, specifically when Salmonella escapes to the cytoplasm from its
Salmonella-containing vacuole (SCV) (Knodler, Crowley, et al., 2014). To test the contribution of
the caspase-4/5 inflammasome earlier during infection and with Salmonella grown under SPI-1inducing conditions, we pretreated Caco-2 cells with siRNA targeting CASP4, CASP5 or both. We
then infected the cells with WT Stm or ∆sipB Stm and assayed for inflammasome activation by
measuring IL-18 release (Fig. 3.14A). As expected, cells treated with a control scrambled siRNA
exhibited IL-18 secretion upon infection with WT Stm, but failed to undergo IL-18 secretion when
infected with ∆sipB Stm (Fig. 3.14A). However, knockdown of CASP4, either alone, or in
conjunction with CASP5, resulted in significant abrogation of IL-18 secretion in cells infected with
WT Stm compared to control siRNA-treated cells, suggesting that caspase-4 is required for
inflammasome activation (Fig. 3.14A). Knockdown of CASP5 alone resulted in a slight decrease
in IL-18 secretion, indicating that while caspase-5 may be playing a role, it is not absolutely
required (Fig. 3.14A). We observed moderately high siRNA-mediated knockdown efficiencies
(Fig. 3.14B). Release of the inflammasome-independent cytokine IL-8 was comparable across
conditions (Fig. 3.14C).
To definitively test the requirement of caspase-4 in inflammasome responses to
Salmonella, we disrupted CASP4 in Caco-2 cells using CRISPR/Cas9 (Fig. 3.15, 3.16). We
sequenced and validated two independent single cell clones of CASP4-/- Caco-2s (CASP4-/- #3,
CASP4-/- #4) (Fig. 3.15). All mutations resulted in a premature stop codon (Fig. 3.15). Both clones
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exhibited decreased mRNA expression of CASP4 and no protein expression relative to WT Caco2s (Fig. 3.16).
To test whether inflammasome activation during Salmonella infection requires caspase-4
in human IECs, we infected WT or CASP4-/- Caco-2s with WT or ∆sipB Stm and assayed for
subsequent IL-18 secretion and cell death as readouts for inflammasome activation (Fig. 3.17).
As expected, WT Caco-2s infected with WT Stm released significant levels of cleaved IL-18 and
underwent cell death (Fig. 3.17A – C, 3.17E). This response was dependent on the presence of
the SPI-1 T3SS, as cells infected with ∆sipB Stm failed to release IL-18 or undergo cell death, as
measured by PI uptake (Fig. 3.17A, E). In contrast to WT Caco-2 cells, CASP4-/- Caco-2s infected
with WT Stm failed to release cleaved IL-18 and exhibited a delay in PI uptake at 4-6 hpi (Fig.
3.17A – C, 3.17E). Interestingly, CASP4-/- Caco-2s began to undergo cell death later in infection,
suggesting that while caspase-4 is required for inducing cell death early in infection, it may not be
required at later timepoints of infection. CASP4-/- cells still released substantial levels of the
inflammasome-independent cytokine IL-8 (Fig. 3.17D). Collectively, these data suggest that
caspase-4 is required for inflammasome response to Salmonella infection in human IECs.
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Figure 3.14: Salmonella infection induces CASP4/5-dependent inflammasome activation in
human intestinal epithelial cells.
WT Caco-2 cells were treated with siRNA targeting CASP4, CASP5, or a control scrambled
siRNA for 72h. Cells were primed with 400 ng/ml of Pam3CSK4 for 3hrs. Cells were then infected
with PBS (Mock), WT S. Typhimurium, or ΔsipB S. Typhimurium for 6hrs. Release of cytokines
IL-18 (A) and IL-8 (C) into the supernatant were measured by ELISA. (B) Knockdown efficiency
was measured by qRT-PCR and normalized to housekeeping gene HPRT, and calculated relative
to control-siRNA-treated cells. ns – not significant, * p < 0.05, **** p < 0.0001 by Tukey’s multiple
comparisons test. Data shown are representative of at least three independent experiments.
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Figure 3.15: Validation of CASP4 mutant Caco-2 cells generated with CRISPR/Cas9
genome editing.
Sequence alignments of WT Caco-2, CASP4-/- #3, and CASP4-/- #4 Caco-2 are shown for
multiple alleles. Red text represents the target guide RNA sequence and red boxes represent the
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mutated region. Purple text represents the predicted impact of the mutation on the amino acid
sequence.

Figure 3.16: Expression of caspase-4 in CASP4 mutant Caco-2 cells generated with
CRISPR/Cas9 genome editing.
(A) Relative mRNA expression of CASP4 compared to the housekeeping control HPRT in WT
Caco-2s, CASP4-/- #3, and CASP4-/- #4 Caco-2s, as measured by qRT-PCR. (B, C) WT Caco-2s,
CASP4-/- #3, and CASP4-/- #4 Caco-2s lysates were immunoblotted for CASP4 and β-actin.
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Figure 3.17: Caspase-4 is required for inflammasome activation in response to Salmonella
infection in human intestinal epithelial cells.
WT or two independent clones of CASP4-/- or CASP1-/- (E only) Caco-2 cells were infected with
PBS (Mock), WT S. Typhimurium, or ΔsipB S. Typhimurium for 6hrs. (A, D) Release of IL-18 or
IL-8 into the supernatant were measured by ELISA at 6hpi. (C) Cell death was measured as
percentage uptake of propidium iodide, normalized to cells treated with 1% Triton. (E) Lysates
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and supernatants collected 6hpi were immunoblotted for IL-18 and β-actin. (A, D) ns – not
significant, *** p < 0.001, **** p < 0.0001 by Dunnett’s multiple comparisons test. Data shown are
representative of at least three independent experiments.

3.4.8 GSDMD-mediated pore formation is required for IL-18 release and PI uptake
in response to Salmonella infection of human intestinal epithelial cells
Active caspases such as caspase-1 and caspase-4 can cleave the pore-forming protein
GSDMD (Kayagaki et al., 2015; Shi et al., 2015). The N-terminal fragment of cleaved GSDMD
inserts into the host cell plasma membrane and oligomerizes to create a pore through which
cellular components such as cleaved IL-1 and IL-18 cytokines can be released (Ding et al., 2016;
He et al., 2015; Liu et al., 2016; Sborgi et al., 2016). These pores eventually cause rupture of the
cell through osmotic flux, resulting in pyroptosis. To determine if pore formation by GSDMD is
required for release of IL-18 and cell death in human IECs infected with Salmonella, we
pretreated Caco-2 cells with disulfiram, which prevents cleaved GSDMD from inserting into the
plasma membrane and thus abrogates pore formation (J. J. Hu et al., 2020). Treatment with
disulfiram led to loss of IL-18 release and PI uptake during Salmonella infection (Fig. 3.18A,
3.18C). Importantly, release of the inflammasome-independent cytokine IL-8 was not affected by
disulfiram treatment (Fig. 3.18B). Collectively, these results suggest that GSDMD-mediated pore
formation is required to observe cytokine release and cell death in response to Salmonella in
human IECs.
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Figure 3.18: GSDMD-mediated pore formation is required for IL-18 release and PI uptake in
response to Salmonella infection in human intestinal epithelial cells.
WT Caco-2 cells were treated with 30 μM disulfiram or DMSO as a vehicle control 1 hour prior to
infection. Cells were then infected with PBS (Mock), WT S. Typhimurium, or ΔsipB S.
Typhimurium. Release of IL-18 (A) and IL-8 (B) into the supernatant were measured by ELISA at
6hpi. (C) Cell death as percentage uptake of propidium iodide, normalized to cells treated with
1% Triton. ns – not significant, * p < 0.05, **** p < 0.0001 by Šídák’s multiple comparisons test.
Data shown are representative of at least three independent experiments.

3.5 Discussion
In this study, we have demonstrated that human IECs undergo inflammasome activation
in response to early infection with SPI-1-expressing Salmonella (Fig. 3.1), but the individual
Salmonella SPI-1 T3SS ligands alone are not sufficient to induce inflammasome activation (Fig.
3.2 – 3.4). Additionally, we found that neither NAIP (Fig. 3.7), nor NLRP3 (Fig. 3.8) are required
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for inflammasome responses during Salmonella infection, and this is likely due to low mRNA
expression of NAIP, NLRC4, and NLRP3 in human IECs and human intestinal organoids (Fig.
3.5, 3.8B). We found that ASC, an adaptor protein that several inflammasomes use to recruit
caspases, is also not required for inflammasome activation (Fig. 3.8), suggesting that
inflammasomes that require ASC for their function are likely not playing a role in human IECs
during Salmonella infection. Interestingly, we found that caspase-1 is partially required for
inflammasome activation in human IECs (Fig. 3.11), leaving the unanswered question of what
upstream sensor is activating caspase-1. Finally, we found that caspase-4 is necessary during
early inflammasome responses to SPI-1-expressing Salmonella (Fig. 3.14, 3.17), and our data
indicate that GSDMD-mediated pore formation is required to observe release of IL-18 and cell
death (Fig. 3.18).
In mice, NAIP/NLRC4 inflammasome activation in IECs is critical for control of
Salmonella infection (Hausmann et al., 2020; Rauch et al., 2017; Sellin et al., 2014). It was
therefore surprising that we found the NAIP/NLRC4 inflammasome to be dispensable in human
IECs during Salmonella infection (Fig. 3.7). The lack of NAIP/NLRC4 activation may be due to
low expression of NAIP and NLRC4 mRNA in human IEC lines as well as human small intestinal
organoids (Fig. 3.5). However, the conditions in which our cultured cells and organoids are
maintained do not entirely mimic physiological conditions. For example, our cultured cells and
organoids are grown under sterile conditions, while IECs within our bodies interact with the
microbiota. Although we attempted to mimic physiological conditions by using various priming
conditions for our assays, we did not observe an effect of priming on NAIP expression (data not
shown). Single cell transcriptome analysis of cells isolated from the ileum, colon, and rectum of
six human donors demonstrate that only a small subset of intestinal cells express NAIP at
detectable levels, while NLRC4 expression is below the limit of detection (Y. Wang et al., 2020).
However, we have previously observed that even low levels of NAIP expression is sufficient to
induce inflammasome activation (Reyes Ruiz et al., 2017). It is therefore possible that a
population of IECs exist that express NAIP and NLRC4 at low levels that may be below the limit
of detection of single-cell transcriptome analysis, but that may be sufficient to activate the
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inflammasome in response to infection under physiological conditions. Indeed, single cell
transcriptome analysis of murine small intestines reveal that expression of NLRC4 is also very
low in murine IECs (Haber et al., 2017), but murine IECs undergo robust NAIP/NLRC4
inflammasome activation despite this (Hausmann et al., 2020; Rauch et al., 2017; Sellin et al.,
2014). IECs form a major barrier site in our bodies, and therefore must balance mounting
inflammatory responses to invading pathogens and maintaining barrier integrity. They may have
evolved to express low levels of NAIP and NLRC4 to avoid overactivation of the inflammasome in
response to the host microbiota. Thus, despite our finding that NAIP/NLRC4 is dispensable in
Caco-2 cells to respond to Salmonella infection, it is possible that under physiological conditions,
this inflammasome still plays an important role during bacterial infection.
A recent study comparing inflammasome responses of human and murine IECs during
Salmonella infection reported that while caspase-1 was required for inflammasome activation in
murine IECs, it was dispensable in inflammasome responses to Salmonella in human IECs (Holly
et al., 2020). We found caspase-1 to be partially required for inflammasome activation in IECs
infected with Salmonella (Fig. 3.11). Variations in our experimental set-up likely explain this
difference in findings. Our Salmonella was grown under SPI-1-inducing conditions, and we
assayed for inflammasome activation at a slightly earlier timepoint. It is possible that caspase-1
plays a role in early inflammasome responses to SPI-1-expressing Salmonella in human IECs,
and is less important at later timepoints when Salmonella has shifted to expressing its SPI-2
T3SS. We also observed decreased inflammasome activation when we treated cells with the
caspase-8 inhibitor IETD (Fig. 3.11), suggesting that caspase-8 may also be playing a role in
inflammasome responses to Salmonella in human IECs. It would be interesting to compare the
relative contribution of these different caspases at various timepoints of infection in human IECs.
The question of what host sensor is acting upstream of caspase-1 remains unknown.
Humans have 22 Nod-like receptors (NLRs) that could serve as potential cytosolic sensors of
bacterial structures and activity. Most of these NLRs do not contain a CARD domain, and would
therefore require an adaptor protein such as ASC to recruit caspases. Given our finding that ASC
is not required for inflammasome activation in human IECs (Fig. 3.8), it is likely that the host
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sensor upstream of caspase-1 contains its own CARD domain. Alternatively, it may interact with a
different CARD-domain containing adaptor protein than ASC. Future studies could focus on
identifying host factors that different caspases interact with during Salmonella infection of human
IECs.
In agreement with previous studies (Holly et al., 2020; Knodler, Crowley, et al., 2014), we
found caspase-4 to be required for inflammasome activation in response to Salmonella in human
IECs (Fig 3.14, 3.17). Additionally, we found that GSDMD-mediated pore formation was required
for observing inflammasome activation (Fig. 3.18). Caspase-4 is activated by intracellular LPS.
Intestinal epithelial cells contain a subpopulation of cytosolic Salmonella that may activate
caspase-4 (Knodler, Crowley, et al., 2014). Importantly, caspase-4 activation restricts bacterial
replication, and specifically restricts replication of cytosolic Salmonella (Holly et al., 2020;
Knodler, Crowley, et al., 2014). How Salmonella escapes into the cytosol remains unknown.
Certain host factors can mediate rupture of pathogen-containing vacuoles and facilitate release of
bacterial ligands into the cytosol. For example, a subfamily of interferon-upregulated GTPases
called guanylate binding proteins (GBPs) can localize to pathogen-containing vacuoles (Kim et
al., 2011). Murine GBPs appear to promote rupture of the Salmonella-containing vacuole (SCV)
(Meunier et al., 2014). Human GBP1 can colocalize to the SCV in macrophages (Fisch et al.,
2019), but it remains unknown whether human GBP1 lead to rupture of the SCV. In human
epithelial cells, GBP1 associates with the surface of cytosolic Salmonella after they escape from
their vacuole, allowing for the recruitment of GBP2-4 and the subsequent recruitment and
activation of caspase-4 in the absence of bacteriolysis (J. C. Santos et al., 2020; Wandel et al.,
2020). It is unclear whether Salmonella’s access into the cytosol is mediated by the bacteria or by
the host. Future studies could explore the mechanism by which cytosolic populations of
Salmonella arise and how they influence inflammasome activation in human IECs.
In mice, inflammasome activation mediates control of Salmonella by restricting bacterial
replication, extruding infected cells, and preventing systemic dissemination of Salmonella
(Hausmann et al., 2020; Knodler, Crowley, et al., 2014; Sellin et al., 2014). Human IECs have
been shown to undergo extrusion, but whether this occurs in a caspase-4-dependent manner
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remains unknown (Knodler et al., 2010). While we know that human IECs and enteroids restrict
bacterial replication in a caspase-4-dependent manner (Holly et al., 2020; Knodler, Crowley, et
al., 2014), it remains unknown if inflammasome activation results in other mechanisms of control
of infection. In mice, IL-18 release during Salmonella infection recruits natural killer (NK) cells that
are critical for early mucosal inflammation responses (Müller et al., 2016). We observe robust
release of the inflammasome-dependent cytokine IL-18, but the downstream role of this cytokine
in human IECs during Salmonella infection has not been explored. Additionally, while our study
focused exclusively on Salmonella infection, it is worth exploring if enteric pathogens with similar
lifestyles to Salmonella, such as Shigella, or ones with different lifestyles, such as the
extracellular pathogen Yersinia, elicit similar responses. WT Shigella infection appears to inhibit
NAIP/NLRC4 inflammasome activation in THP-1 macrophages, but whether it can similarly inhibit
the inflammasome in IECs remains unknown (Mitchell et al., 2020). Future studies that
interrogate downstream consequences of inflammasome activation in human IECs in response to
various enteric pathogens could shed light on human mucosal inflammasome responses to
bacterial pathogens.
Overall, our data indicate that Salmonella infection of human IECs triggers inflammasome
pathways that are distinct from that in mice. Pathways that are activated in mice and important for
control of infection, such as the NAIP/NLRC4 and NLRP3 inflammasomes, were not required for
inflammasome responses in human IECs under the conditions we investigated. Instead,
inflammasome responses in human IECs required caspases-1 and -4. Our findings provide a
foundation for future studies aimed at uncovering the relative contribution of different caspases,
and the downstream responses that they mediate in human IECs.
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CHAPTER 4

4.1 Data Summary
Non-typhoidal Salmonella is one of the leading causes of death from diarrheal disease
world-wide (Majowicz et al., 2010). Most studies investigating innate immune responses to
Salmonella have been conducted in mice. However, differences in disease presentation, as well
as differences in innate immune genes encoded by mice and humans, make it unclear whether
mice fully recapitulate how humans respond to Salmonella infection. Thus, there is a need to
better understand human-specific immune responses to Salmonella. We have been investigating
human innate immune responses to Salmonella infection in human macrophages and human
intestinal epithelial cells (IECs). In this dissertation, we present work that elucidates the cell typespecific role of various inflammasomes in sensing and responding to Salmonella infection.
In Chapter 2, we investigated the role of the NAIP/NLRC4 inflammasome in sensing and
responding to Salmonella infection in human macrophages (Fig. 4.1). We found that while NAIP
and NLRC4 are necessary for mounting inflammasome responses to individual bacterial T3SS
ligands, they were only partially required for mounting inflammasome responses to bacterial
infection. In the context of bacterial infection, human macrophages underwent NAIP/NLRC4-, and
CASP4/5-, and NLRP3-dependent inflammasome activation. We also observed NAIP/NLRC4and NLRP3-mediated restriction of bacterial replication. These findings provide important insight
into how human macrophages sense and respond to Salmonella infection.
In Chapter 3, we explored what inflammasomes are activated in response to Salmonella
infection in human IECs (Fig. 4.2). We found that in contrast to human macrophages, in human
IECs, the NAIP/NLRC4 inflammasome and the NLRP3 inflammasome are both dispensable for
responses to Salmonella infection. Instead, inflammasome activation is mediated partially by
caspase-1, and requires caspase-4. The host sensor upstream of caspase-1 remains unknown,
although it likely does not require the adaptor protein ASC, which we found to also be
dispensable during Salmonella infection of human IECs.
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Collectively, these data highlight key differences between how human macrophages and
human IECs sense and respond to Salmonella infection (Fig. 4.3). Additionally, they shed light on
key differences in inflammasome responses between human cells and murine cells (Fig. 4.3). In
this chapter, we discuss remaining open questions about how inflammasomes sense and
respond to Salmonella infection.

Figure 4.1: Salmonella infection induces NAIP- and NLRP3-, and CASP4/5-dependent
inflammasome activation in human macrophages.
Human macrophages require NAIP/NLRC4 to sense and respond to T3SS bacterial ligands.
NAIP/NLRC4 and NLRP3 are both partially required for inflammasome responses to Salmonella
infection and mediate restriction of bacterial replication, in addition to cytokine release and cell
death. The CASP4/5 inflammasome also contributes to inflammasome responses during
Salmonella infection. Image created with BiorRender.com.

Figure 4.2: Salmonella infection induces NAIP/NLRC4-independent, CASP4-dependent
inflammasome activation in human intestinal epithelial cells (IECs).
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Inflammasome activation occurs in human IECs in response to Salmonella infection. However,
bacterial T3SS ligands fail to activate the inflammasome. The NAIP/NLRC4 and NLRP3
inflammasomes, as well as the inflammasome adaptor protein ASC are all dispensable for
inflammasome responses to Salmonella in human IECs (greyed out). Inflammasome responses
to Salmonella partially requires caspase-1, but the upstream host sensor is not known. Caspase4 is required for inflammasome responses to Salmonella in human IECs. Image created with
BiorRender.com.

Figure 4.3: Current model of inflammasome responses to Salmonella.
In both murine macrophages and IECs (left), Salmonella primarily activates the NAIP/NLRC4
inflammasome. In contrast, human macrophages and IECs engage distinct pathways in response
to Salmonella infection. Human macrophages (center) activate multiple inflammasome pathways,
including the NAIP/NLRC4, NLRP3, and CASP4/5 inflammasomes, while human IECs (right)
activate the CASP4 inflammasome. Image created with BiorRender.com.

4.2 Future Directions: Inflammasome responses to Salmonella in Human
Macrophages
4.2.1 How is the NLRP3 inflammasome activated in human macrophages?
In Chapter 2, we showed that human macrophages undergo NLRP3-dependent
inflammasome activation and restriction of bacterial replication (Fig. 2.8, 2.9, 2.12). However, it
remains unknown what activates NLRP3 in these cells. The NLRP3 inflammasome has a variety
of different agonists, the most common of which is potassium efflux. Another recent study
investigating inflammasome responses to Salmonella in human macrophages concluded that
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Salmonella flagellin can activate the NLRP3 inflammasome (Gram et al., 2021). In contrast, our
findings suggest that inflammasome activation in response to flagellin is entirely dependent on
the NAIP/NLRC4 inflammasome in human macrophages (Fig. 2.3 – 2.5). It is possible that this
discrepancy in findings is due to the type of flagellin used: we used a truncated flagellin that only
contains the C-terminal D0 domain and is therefore not capable of stimulating TLR5 signaling
(Lightfield et al., 2008, 2011). Full-length flagellin can prime cells via TLR5 signaling, leading to
upregulation of inflammasome-related genes, and may subsequently activate the NLRP3
inflammasome. We could test the role of flagellin in activating NLRP3-dependent inflammasome
activation in the context of bacterial infection by infecting WT and NAIP-/- THP-1 macrophages
with a flagellin-deficient strain of Salmonella such as ∆fliCfljB in the presence or absence of
MCC950. If flagellin does mediate NLRP3 activation, we would expect both untreated and
MCC950-treated cells to have comparable levels of inflammasome activation when infected with
∆fliCfljB. WT THP-1 macrophages would have significantly higher levels of activation relative to
NAIP-/- THP-1 macrophages due to NAIP/NLRC4 activation mediated by T3SS ligands. However,
if flagellin does not mediate NLRP3 activation, or if it is not the only Salmonella ligand responsible
for activating the NLRP3 inflammasome, then we would expect to see higher levels of
inflammasome activation in untreated cells compared to MCC950-treated cells infected with
∆fliCfljB.
It is possible that a different Salmonella ligand is responsible for NLRP3 inflammasome
activation. We could use a Salmonella transposon (Tn) mutant library to conduct a screen in
NAIP-/- THP-1 macrophages in the presence or absence of MCC950. We would select for Tn
mutants that abrogate inflammasome activation in DMSO-treated NAIP-/- cells to levels
comparable to MCC950-treated cells as potential candidates. This would suggest that the gene
deleted contributes to NLRP3-mediated inflammasome activation. We could confirm this by
generating a clean deletion of the gene and repeat the assay with the new strain. It is possible
that flagellin as well as additional Salmonella ligands contribute to NLRP3 inflammasome
activation during Salmonella infection of human macrophages. We could use a Tn library that is
generated in the ∆fliCfljB background strain to investigate flagellin-independent NLRP3
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inflammasome activation. A similar screen was conducted in murine bone-marrow derived
macrophages (BMDMs) to identify Salmonella genes that modulate NLRP3 inflammasome
activation (Wynosky-Dolfi et al., 2014). Parallel screens in human macrophages have not been
previously conducted and could shed light on Salmonella NLRP3 agonists in human
macrophages.

4.2.2 How is the CASP4/5 inflammasome activated in human macrophages?
In Chapter 2, we showed that human macrophages undergo CASP4/5-dependent
inflammasome activation (Fig. 2.10). Caspases-4 and -5 are intracellular sensors of LPS (Shi et
al., 2014). Given that Salmonella is traditionally considered a vacuolar pathogen in macrophages,
it remains unclear how Salmonella LPS may be accessing the cytosol. Human IECs contain
cytosolic populations of Salmonella that can activate the CASP4/5 inflammasome. (Knodler,
Crowley, et al., 2014). Whether human macrophages contain similar cytosolic populations is not
known.
We could test if cytosolic populations of Salmonella exist by conducting a chloroquine
resistance assay (Knodler, Nair, et al., 2014). Chloroquine is a drug that is microbicidal in acidic
pH such as that of the Salmonella-containing vacuole (SCV). We can infect cells with Salmonella
and enumerate intracellular colony-forming units (CFUs) in the presence or absence of
chloroquine. CFUs in the presence of chloroquine would provide us with the number of cytosolic
Salmonella, while CFUs in the absence of chloroquine would provide us with the number of total
intracellular Salmonella.
An alternative assay to enumerate cytosolic Salmonella is the phagosome
integrity assay (Meunier & Broz, 2015). In this assay, vacuolar or plasma membranes are
selectively permeabilized using detergents and antibodies are used to detect Salmonella.
Cytosolic Salmonella will be antibody-labeled with permeabilization of the plasma membrane
only, while vacuolar Salmonella will also require permeabilization of the vacuolar membrane.
Flow cytometry or microscopy-based assays can then be used to analyze cytosolic versus
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vacuolar populations. The advantage of this assay is that it provides information at the single-cell
level, whereas the chloroquine resistance assay is a bulk population-based assay.
If a cytosolic population of Salmonella does exist, we would hypothesize that LPS from
cytosolic bacteria activate the CASP4/5 inflammasome. However, it is possible that we might find
human macrophages do not contain cytosolic Salmonella. Intracellular Salmonella in epithelial
cells do not experience as much redox stress as those in macrophages (van der Heijden et al.,
2015). It is therefore possible that Salmonella has evolved to escape into the cytosol in IECs, but
not in macrophages. There are host immune factors such as guanylate binding proteins (GBPs)
that can colocalize to the SCV in mice and promote its rupture, releasing bacterial PAMPs into
the host cell cytosol (Meunier et al., 2014). Human GBP1 can colocalize to the SCV (Fisch et al.,
2019), but it remains unknown if it can promote its rupture. In human epithelial cells, human
GBP1 associates with cytosolic Salmonella and triggers the recruitment of GBP2-4, leading to
downstream caspase-4 activation (J. C. Santos et al., 2020; Wandel et al., 2020). We could
assess the contribution of GBP1 in activating inflammasome responses to Salmonella by
knocking down GBP1 in conjunction with CASP4/5 in NAIP-/- THP-1 macrophages. If GBP1 does
play a role in caspase-4/5-mediated inflammasome activation, we would expect knockdown of
GBP1 to abrogate inflammasome activation. The role of GBP2-4 could also be explored using
similar techniques.
LPS can also access the cytosol through bacterial outer membrane vesicles (OMVs).
LPS in OMVs can activate the caspase-11 inflammasome in mice (J. C. Santos et al., 2018;
Vanaja et al., 2016). We could test the role of Salmonella OMV production in CASP4/5
inflammasome activation by modulating the genes involved in the Salmonella OMV biogenesis
pathway. Hypo- and hypervesiculating strains of Salmonella could be generated, and
inflammasome responses to these strains relative to WT Salmonella could be measured. We
therefore have a variety of different tools at our disposal on both the bacterial and host side to
interrogate how Salmonella activates the CASP4/5 inflammasome in human macrophages.
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4.3 Future Directions: Inflammasome responses to Salmonella in Human
Intestinal Epithelial Cells
4.3.1 Is the NAIP/NLRC4 inflammasome truly dispensable for inflammasome
activation in response to Salmonella in intestinal epithelial cells?
In Chapter 3, we demonstrated that inflammasome activation in response to Salmonella
infection in human IECs does not require NAIP (Fig 3.7). In fact, bacterial T3SS ligands, typical
agonists for NAIP, failed to induce inflammasome activation in both human IECs and intestinal
organoids (Fig. 3.2 – 3.4). Given the importance of the NAIP/NLRC4 inflammasome in sensing
Salmonella in mice as well as human macrophages (Chapter 2), this finding was quite surprising.
It is possible that we did not observe a role for the NAIP/NLRC4 inflammasome because human
IECs and intestinal organoids express very low levels of NAIP and NLRC4 compared to human
myeloid cells (Fig. 3.5). However, murine intestinal cells also express NLRC4 at very low levels,
and yet mice undergo robust NAIP/NLRC4 inflammasome activation (Haber et al., 2017). Singlecell transcriptome analysis of human intestinal samples demonstrate that only a small number of
cells express NAIP. It is therefore possible that we have not captured the physiologically relevant
intestinal cell type to conduct these experiments in. New techniques are emerging to culture rare
intestinal cell types or to better recapitulate the in vivo intestinal environment (Fasciano, Mecsas,
et al., 2019). For example, a protocol was recently described to culture M-cells from organoids
(Fasciano, Blutt, et al., 2019). Such strategies could be explored to better clarify the role of
NAIP/NLRC4 inflammasome in the human intestine.
4.3.2 What is the relative contribution of different caspases for inflammasome activation in
response to Salmonella in human intestinal epithelial cells?
In Chapter 3, we found caspase-1 to be partially required, and caspase-4 to be
absolutely required for inflammasome activation in human IECs during Salmonella infection (Fig.
3.11, 3.15). In addition, we observed decreased inflammasome activation when IECs were
treated with the caspase-8 inhibitor, IETD (Fig. 3.11C), suggesting that caspase-8 may also be
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involved in inflammasome responses to Salmonella. In mice, caspase-8 functions with the
NAIP/NLRC4 inflammasome in the absence of caspase-1 to mediate downstream responses
(Rauch et al., 2017). In human macrophages, caspase-8 has been shown to associate with
NLRP3 and NLRC4 during Salmonella infection (Man, Hopkins, et al., 2014). Inactivating
mutations in human caspase-8 are linked to increased susceptibility to infection, suggesting that
caspase-8 may play an important role in defense against pathogens (Chun et al., 2002). Humans
have a close homolog of caspase-8, caspase-10, but the role of these two caspases in
inflammasome responses to Salmonella in human IECs has not been explored. Different
caspases may be important at distinct timepoints of infection. To determine this, we could
conduct the assays described below at different timepoints following Salmonella infection.
To investigate which caspases are activated during Salmonella infection of human IECs,
we can perform a biotin-VAD pulldown assay. In this assay, we can infect human IECs with
Salmonella and treat them with biotinylated-VAD. Biotinylated-VAD will bind to active caspases.
We can then perform a pull-down using streptavidin, which binds specifically to biotin, and
perform immunoblots for different caspases.
It is possible that various caspases could be working cooperatively. If we observe
multiple active caspases with the biotin-VAD assay, we could perform co-immunoprecipitation
studies to determine if the caspases are recruited to the same complex. For example, if in the
biotin-VAD assay we observe both caspase-1 and caspase-8 are activated during Salmonella
infection, we could use a caspase-1 antibody for immunoprecipitation, and blot for caspase-8. If
we can detect caspase-8, it would suggest that caspase-1 and caspase-8 may be working
together in one complex. In addition to isotype antibody controls, we could conduct these assays
in both WT Caco-2s and in CASP1-/- Caco-2s.
To take a more targeted approach and determine if caspase-8 or caspase-10 are
involved in the inflammasome responses to Salmonella, we could conduct siRNA-mediated
knockdown of CASP8 and CASP10 in WT and CASP1-/- Caco-2s. If caspase-8 or caspase-10 are
involved in the inflammasome response, we would expect to observe a decrease in
inflammasome activation when they are knocked down. If they function downstream of caspase-1
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activation, then we would expect to observe this decrease in WT Caco-2s, but not in CASP1-/Caco-2s. Collectively, these experiments could help elucidate which caspases are important for
inflammasome responses to Salmonella in human IECs.
4.3.3 What is the host sensor upstream of caspase-1 in human intestinal epithelial cells?
Although we observed a partial requirement for caspase-1 in human intestinal epithelial
cells (Fig. 3.11) in Chapter 3, we do not know what upstream host sensor is mediating caspase-1
activation. Given that we corroborated a requirement for caspase-4 for inflammasome activation,
it is possible that caspase-4 serves as the upstream host sensor. Aside from triggering noncanonical NLRP3 inflammasome activation, caspase-4 has not previously been shown to induce
caspase-1 cleavage. We could determine if caspase-4 is a candidate upstream host sensor by
conducting a co-immunoprecipitation using caspase-1 antibody and blotting for caspase-4.
Additionally, we could determine if caspase-4 can induce caspase-1 cleavage by co-expressing
caspase-1 and caspase-4 in HEK293 cells, which do not generally express inflammasome
components. We could transfect these cells with LPS to induce caspase-4 activation, and detect
for caspase-1 activation via immunoblotting and other assays.
There are 22 Nod-like receptors (NLRs) in humans that could serve as potential cytosolic
sensors of Salmonella. However, most of these NLRs do not contain a CARD domain and
therefore cannot recruit caspases directly. These NLRs would require an adaptor protein such as
ASC to recruit caspases. Since we did not observe a role for ASC in inflammasome responses to
Salmonella in human IECs (Fig. 3.8), it is likely that the host sensor upstream of caspase-1
contains its own CARD domain. The only NLRs that contain their own CARD domains are
NLRC4, NOD1, and NOD2. We found NAIP to be dispensable for inflammasome activation in
human IECs, so it is unlikely that the NAIP/NLRC4 inflammasome is the sensor upstream of
caspase-1. However, NOD1 has been shown to bind caspase-1 and promote caspase-1
processing in a human fibrosarcoma cell line upon LPS transfection (Yoo et al., 2002). In mice,
NOD2 associated with NLRP1b and caspase-1 to mediate caspase-1 activation in response to B.
anthracis infection (Hsu et al., 2008). To determine if NOD1 or NOD2 activate caspase-1 in
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human IECs during Salmonella infection, we could perform the same assay described above to
test if caspase-1 co-immunoprecipitates with either NOD1 or NOD2. If we find one or both NLRs
to co-immunoprecipitate with caspase-1, we could perform siRNA-mediated knockdown of NOD1
and NOD2 in WT and CASP1-/- Caco-2s and assay for inflammasome activation in response to
Salmonella infection. If these NLRs are the upstream host sensor, we would expect to observe a
decrease in inflammasome activation in WT cells treated with NOD1/NOD2 siRNA that is
comparable to inflammasome activation in CASP1-/- Caco-2s treated with control siRNA.
To use an unbiased approach and determine what host sensors might be associating
with caspase-1 to mediate its activation, we could perform immunoprecipitation-mass
spectrometry, where we would use a caspase-1 antibody to precipitate the protein complex, and
subsequently perform mass spectrometry to determine what the components in the complex may
be. Determining what the host sensor upstream of caspase-1 can help us better understand what
ligands from the Salmonella side might be activating the inflammasome in human IECs.

4.4 Overarching Questions
4.4.1 How does a single human NAIP sense and respond to multiple bacterial ligands?
One key difference between mice and humans with regards to inflammasome activation
is that mice have multiple NAIPs, and each NAIP specifically recognizes one particular bacterial
ligand. For example, mNAIP1 recognizes the SPI-1 T3SS needle PrgI, mNAIP2 recognizes the
SPI-1 T3SS inner rod PrgJ, and mNAIP5/6 recognize flagellin (Kofoed & Vance, 2011; Rauch et
al., 2016; Rayamajhi et al., 2013; J. Yang et al., 2013; Zhao et al., 2011, 2016). In contrast,
humans only have one NAIP, and this single hNAIP is capable of recognizing all three bacterial
ligands from various Gram-negative bacterial pathogens (Kortmann et al., 2015; Reyes Ruiz et
al., 2017). Like mNAIPs, hNAIP fails to recognize the SPI-2 T3SS inner rod protein SsaI (Miao,
Mao, et al., 2010; Reyes Ruiz et al., 2017). This led to the prevailing model in the field that the
SPI-2 T3SS can evade NAIP/NLRC4-mediated detection. However, in Chapter 2, we found that
the SPI-2 needle protein SsaG is recognized by NAIP/NLRC4, and further demonstrated that
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recognition of bacterial SPI-1 T3SS inner rod, needle, and flagellin proteins required the
NAIP/NLRC4 inflammasome in human macrophages (Fig. 2.3 – 2.5, 2.14 – 2.16). How a single
human NAIP can broadly recognize these T3SS structures from various Gram-negative bacterial
pathogens remains an open question.
The Salmonella SPI-1 T3SS inner rod (PrgJ), SPI-1 T3SS needle (PrgI), SPI-2 T3SS
needle protein (SsaG) and flagellin (FliC) all contain structurally homologous C-terminal helices
(Kubori et al., 2000; Miao, Mao, et al., 2010) (Fig. 2.18). These C-terminal helices have several
conserved hydrophobic amino acid residues (Kubori et al., 2000; Miao, Mao, et al., 2010).
mNAIP2 and mNAIP5 recognize C-terminal leucine residues in the LRR motifs of PrgJ and FliC
respectively (Halff et al., 2012; Lightfield et al., 2008; Tenthorey et al., 2017; J. Yang et al., 2018;
X. Yang et al., 2018). PrgI does not contain these leucine residues, and instead has other
hydrophobic residues such as valine and isoleucine that are important for activating the
inflammasome in human macrophages (J. Yang et al., 2013). SsaG also contains C-terminal
isoleucine residues like PrgI. In contrast, the SPI-2 T3SS inner rod protein SsaI, which does not
activate the inflammasome in human macrophages, does not contain these conserved C-terminal
hydrophobic residues. Thus, these conserved motifs may be important for NAIP to recognize
these bacterial ligands. To determine if these hydrophobic residues enable hNAIP to recognize
bacterial ligands, we could generate mutated versions of each ligand such that they no longer
harbor these conserved residues. We could then test the ability of human NAIP to bind each
mutated ligand relative to the WT ligand by performing co-immunoprecipitation. We could also
express these ligands in WT and NAIP-/- human macrophages and assess inflammasome
activation. If these residues are indeed important for hNAIP to recognize the bacterial ligands, we
would expect loss of binding and inflammasome activation with the mutated ligands relative to the
WT ligands.
The murine NAIPs use their nucleotide-binding domain (NBD)-associated α-helical
domains to detect the conserved residues of their cognate bacterial ligand (Halff et al., 2012;
Lightfield et al., 2008; Tenthorey et al., 2014, 2017; J. Yang et al., 2018; X. Yang et al., 2018).
These domains have evolved under positive selection in both rodents and primates and are what
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confer ligand specificity for the mNAIPs (Tenthorey et al., 2017). Given that hNAIP shares 64%67% amino acid identity with these mNAIP NBD-associated domains, it is possible that hNAIP
also uses the NBD-associated domains to recognize bacterial ligands. We can test this by
generating chimeric NAIPs that contain a mNAIP domain swapped in place of the native hNAIP
domain. We can then determine whether the chimeric NAIPs are capable of binding to PrgJ, PrgI,
FliC, and SsaG, by performing co-immunoprecipitation analysis. We can subsequently assess
inflammasome activation by co-expressing these chimeric NAIPs along with other inflammasome
components in HEK293 cells and treating them with bacterial ligands, and assaying for
inflammasome activation. For example, if the NBD-associated domain in hNAIP confers its ability
to broadly recognize bacterial ligands, we would expect that when the NBD-associated domain of
hNAIP is replaced with that of mNAIP1, the chimeric NAIP would be capable of only recognizing
PrgI, and not the other bacterial ligands. Overall, these studies can help us better understand the
molecular determinants of hNAIP broad recognition of diverse bacterial ligands.
4.4.2 Are there consequences to being a generalist NAIP?
Because hNAIP is capable of sensing different bacterial ligands, it is considered a
generalist NAIP. In contrast, the murine NAIPs are specific to a particular bacterial ligand and are
thus considered specialist NAIPs. The functional consequences of being a generalist NAIP
versus a specific NAIP are currently not known. Having multiple mNAIPs that each sense a
unique ligand may allow mice to better modulate inflammasome responses. For example, some
bacteria such as Legionella pneumophila do not express a T3SS, but do express flagellin. In
mice, this triggers activation of the NAIP5 and/or NAIP6 inflammasomes, but not the NAIP1 or
NAIP2 inflammasomes. Thus, the murine response to Legionella might be less potent than the
response to e.g. Salmonella, which contains both flagellin and T3SS, and is thus able to activate
all four functional murine NAIP/NLRC4 inflammasomes. In contrast, since humans only have one
hNAIP, the inflammasome response might be less fine-tuned to the ligand sensed, and more of
an ON/OFF system.
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We observed higher levels of inflammasome activation in human macrophages in
response to the SPI-1 T3SS needle protein relative to the other NAIP agonists (Fig. 2.3). Thus,
one possible consequence of being a generalist NAIP could be that hNAIP binds the different
bacterial ligands with varying affinities. We could perform bio-layer interferometry and
fluorescence polarization analyses to determine the affinity and binding kinetics of hNAIP to each
bacterial ligand. We could assess the functional consequences of variable binding affinity and
kinetics by determining if the degree of restriction of replication varies depending on the ligand
that is sensed. We could do this by infecting WT and NAIP-/- THP-1 macrophages with Listeria
expressing each bacterial ligand, and assess replication of Listeria. If the needle initiates a more
potent response, we would expect better restriction of the Listeria strain expressing the needle
protein relative to the strains expressing the other ligands in the WT THP-1s.
Another possible disadvantage of being a generalist NAIP may be that hNAIP could bind
its bacterial ligands with lower affinity than the mNAIPs, leading to less potent inflammasome
responses. We could compare inflammasome responses between hNAIP and mNAIP by
complementing our NAIP-/- THP-1 macrophages with a copy of hNAIP or one of the mNAIPs. We
could then deliver bacterial ligands into the host cell cytosol and measure downstream
inflammasome activation and restriction of bacterial replication. By pursuing some of these
assays, we could determine if there are functional consequences to being a generalist NAIP.
4.4.3 How does inflammasome activation promote restriction of bacterial replication?
We observed NAIP- and NLRP3-dependent restriction of bacterial replication in human
macrophages upon Salmonella infection (Fig. 2.14). In addition, caspase-4 mediates restriction of
Salmonella replication in human IECs (Holly et al., 2020; Knodler, Crowley, et al., 2014).
However, the mechanism by which inflammasome activation promotes restriction of bacterial
intracellular replication remains unknown.
In murine macrophages, NAIP5 activation in response to Legionella infection leads to
colocalization of lysosomal markers cathepsin-D and Lamp-1, suggesting that NAIP/NLRC4
inflammasome activation may promote phagolysosomal maturation (Amer et al., 2006; Fortier et
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al., 2007). Whether similar events occur in human macrophages is not known. We could test for
the presence of similar lysosomal markers upon infection of WT and NAIP-/- human macrophages
with Salmonella. We could also determine if a similar process takes place in human IECs by
comparing WT and CASP4-/- Caco-2 cells.
One of the main consequences of inflammasome activation is host cell death, which
helps eliminate Salmonella’s intracellular replicative niche. In mice, pyroptosis induces the
formation of pore-induced intracellular traps (PITs). These PITs entrap bacteria and leave them
susceptible to efferocytosis by neutrophils that are trafficked to the site of infection (Jorgensen et
al., 2016). In mice, NAIP/NLRC4 inflammasome activation also prevents systemic dissemination
of Salmonella to distal organs (Hausmann et al., 2020). However, these events do not explain
how restriction occurs in our in vitro assays. It has been proposed that restriction of cytosolic
Salmonella is mediated by the enzymatic activity of caspase-1 and caspase-11, and occurs
independent of or prior to the onset of cell death (Thurston et al., 2016). We could determine if
pyroptosis is required for restriction of replication by treating cells with the GSDMD inhibitor
disulfiram to prevent pyroptosis, and assaying for restriction of replication. If restriction requires
pyroptosis, we would expect to observe a loss of restriction of replication in cells treated with
disulfiram relative to untreated cells.
In both human and murine IECs, extrusion of infected IECs has also been reported to
contribute to controlling Salmonella burdens (Knodler et al., 2010; Rauch et al., 2017). In mice,
extrusion of IECs relies on the NAIP/NLRC4 inflammasome (Rauch et al., 2017). It remains
unknown what mediates extrusion in human IECs. We could test the requirement of various
inflammasome components for extrusion using the CRISPR/Cas9 knockout cells generated in
Chapter 3. In addition, we could use combinations of siRNA knockdowns and inhibitor treatments
to test if different components function together to mediate extrusion. Overall, these experiments
could help us better understand the mechanism by which bacterial replication might be restricted
in human cells.
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4.4.4 What are the downstream consequences of inflammasome activation?
Aside from cell death, which is discussed in detail in the previous section, the other main
consequence of inflammasome activation is release of proinflammatory cytokines such as IL-1β
and IL-18. These cytokines behave as alarmins and alert neighboring cells of the infection. In
mice, release of IL-1β promotes neutrophil recruitment to the site of infection (R. L. Santos et al.,
2009). Neutrophils may contribute to efferocytosis of bacteria in PITs (Jorgensen et al., 2016). IL18 induces IFN-γ production in natural killer (NK) cells and T-cells recruited to the site of infection
(Müller et al., 2016; R. L. Santos et al., 2009). IFN-γ activates macrophages, making them more
bactericidal. Whether similar events occur downstream of inflammasome activation in humans
has not been investigated as it is challenging to conduct in vivo experiments in humans.
In mice, intestinal NAIP/NLRC4 inflammasome activation also promotes the production of
prostaglandin E2 (Rauch et al., 2017). Whether prostaglandins are produced in human IECs is not
known. We could measure release of prostaglandins upon Salmonella infection of human IECs
using ELISAs. If we do observe prostaglandin production, we could use the CRISPR KO cells
generated in Chapter 3, as well as siRNA and inhibitor treatments, to determine what host
inflammasome components mediate prostaglandin secretion from human IECs. To determine if
prostaglandin production is linked to restriction of bacterial replication, we could treat cells with
non-steroidal anti-inflammatory drugs (NSAIDs), which block the enzymes that produce
prostaglandins, and assess restriction of bacterial replication. If prostaglandin production is
required for restriction, we would expect to see higher bacterial burdens in cells treated with
NSAIDs.
Organoid culturing techniques have advanced in the past few years, and it is possible to
co-culture intestinal organoids with immune cells (Fasciano, Mecsas, et al., 2019). It would be
worthwhile to use these new tools to explore if some of the events that are known to occur in
mice also happen in human cells.
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4.4.5 Why have human macrophages and intestinal epithelial cells evolved such different
mechanisms of responses to Salmonella infection?
A central theme of this dissertation is the cell type-specific inflammasome responses that
we observed during Salmonella infection. In Chapter 2, we showed that human macrophages
engage multiple inflammasome pathways in response to Salmonella infection. Importantly, the
NAIP and NLRP3 inflammasomes mediate restriction of bacterial replication in human
macrophages. In contrast, in Chapter 3, we showed that the NAIP and NLRP3 inflammasomes
are dispensable during Salmonella infection of human IECs. Instead, caspase-4 was required for
inflammasome activation, and it has been previously shown that caspase-4 mediates restriction
of Salmonella replication in human IECs (Holly et al., 2020; Knodler, Crowley, et al., 2014). It is
intriguing that two different cell types have evolved such distinct mechanisms of inflammasome
responses to the same bacterial pathogen.
We observed very low levels of expression of NAIP, NLRC4, and NLRP3 in human IECs
compared to human myeloid cells. This may help explain why we do not observe a role for these
inflammasomes in IECs. It is possible that the cells of the human intestine have evolved to
modulate expression of inflammasome-related genes to avoid overactivation of the
inflammasome. The intestinal epithelium serves as a major barrier site of the body, and
inflammatory responses can damage the integrity of the barrier. IECs might therefore trigger more
muted, modulated inflammasome responses to bacterial pathogens, and thus only engage a
limited set of immune pathways compared to macrophages. It would be interesting to explore if
these two cell types mount such distinct responses to other intestinal bacterial pathogens, such
as Shigella or Yersinia.
It is possible that these two cell types have evolved different mechanisms of responding
to the same pathogen because Salmonella employs distinct mechanisms of pathogenesis and
lifestyles in these two cell types. For example, while IECs have been reported to contain cytosolic
populations of Salmonella, macrophages are thought to harbor vacuolar Salmonella only. It has
been postulated that Salmonella has evolved to escape into the cytosol in IECs. In fact, a recent
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study demonstrated that Salmonella replication in the cytosol of murine IECs promotes its
expansion within the intestine and is required for chronic fecal shedding of Salmonella (Chong et
al., 2021). It is thus possible that human IECs have evolved to engage primarily the caspase-4
inflammasome due to the potential abundance of cytosolic LPS in IECs relative to macrophages.
It remains unknown if there is any crosstalk between human macrophages and IECs. It is
worth investigating if control of bacterial replication is altered if e.g. human macrophages are
cultured in supernatant from infected IECs, or vice versa. Alternatively, we could conduct cocultures of IECs and macrophages as described in the previous section, and determine if different
cytokines are produced by infected cells when they are co-cultured compared to monocultures.
Thus, additional studies are needed to understand why these two cell types have evolved nonredundant mechanisms of inflammasome activation to the same bacterial pathogen.
4.4.6 Why have mice and humans evolved such different mechanisms of responses to
Salmonella infection?
This dissertation has focused on investigating human-specific inflammasome responses.
Most studies on innate immune responses to pathogen are conducted in mice, but it is clear from
our findings that mice and humans can respond very differently to the same pathogen. Both
murine macrophages and murine IECs engage primarily the NAIP/NLRC4 inflammasome during
early Salmonella infection (Rauch et al., 2017; Sellin et al., 2014). In mice, the NLRP3 and
caspase-11 inflammasomes become important at later time points of infection, or as a backup
mechanism (Broz et al., 2010, 2012). In contrast, human macrophages engage both NAIP and
NLRP3 inflammasomes simultaneously, while human IECs only activate the capase-4
inflammasome. Why these two species have evolved such distinct pathways and responses to
the same pathogen remains an open question.
As coprophagic animals living primarily outdoors in the wild, the types of microbes that
mice encounter are likely very different from those that humans encounter. These interactions
with microbes, both commensal and pathogenic, may have shaped different immune response
pathways in mice versus humans. Comparing human inflammasome responses between a
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zoonotic pathogen such as Salmonella Typhimurium to a human-adapted pathogen such as
Salmonella Typhi or Salmonella Paratyphi may prove to be insightful.
It would be interesting to explore inflammasome responses of other mammals and
determine if they too have evolved distinct response pathways. At the genetic level, mice and
humans express a different number of functional inflammasome-related genes. Only rats and
mice have multiple NAIPs, which are a result of gene duplication events (Growney et al., 2000;
Growney & Dietrich, 2000). All other mammals have only one NAIP. Additionally, mice have one
caspase-11, while humans express two orthologs, caspase-4 and caspase-5. Similarly, mice
have one caspase-8, while humans express two orthologs, caspase-8 and caspase-10. These
genetic differences, which may arise due to environmental and lifestyle differences between mice
and humans, may account for the variable inflammasome responses we observed, and
underscores the importance of studying human-specific immune responses.
4.5 Concluding Remarks
The studies conducted in this dissertation provide insight into how human macrophages
and intestinal epithelial cells sense and respond to Salmonella infection. We demonstrated that
human macrophages use the NAIP/NLRC4 inflammasome to sense Salmonella T3SS ligands
and flagellin. In addition to the NAIP/NLRC4 inflammasome, human macrophages also engage
the NLRP3 and CASP4/5 inflammasome pathways. Restriction of Salmonella replication was
mediated by both the NAIP and NLRP3 inflammasomes. In contrast, human IECs do not require
the NAIP or NLRP3 inflammasomes during Salmonella infection. Instead, Salmonella infection
triggers caspase-1- and caspase-4-dependent inflammasome activation in human IECs. Future
studies are necessary to delineate some of the mechanistic details of how specific
inflammasomes are activated in each cell type, and how downstream consequences such as
restriction of replication are mediated.
Importantly, our findings highlight key differences in the response between cell types
(macrophages versus IECs), as well as between species (mice versus humans). This leaves
important conceptual questions regarding how different cell types and species evolve distinct
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mechanisms to respond to the same bacterial pathogen. Additional studies exploring these
pathways in other mammals, and in response to other pathogens, can provide further insight into
how our bodies have evolved to sense and respond to infection.
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